10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number: 001-37763

TURNING POINT BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware	20-0709285
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)

5201 Interchange Way, Louisville, KY	40229
(Address of principal executive offices)	(Zip Code)

(502) 778-4421

(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: not applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	TPB	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☑    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☑    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☑
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ☐    No  ☑

At November 1, 2023, there were 17,604,527 shares outstanding of the registrant’s voting common stock, par value $0.01 per share.

TURNING POINT BRANDS, INC.

TABLE OF CONTENTS

			Page No.
PART I—FINANCIAL INFORMATION
	ITEM 1	Financial Statements (Unaudited)
		Consolidated Balance Sheets as of September 30, 2023, and December 31, 2022	5
		Consolidated Statements of Income for the three months ended September 30, 2023 and 2022	6
		Consolidated Statements of Income for the nine months ended September 30, 2023 and 2022	7
		Consolidated Statements of Comprehensive Income for the three months ended September 30, 2023 and 2022	8
		Consolidated Statements of Comprehensive Income for the nine months ended September 30, 2023 and 2022	8
		Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022	9
		Consolidated Statements of Changes in Stockholders’ Equity for the three months ended September 30, 2023 and 2022	10
		Consolidated Statements of Changes in Stockholders’ Equity for the nine months ended September 30, 2023 and 2022	11
		Notes to Consolidated Financial Statements	12
	ITEM 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	37
	ITEM 3	Quantitative and Qualitative Disclosures about Market Risk	49
	ITEM 4	Controls and Procedures	49
PART II—OTHER INFORMATION
	ITEM 1	Legal Proceedings	50
	ITEM 1A	Risk Factors	50
	ITEM 2	Unregistered Sales of Equity Securities and Use of Proceeds	50
	ITEM 3	Defaults Upon Senior Securities	50
	ITEM 4	Mine Safety Disclosures	50
	ITEM 5	Other Information	51
	ITEM 6	Exhibits	52
	Signatures		53

2

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. (“TPB”), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to:

● declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall;

● our dependence on a small number of third-party suppliers and producers;

● the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost;

● the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;

● failure to maintain consumer brand recognition and loyalty of our customers;

● our reliance on relationships with several large retailers and national chains for distribution of our products;

● intense competition and our ability to compete effectively;

● competition from illicit sources and the damage caused by illicit products to brand equity;

● contamination of our tobacco supply or products;

● uncertainty and continued evolution of the markets for our Creative Distribution Solutions products;

● complications with the design or implementation of our new enterprise resource planning system could adversely impact our business and operations;

● substantial and increasing U.S. regulation;

● regulation or marketing denials of our products by the U.S. Food and Drug Administration, which has broad regulatory powers;

● many of our products contain nicotine, which is considered to be a highly addictive substance;

● requirement to maintain compliance with master settlement agreement escrow account;

● possible significant increases in federal, state and local municipal tobacco- and vapor-related taxes;

● our products are subject to developing and unpredictable regulation, such as court actions that impact obligations;

● an increase in state and local regulation of our Creative Distribution Solutions products has been proposed or enacted;

● an increase in tax of our Creative Distribution Solutions products could adversely affect our business;

● sensitivity of end-customers to increased sales taxes and economic conditions including significant increases in the rate of inflation and other declines in purchasing power;

● uncertainty surrounding FDA compliance policy;

● possible increasing international control and regulation;

● failure to comply with environmental, health and safety regulations;

● imposition of significant tariffs on imports into the U.S.;

● the scientific community’s lack of information regarding the long-term health effects of certain substances contained in some of our products;

● significant product liability litigation;

● our amount of indebtedness;

● the terms of our indebtedness, which may restrict our current and future operations;

● our ability to comply with required disclosure requirements;

● identification of material weaknesses in our internal control over financial reporting, which, if not remediated appropriately or timely, could result in loss of investor confidence and adversely impact our stock price;

● our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger proposals, which may adversely affect the market price of our common stock;

● our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors. These restrictions may affect the liquidity of our common stock and may result in Restricted Investors (as defined in our Certificate of Incorporation) being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights;

● future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us;

3

● we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock;

● our business may be damaged by events outside of our suppliers’ control, such as the impact of epidemics (e.g., coronavirus), political upheavals, or natural disasters;

● adverse impact of climate change;

● our reliance on information technology;

● cybersecurity and privacy breaches;

● failure to manage our growth;

● failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;

● fluctuations in our results;

● exchange rate fluctuations;

● adverse U.S. and global economic conditions;

● departure of key management personnel or our inability to attract and retain talent;

● infringement on or misappropriation of our intellectual property;

● third-party claims that we infringe on their intellectual property; and

● failure to meet expectations relating to environmental, social and governance factors.

4

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Turning Point Brands, Inc.

Consolidated Balance Sheets

(dollars in thousands except share data)

	(unaudited)
	September 30,			December 31,
ASSETS	2023			2022
Current assets:
Cash	$	96,071		$	106,403
Accounts receivable, net of allowances of $59 in 2023 and $114 in 2022		10,493			8,377
Inventories, net		116,926			119,915
Other current assets		23,322			22,959
Total current assets		246,812			257,654
Property, plant, and equipment, net		24,613			22,788
Deferred income taxes		8,190			8,443
Right of use assets		12,060			12,465
Deferred financing costs, net		203			282
Goodwill		136,280			136,253
Other intangible assets, net		81,725			83,592
Master Settlement Agreement (MSA) escrow deposits		27,534			27,980
Other assets		16,526			22,649
Total assets	$	553,943		$	572,106
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	11,237		$	8,355
Accrued liabilities		27,227			33,001
Current portion of long-term debt		48,248			–
Other current liabilities		6			20
Total current liabilities		86,718			41,376
Notes payable and long-term debt		316,573			406,757
Lease liabilities		10,433			10,593
Total liabilities		413,724			458,726
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-		–			–
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 19,912,882 issued shares and 17,596,422 outstanding shares at September 30, 2023, and 19,801,623 issued shares and 17,485,163 outstanding shares at December 31, 2022		199			198
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-		–			–
Additional paid-in capital		117,143			113,242
Cost of repurchased common stock (2,316,460 shares at September 30, 2023 and December 31, 2022)		(78,093	)		(78,093	)
Accumulated other comprehensive loss		(3,855	)		(2,393	)
Accumulated earnings		103,517			78,691
Non-controlling interest		1,308			1,735
Total stockholders’ equity		140,219			113,380
Total liabilities and stockholders’ equity	$	553,943		$	572,106

The accompanying notes are an integral part of the consolidated financial statements.

5

Turning Point Brands, Inc.

Consolidated Statements of Income

(dollars in thousands except share data)

(unaudited)

	Three Months Ended September 30,
	2023			2022
Net sales	$	101,722		$	107,802
Cost of sales		50,100			55,090
Gross profit		51,622			52,712
Selling, general, and administrative expenses		31,385			32,891
Operating income		20,237			19,821
Interest expense, net		3,984			4,802
Investment loss (gain)		2,101			(75	)
Gain on extinguishment of debt		(481	)		–
Income before income taxes		14,633			15,094
Income tax expense		3,767			3,797
Consolidated net income		10,866			11,297
Net gain (loss) attributable to non-controlling interest		35			(239	)
Net income attributable to Turning Point Brands, Inc.	$	10,831		$	11,536
Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.62		$	0.65
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.58		$	0.60
Weighted average common shares outstanding:
Basic		17,595,980			17,749,294
Diluted		20,098,450			21,102,006

The accompanying notes are an integral part of the consolidated financial statements.

6

Turning Point Brands, Inc.

Consolidated Statements of Income

(dollars in thousands except share data)

(unaudited)

	Nine Months Ended September 30,
	2023			2022
Net sales	$	308,273		$	311,621
Cost of sales		155,556			155,646
Gross profit		152,717			155,975
Selling, general, and administrative expenses		94,093			98,779
Operating income		58,624			57,196
Interest expense, net		12,013			15,142
Investment loss		10,980			6,074
Gain on extinguishment of debt		(1,858	)		–
Income before income taxes		37,489			35,980
Income tax expense		9,573			8,706
Consolidated net income		27,916			27,274
Net loss attributable to non-controlling interest		(437	)		(684	)
Net income attributable to Turning Point Brands, Inc.	$	28,353		$	27,958
Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	1.61		$	1.55
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	1.51		$	1.45
Weighted average common shares outstanding:
Basic		17,569,493			18,021,554
Diluted		20,415,786			21,401,485

The accompanying notes are an integral part of the consolidated financial statements.

7

Turning Point Brands, Inc.

Consolidated Statements of Comprehensive Income

(dollars in thousands)

(unaudited)

	Three Months Ended September 30,
	2023			2022
Consolidated net income	$	10,866		$	11,297
Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax of $168 in 2023 and $333 in 2022		(527	)		(1,046	)
Foreign currency translation, net of tax of $0 in 2023 and 2022		270			(160	)
Unrealized loss on derivative instruments, net of tax of $102 in 2023 and $67 in 2022		(320	)		(210	)
		(577	)		(1,416	)
Consolidated comprehensive income		10,289			9,881
Comprehensive gain (loss) attributable to non-controlling interest		35			(295	)
Comprehensive income attributable to Turning Point Brands, Inc.	$	10,254		$	10,176

	Nine Months Ended September 30,
	2023			2022
Consolidated net income	$	27,916		$	27,274
Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax of $108 in 2023 and $934 in 2022		(339	)		(2,940	)
Foreign currency translation, net of tax of $0 in 2023 and 2022		23			(122	)
Unrealized loss on derivative instruments, net of tax of $361 in 2023 and $67 in 2022		(1,136	)		(210	)
		(1,452	)		(3,272	)
Consolidated comprehensive income		26,464			24,002
Comprehensive loss attributable to non-controlling interest		(437	)		(727	)
Comprehensive income attributable to Turning Point Brands, Inc.	$	26,901		$	24,729

The accompanying notes are an integral part of the consolidated financial statements.

8

Turning Point Brands, Inc.

Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)

	Nine Months Ended September 30,
	2023			2022
Cash flows from operating activities:
Consolidated net income	$	27,916		$	27,274
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on extinguishment of debt		(1,858	)		–
Loss (gain) on sale of property, plant, and equipment		34			(8	)
Depreciation and other amortization expense		2,388			2,611
Amortization of other intangible assets		2,315			1,373
Amortization of deferred financing costs		1,795			1,936
Deferred income tax expense (benefit)		694			(431	)
Stock compensation expense		4,660			4,103
Noncash lease income		(48	)		–
Loss on investments		11,162			6,244
Changes in operating assets and liabilities:
Accounts receivable		(2,112	)		(5,030	)
Inventories		3,036			(26,467	)
Other current assets		(1,384	)		1,891
Other assets		(5,110	)		1,211
Accounts payable		2,865			2,074
Accrued liabilities and other		(6,348	)		(392	)
Net cash provided by operating activities	$	40,005		$	16,389
Cash flows from investing activities:
Capital expenditures	$	(4,206	)	$	(6,662	)
Payments for investments		(200	)		(1,000	)
Restricted cash, MSA escrow deposits		–			(10,169	)
Proceeds on the sale of property, plant and equipment		3			63
Net cash used in investing activities	$	(4,403	)	$	(17,768	)
Cash flows from financing activities:
Convertible Senior Notes repurchased	$	(41,794	)	$	–
Proceeds from call options		114			–
Payment of dividends		(3,354	)		(3,259	)
Exercise of options		419			504
Redemption of options		(346	)		(155	)
Redemption of performance restricted stock units		(995	)		(1,228	)
Common stock repurchased		–			(27,032	)
Net cash used in financing activities	$	(45,956	)	$	(31,170	)
Net decrease in cash	$	(10,354	)	$	(32,549	)
Effect of foreign currency translation on cash	$	22		$	(324	)
Cash, beginning of period:
Unrestricted	$	106,403		$	128,320
Restricted		4,929			15,155
Total cash at beginning of period	$	111,332		$	143,475
Cash, end of period:
Unrestricted	$	96,071		$	105,672
Restricted		4,929			4,930
Total cash at end of period	$	101,000		$	110,602
Supplemental schedule of noncash investing activities:
Accrued capital expenditures	$	66		$	57
Accrued consideration for acquisition of investments	$	250		$	–
Supplemental schedule of noncash financing activities:
Dividends declared not paid	$	1,187		$	1,089

The accompanying notes are an integral part of the consolidated financial statements.

9

Turning Point Brands, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

For the Three Months Ended September 30, 2023 and 2022

(dollars in thousands except share data)

(unaudited)

								Cost of			Accumulated
				Common		Additional		Repurchased			Other						Non-
	Voting			Stock,		Paid-In		Common			Comprehensive			Accumulated			Controlling
	Shares			Voting		Capital		Stock			Income (Loss)			Earnings			Interest			Total
Beginning balance July 1, 2023		17,595,579		$	199	$	115,272	$	(78,093	)	$	(3,181	)	$	93,873		$	1,176		$	129,246
Unrealized loss on MSA investments, net of tax of $168		–			–		–		–			(527	)		–			–			(527	)
Unrealized loss on derivative instruments, net of tax of $102		–			–		–		–			(320	)		–			–			(320	)
Foreign currency translation, net of tax of $0		–			–		–		–			173			–			97			270
Stock compensation expense		–			–		1,824		–			–			–			–			1,824
Exercise of options		843			–		13		–			–			–			–			13
Settlement of call options, net of tax of $11		–			–		34		–			–			–			–			34
Dividends		–			–		–		–			–			(1,187	)		–			(1,187	)
Net income		–			–		–		–			–			10,831			35			10,866
Ending balance September 30, 2023		17,596,422		$	199	$	117,143	$	(78,093	)	$	(3,855	)	$	103,517		$	1,308		$	140,219
Beginning balance July 1, 2022		17,890,441		$	198	$	110,563	$	(68,287	)	$	(2,064	)	$	85,641		$	1,880		$	127,931
Unrealized loss on MSA investments, net of tax of $333		–			–		–		–			(1,046	)		–			–			(1,046	)
Unrealized loss on derivative instruments, net of tax of $67		–			–		–		–			(210	)		–			–			(210	)
Foreign currency translation, net of tax of $0		–			–		–		–			(104	)		–			(56	)		(160	)
Stock compensation expense		–			–		1,442		–			–			–			–			1,442
Exercise of options		3,053			–		29		–			–			–			–			29
Performance restricted stock units issuance		835			–		–		–			–			–			–			–
Cost of repurchased common stock		(307,207	)		–		–		(7,614	)		–			–			–			(7,614	)
Dividends		–			–		–		–			–			(1,089	)		–			(1,089	)
Net income		–			–		–		–			–			11,536			(239	)		11,297
Ending balance September 30, 2022		17,587,122		$	198	$	112,034	$	(75,901	)	$	(3,424	)	$	96,088		$	1,585		$	130,580

The accompanying notes are an integral part of the consolidated financial statements.

10

Turning Point Brands, Inc.

Consolidated Statements of Changes in Stockholders’ Equity  

For the Nine Months Ended September 30, 2023 and 2022

(dollars in thousands except share data)  

(unaudited)

												Accumulated
				Common		Additional			Cost of			Other						Non-
	Voting			Stock,		Paid-In			Repurchased			Comprehensive			Accumulated			Controlling
	Shares			Voting		Capital			Common Stock			Income (Loss)			Earnings			Interest			Total
Beginning balance January 1, 2023		17,485,163		$	198	$	113,242		$	(78,093	)	$	(2,393	)	$	78,691		$	1,735		$	113,380
Unrealized gain on MSA investments, net of tax of $108		–			–		–			–			(339	)		–			–			(339	)
Unrealized loss on derivative instruments, net of tax of $361		–			–		–			–			(1,136	)		–			–			(1,136	)
Foreign currency translation, net of tax of $0		–			–		–			–			13			–			10			23
Stock compensation expense		–			–		4,660			–			–			–			–			4,660
Exercise of options		30,214			–		419			–			–			–			–			419
Redemption of options		(15,985	)		–		(346	)		–			–			–			–			(346	)
Performance restricted stock units issuance		140,324			1		77			–			–			–			–			78
Performance restricted stock units redeemed		(43,294	)		–		(995	)		–			–			–			–			(995	)
Settlement of call options, net of tax of $28		–			–		86			–			–			–			–			86
Dividends		–			–		–			–			–			(3,527	)		–			(3,527	)
Net income		–			–		–			–			–			28,353			(437	)		27,916
Ending balance September 30, 2023		17,596,422		$	199	$	117,143		$	(78,093	)	$	(3,855	)	$	103,517		$	1,308		$	140,219
Beginning balance January 1, 2022		18,395,476		$	197	$	108,811		$	(48,869	)	$	(195	)	$	71,460		$	2,312		$	133,716
Unrealized loss on MSA investments, net of tax of $934		–			–		–			–			(2,940	)		–			–			(2,940	)
Unrealized loss on derivative instruments, net of tax of $67		–			–		–			–			(210	)		–			–			(210	)
Foreign currency translation, net of tax of $0		–			–		–			–			(79	)		–			(43)			(122	)
Stock compensation expense		–			–		4,103			–			–			–			–			4,103
Exercise of options		35,394			–		504			–			–			–			–			504
Redemption of options		–			–		(155	)		–			–			–			–			(155	)
Performance restricted stock units issuance		75,345			1		(1	)		–			–			–			–			–
Performance restricted stock units redeemed		–			–		(1,141	)		–			–			–			–			(1,141	)
Redemption of restricted stock units		–			–		(87	)		–			–			–			–			(87	)
Cost of repurchased common stock		(919,093	)		–		–			(27,032	)		–			–			–			(27,032	)
Dividends		–			–		–			–			–			(3,330	)		–			(3,330	)
Net income		–			–		–			–			–			27,958			(684	)		27,274
Ending balance September 30, 2022		17,587,122		$	198	$	112,034		$	(75,901	)	$	(3,424	)	$	96,088		$	1,585		$	130,580

The accompanying notes are an integral part of the consolidated financial statements.

11

Turning Point Brands, Inc.

Notes to Consolidated Financial Statements

(dollars in thousands, except where designated and per share data)

Note 1. Description of Business and Basis of Presentation

Description of Business

Turning Point Brands, Inc. and its subsidiaries (collectively referred to herein as the “Company,” “we,” “our,” or “us”) is a leading manufacturer, marketer and distributor of branded consumer products. The Company sells a wide range of products to adult consumers consisting of staple products with its iconic brands Zig-Zag^® and Stoker’s^® and its next generation products to fulfill evolving consumer preferences. Its segments are led by its core, proprietary brands: Zig-Zag^® and CLIPPER^® in the Zig-Zag Products segment and Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment. The Company’s products are available in more than 217,000 retail outlets in North America. The Company operates in three segments: (i) Zig-Zag Products, (ii) Stoker’s Products, and (iii) Creative Distribution Solutions (formerly known as NewGen).

Basis of Presentation

The accompanying unaudited, interim, consolidated financial statements have been prepared in accordance with the accounting practices described in the Company’s audited, consolidated financial statements as of and for the year ended December 31, 2022. In the opinion of management, the unaudited, interim, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods presented. Such adjustments, other than nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, 2022. The accompanying interim, consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the United States (“GAAP”) with respect to annual financial statements.

Note 2. Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries, all of which are wholly-owned, and variable interest entities (“VIEs”) for which the Company is considered the primary beneficiary. All significant intercompany transactions have been eliminated.

Revenue Recognition

The Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606), which includes excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns and incentives, upon delivery of goods to the customer – at which time the Company’s performance obligation is satisfied - at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. The Company excludes from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on smokeless tobacco, cigars or vaping products billed to customers).

The Company records an allowance for sales returns, based principally on historical volume and return rates, which is included in accrued liabilities on the consolidated balance sheets. The Company records sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction in revenues (a portion of which is based on amounts estimated to be due to wholesalers, retailers and consumers at the end of the period) based principally on historical volume and utilization rates. Expected payments for sales incentives are included in accrued liabilities on the consolidated balance sheets.

12

A further requirement of ASC 606 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company’s management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16, “Segment Information”. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.

Shipping Costs

The Company records shipping costs incurred as a component of selling, general, and administrative expenses. Shipping costs incurred were approximately $5.1 million and $5.8 million for the three months ending September 30, 2023 and 2022, respectively. Shipping costs incurred were approximately $17.0 million and $17.9 million for the nine months ending September 30, 2023 and 2022, respectively.

Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out (“FIFO”) method. Leaf tobacco is presented in current assets in accordance with standard industry practice, notwithstanding the fact that such tobaccos are carried longer than one year for the purpose of curing.

Fair Value

GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

The three levels of the fair value hierarchy under GAAP are described below:

● Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.

● Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

Derivative Instruments

The Company enters into foreign currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging. Under the Company’s policy, the Company may hedge up to 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed twelve months. The Company may also, from time to time, hedge up to 100% of its non-inventory purchases (e.g. production equipment) in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are reclassified from other comprehensive income into inventory as the related inventories are received and are transferred to net income as inventory is sold. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

13

Risks and Uncertainties

Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others, labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In a number of states, targeted flavor bans have been proposed or enacted legislatively or by the administrative process. Depending on the number and location of such bans, that legislation or regulation could have a material adverse effect on the Company’s financial position, results of operations or cash flows. The U.S. Food and Drug Administration (“FDA”) continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing, and ultimate implementation of such measures remain unclear.

The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of Creative Distribution Solutions products due to malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

Master Settlement Agreement (MSA):  Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General) and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. Such companies are entitled to direct the investment of the escrowed funds and withdraw any appreciation but cannot withdraw the principal for twenty-five years from the year of each annual deposit, except to withdraw funds deposited pursuant to an individual state’s escrow statute to pay a final judgement to that state’s plaintiffs in the event of such a final judgement against the Company. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy to record amounts on deposit in the escrow account for prior years as a non-current asset. As of September 30, 2023, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $27.5 million. At December 31, 2022, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.0 million. The Company discontinued its generic category of MYO in 2019 and its Zig-Zag branded MYO cigarette smoking tobacco in 2017. Thus, pending a change in MSA legislation, the Company has no remaining product lines covered by the MSA and will not be required to make future escrow deposits. We expect to begin withdrawal of the funds deposited beginning in 2024 so long as these deposits do not become subject to litigation under the MSA-related statutes.

The Company has chosen to invest a portion of the MSA escrow, from time to time, in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity.

14

Fair values for the U.S. Governmental agency obligations are Level 2 in the fair value hierarchy. The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

	As of September 30, 2023							As of December 31, 2022
			Gross			Estimated				Gross			Estimated
			Unrealized			Fair				Unrealized			Fair
	Cost		Losses			Value		Cost		Losses			Value
Cash and cash equivalents	$	1,929	$	–		$	1,929	$	1,929	$	–		$	1,929
U.S. Governmental agency obligations (unrealized position < 12 months)		–		–			–		10,226		(1,251	)		8,975
U.S. Governmental agency obligations (unrealized position > 12 months)		30,144		(4,539	)		25,605		19,918		(2,842	)		17,076
	$	32,073	$	(4,539	)	$	27,534	$	32,073	$	(4,093	)	$	27,980

	As of
	September 30, 2023
Less than one year	$	2,200
One to five years		10,238
Five to ten years		15,751
Greater than ten years		1,955
Total	$	30,144

The following shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of
Sales Year	September 30, 2023		December 31, 2022
1999	$	211	$	211
2000		1,017		1,017
2001		1,673		1,673
2002		2,271		2,271
2003		4,249		4,249
2004		3,714		3,714
2005		4,553		4,553
2006		3,847		3,847
2007		4,167		4,167
2008		3,364		3,364
2009		1,619		1,619
2010		406		406
2011		193		193
2012		199		199
2013		173		173
2014		143		143
2015		101		101
2016		91		91
2017		82		82
Total	$	32,073	$	32,073

15

FDA: On June 22, 2009, the Family Smoking Prevention and Tobacco Control Act (the “FSPTCA”) authorized the FDA to immediately regulate the manufacturing, sale, and marketing of four categories of tobacco products – cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. On August 8, 2016, the FDA deeming regulation became effective. The deeming regulation gave the FDA the authority to also regulate cigars, pipe tobacco, e-cigarettes, vaporizers, and e-liquids as “deemed” tobacco products under the FSPTCA.

The FDA currently assesses tobacco product user fees on six classes of regulated tobacco products and computes user fees using a methodology similar to the methodology used by the U.S Department of Agriculture to compute the Tobacco Transition Payment Program (“TTPP,” also known as the “Tobacco Buyout”) assessment. First, the total, annual, congressionally established user fee assessment is allocated among the various classes of tobacco products using the federal excise tax weighted market share of tobacco products subject to regulation. Then, the assessment for each class of tobacco products is divided among individual manufacturers and importers.

In August 2016, the FDA’s regulatory authority under the Tobacco Control Act was extended to all tobacco products not previously covered, including: (i) certain Creative Distribution Solutions products (such as electronic cigarettes, vaporizers and e-liquids) and their components or parts (such as tanks, coils and batteries); (ii) cigars and their components or parts (such as cigar tobacco and wraps); (iii) pipe tobacco; (iv) hookah products; and (v) any other tobacco product “newly deemed” by the FDA. These “deeming regulations” apply to all products made or derived from tobacco intended for human consumption, but excluding accessories of tobacco products (such as lighters). Accordingly, the FDA has since regulated our cigar and cigar wrap products as well as our vapor products containing tobacco-derived nicotine and products intended or reasonably expected to be used to consume such e-liquids.

Subsequently, on April 14, 2022, the FDA Center for Tobacco Products also obtained jurisdiction over non-tobacco nicotine products (“NTN Products”), including synthetic nicotine. That law subjects NTN Products to the same requirements as tobacco-derived products, including not selling these products to persons under 21 years of age, not marketing these products as modified risk tobacco products without authorization, and not distributing free samples of these products. Additionally, NTN Products became subject to premarket filing requirements. Under the new law, manufacturers were required to file a Premarket Tobacco Application (“PMTA”) by May 14, 2022, in order to continue selling products currently on the market. NTN Products subject of a timely-filed PMTA, and not in receipt of a negative action, were allowed to remain on the market until July 13, 2022, at which time these products became subject to enforcement, similar to tobacco-derived products remaining under review.

A successful PMTA must demonstrate that the subject product is “appropriate for the protection of public health,” taking into account the effect of the marketing of the product on all sub-populations while a Substantial Equivalence Report must demonstrate that a new product either has the same characteristics as its predicate product or different characteristics but does not raise different questions of public health. We submitted premarket filings for certain of our regulated products in order to continue selling these products while they remain under review. We have continued to supplement these applications with additional information and have responded to information requests from the FDA; however, there can be no guarantee that the FDA will accept such amendments and responses or that the applications will meet the standard of “appropriate for the protection of public health” or “substantially equivalent,” as appropriate. The FDA has indicated its enforcement priority is those applicants who have received negative action on their application, such as a Marketing Denial Order or Refuse to File notification and who continue to illegally sell those unauthorized products, as well as products for which manufacturers failed to submit a marketing application. Despite these stated enforcement priorities, given the FDA’s limited resources we expect that for a period of time there may be a lack of enforcement, which may adversely impact our ability to compete in the marketplace against those who continue to sell unauthorized products. There can be no guarantee that the FDA will not shift its enforcement priorities or that it will increase in ability to enforce against unauthorized products over time.

On October 5, 2021, the FDA finalized two rules related to the Substantial Equivalence process and the Premarket Tobacco Product Application process, respectively, which both became effective November 4, 2021. Both final rules (collectively, the “Rules”) indicate that any new or additional requirements will not retroactively apply to currently pending PMTAs for tobacco and tobacco-derived products; however, the information outlined in the rule remains important to the FDA’s substantive review of an application. The FDA has yet to indicate how it might apply these Rules to NTN Product filings. We believe we have products that meet the Rules and have filed premarket filings supporting a showing of the respective required standards. However, there is no assurance that the FDA’s guidance or regulations will not change, or that the FDA will not prioritize its enforcement in a manner that negatively affects our pending applications, or that unforeseen circumstances will not arise that prevent us from sufficiently supplementing or completing our applications or otherwise increases the amount of time and money we are required to spend to receive all necessary marketing orders. Although we filed many premarket applications in a timely manner, no assurance can be given that the applications will ultimately be successful. This may result in the prioritization of supplementing or completing applications for high priority SKUs in our inventory position, which could adversely impact future revenues generated by lower priority SKUs.

16

In addition, we currently distribute many third-party manufactured vapor products for which we are completely dependent on the manufacturer complying with the premarket filing requirements. There can be no assurance that these third-party products will receive a marketing order or otherwise remain in compliance with relevant legal requirements. While we will take measures to pursue regulatory compliance for our own privately-branded or proprietary vape products that compete with these third-party products, there is no assurance that such proprietary products would be as successful in the marketplace or can fully displace third-party products that are currently being distributed by us, which could adversely affect our results of operations and liquidity. Additionally, FDA has limited resources, which may impact its ability to meaningfully enforce these provisions. This may adversely affect our ability to compete in the marketplace against those who continue to sell unauthorized products; however, regulatory uncertainty in the FDA’s enforcement policies may likewise affect operations or sales of our proprietary products if the FDA’s policies or priorities shift.

On May 4, 2022, the FDA proposed two tobacco product standards related to combusted tobacco products: (1) a ban on menthol as a characterizing flavor in cigarettes; and (2) a ban on all characterizing flavors (including menthol) in cigars. On June 21, 2022, the FDA also issued a proposed product standard related to restricting the level of nicotine in traditional cigarettes. These product standards are required to go through the formal rulemaking process where we have had the opportunity to provide comments with regard to the impact such standards would have on our products. These proposed rules remain pending. The FDA’s policy on these and other regulated products may change or expand over time in ways not yet known and may significantly impact our products or our premarket filings.

Prevent All Cigarette Trafficking Act (“PACT Act”): On December 27, 2020, President Trump signed the Further Consolidated Appropriations Act, 2021, into law. This law included an amendment to the Jenkins Act expanding the definition of “cigarette” to include “electronic nicotine delivery systems,” or ENDS, and required that the United States Postal Service (“USPS”) promulgate regulations clarifying the applicability of the prohibition on delivery sales of cigarettes to ENDS. USPS issued its final rule on October 21, 2021. We have received appropriate shipping exemptions from carrier services we use to carry the affected freight. Failure to comply with the PACT Act could result in significant financial or criminal penalties. To the extent we are unable to respond to, or comply with, these new requirements, we could lose our shipping exemptions, be subject to civil or criminal penalties, or there could be a material adverse effect on our business, results of operations and financial condition. 

Note 3. Derivative Instruments

Foreign Currency

During the nine months ended September 30, 2023, the Company executed various foreign exchange contracts, which met hedge accounting requirements for the purchase of €20.1 million and the sale of €15.2 million.

At September 30, 2023, the Company had foreign currency contracts outstanding for the purchase of €17.1 million and sale of €15.2 million. The foreign currency contracts’ fair value at September 30, 2023, resulted in an asset of $0.1 million included in Other current assets and a liability of $0.5 million included in Accrued liabilities. At December 31, 2022, the Company had foreign currency contracts for the purchase of €18.5 million and sale of €18.5 million. The foreign currency contracts’ fair value at December 31, 2022, resulted in an asset of $1.2 million included in Other current assets and a liability of $0.0 million included in Accrued liabilities.

Note 4. Fair Value of Financial Instruments

The estimated fair value amounts have been determined by the Company using the methods and assumptions described below. However, considerable judgment is required to interpret market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

Cash and Cash Equivalents

Cash and cash equivalents are, by definition, short-term. Thus, the carrying amount is a reasonable estimate of fair value.

Accounts Receivable

The fair value of accounts receivable approximates their carrying value due to their short-term nature.

17

Long-Term Debt

The Company’s Senior Secured Notes (as defined in Note 10) bear interest at a rate of 5.625% per year. As of September 30, 2023, the fair value approximated $226.7 million, with a carrying value of $250 million. As of December 31, 2022, the fair value of the Senior Secured Notes approximated $226.4 million, with a carrying value of $250 million.

The Convertible Senior Notes (as defined in Note 10) bear interest at a rate of 2.50% per year, and the fair value of the Convertible Senior Notes without the conversion feature approximated $112.4 million, with a carrying value of $118.5 million as of September 30, 2023. As of December 31, 2022, the fair value of the Convertible Senior Notes without the conversion feature approximated $139.2 million, with a carrying value of $162.5 million.

See Note 10, “Notes Payable and Long-Term Debt”, for further information regarding the Company’s long-term debt.

Note 5. Inventories

The components of inventories are as follows:

	September 30,		December 31,
	2023		2022
Raw materials and work in process	$	5,512	$	7,283
Leaf tobacco		53,018		43,468
Finished goods - Zig-Zag Products		40,988		42,279
Finished goods - Stoker’s Products		8,729		9,667
Finished goods - Creative Distribution Solutions		7,059		15,431
Other		1,620		1,787
Inventories	$	116,926	$	119,915

The inventory valuation allowance was $4.1 million and $4.5 million as of  September 30, 2023, and December 31, 2022, respectively.

Note 6. Other Current Assets

Other current assets consist of:

	September 30,		December 31,
	2023		2022
Inventory deposits	$	5,357	$	6,395
Insurance deposit		3,000		3,000
Prepaid taxes		1,675		448
Other		13,290		13,116
Total	$	23,322	$	22,959

18

Note 7. Property, Plant, and Equipment

Property, plant, and equipment consists of:

	September 30,			December 31,
	2023			2022
Land	$	22		$	22
Buildings and improvements		3,940			3,096
Leasehold improvements		5,252			5,404
Machinery and equipment		28,837			25,832
Furniture and fixtures		8,138			9,264
Gross property, plant and equipment		46,189			43,618
Accumulated depreciation		(21,576	)		(20,830	)
Net property, plant and equipment	$	24,613		$	22,788

Note 8. Other Assets

Other assets consist of:

	September 30,		December 31,
	2023		2022
Equity investments	$	2,421	$	13,376
Debt security investment		7,765		7,820
Other		6,340		1,453
Total	$	16,526	$	22,649

The Company records its equity investments without a readily determinable fair value, that are not accounted for under the equity method, at cost, with adjustments for impairment and observable price changes.

In July 2021, the Company invested $8.0 million in Old Pal Holding Company LLC (“Old Pal”). In July 2022, the Company invested an additional $1.0 million in Old Pal.  The Company invested in the form of a convertible note which includes additional follow-on investment rights. The accrued interest of $0.2 million from July 2021 to July 2022 was rolled into the convertible note in July 2022 resulting in a total investment of $9.2 million. Old Pal is a leading brand in the cannabis lifestyle space that operates a non-plant touching licensing model. The convertible note bears an interest rate of 3.0% per year and matures July 31, 2026.Interest and principal not paid to date are receivable at maturity. Old Pal has the option to extend the maturity date in one-year increments. The interest rate is subject to change based on Old Pal reaching certain sales thresholds. The weighted average interest rate on the convertible note was 3.0% for the three and nine months ended September 30, 2023. Old Pal has the option to convert the note into shares once sales reach a certain threshold. The conditions required to allow Old Pal to convert the note were not met as of September 30, 2023. Additionally, the Company has the right to convert the note into shares at any time after January 1, 2022. The Company has classified the debt security with Old Pal as available for sale. The Company reports interest income on available for sale debt securities in interest income in our Consolidated Statements of Income. Quarterly, we perform a qualitative assessment to determine if the fair value of the investment could be less than the amortized cost basis.  The fourth quarter 2022 qualitative assessment determined that the fair value of the investment could be less than the amortized cost basis and therefore the Company performed a quantitative assessment of the fair value of the investment.  The fair value as of December 31, 2022 was determined to be $7.9 million based on a Monte Carlo simulation (Level 3).  The Company determined that the impairment was a result of credit related factors and, as such, recorded an allowance for credit losses of $1.4 million which is included in investment loss for the year ended December 31, 2022. In the second quarter of 2023, based on a subsequent quantitative assessment of the fair value using a Monte Carlo simulation, the Company determined the fair value to be $7.7 million and recorded an additional allowance for credit losses of $0.3 million which is included in investment loss for the nine months ended September 30, 2023. The Company has recorded accrued interest receivable of $0.1 million and $0.1 million at September 30, 2023 and December 31, 2022, respectively, in other current assets on our Consolidated Balance Sheets.

19

In April 2021, the Company invested $8.7 million in Docklight Brands, Inc., a pioneering consumer products company with celebrated brands including Marley Natural® cannabis and Marley™ CBD. The Company has additional follow-on investment rights. As part of the investment, the Company has obtained exclusive U.S. distribution rights for Docklight’s Marley™ CBD topical products. In the first quarter of 2023, based on Docklight’s financial results and other operating difficulties, and the decline in the revenue multiples for public companies comparable to Docklight, the Company deemed the investment in Docklight was impaired resulting in the fair value of the Company’s investment decreasing to $3.8 million resulting in a loss of $4.9 million which was recorded for the three months ended March 31, 2023. In the second quarter of 2023, based on a significant change in Docklight’s business model, the Company deemed its investment in Docklight fully impaired resulting in an additional loss of $3.8 million bringing the fair value of the Company’s investment in Docklight to zero. Impairment losses for the Company’s investment in Docklight are recorded in Investment loss on our Consolidated Statements of Income.  Fair value for both periods was determined using a valuation derived from relevant revenue multiples (Level 3).

In October 2020, the Company invested $2.5 million to acquire a 20% stake in Wild Hempettes, LLC, a manufacturer of natural CBD cigarettes designed as the first cigarette-styled CBD pre-roll in the world. The Company has options to increase its stake to a 100% ownership position based on certain milestones. As part of the transaction, the Wild Hempettes joint venture was spun off from Crown Distributing LLC and formed as a vehicle for the Company to be the exclusive distributor of Hempettes™ cigarettes to U.S. bricks and mortar retailers under a profit-sharing arrangement. Effective January 2023, the Company terminated its distribution agreement. The Company accounts for its 20% share of Wild Hempettes profit or loss using the equity method of accounting. In the third quarter of 2023, based on Wild Hempettes financial results, the Company deemed its investment in Wild Hempettes to be other-than-temporarily impaired resulting in a $2.2 million impairment charge included in investment loss for the three and nine months ended September 30, 2023. Fair value for its share of investment in Wild Hempettes was determined using a valuation derived from relevant revenue multiples (Level 3).  As a result of the analysis, the Company’s 20% stake represents a fair value of $0.3 million.

In October 2020, the Company invested $15.0 million in dosist™ (“Dosist”), a global cannabinoid company, with an option to invest an additional $15.0 million on pre-determined terms over the twelve month period ending October 2021. The Company received a warrant exercisable for preferred shares of Dosist that would automatically be exercised upon the changing of certain federal cannabis laws in the United States, rescheduling cannabis and/or permitting the general cultivation, distribution and possession of cannabis. In the fourth quarter 2021, based on the financial results of Dosist and the overall cannabinoid market, the Company deemed its investment was impaired resulting in the fair value decreasing to $7.9 million. In the second quarter of 2022, based on a contemplated sale of the assets of Dosist, the Company deemed its investment was impaired resulting in a further decrease in fair value of the investment to $1.6 million. Fair value was determined using a valuation derived from the contemplated purchase price (Level 3). This resulted in a loss of $6.3 million which is recorded in investment loss for the nine months ended September 30, 2022. Subsequent to the second quarter of 2022 impairment, the contemplated sale of assets did not occur and Dosist entered into a new agreement with a new buyer receiving the assets of Dosist for the assumption of its liabilities. As such, the Company considered its $1.6 million remaining investment to be fully impaired as of December 31, 2022.

Note 9. Accrued Liabilities

Accrued liabilities consist of:

	September 30,		December 31,
	2023		2022
Accrued payroll and related items	$	6,299	$	7,685
Customer returns and allowances		6,384		7,291
Taxes payable		1,259		1,867
Lease liabilities		2,809		3,102
Accrued interest		2,507		7,277
Other		7,969		5,779
Total	$	27,227	$	33,001

Note 10. Notes Payable and Long-Term Debt

Notes payable and long-term debt consists of the following in order of preference:

	September 30,			December 31,
	2023			2022
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		118,541			162,500
Gross notes payable and long-term debt		368,541			412,500
Less deferred finance charges		(3,720	)		(5,743	)
Less current maturities		(48,248	)		–
Notes payable and long-term debt	$	316,573		$	406,757

Senior Secured Notes

On February 11, 2021, the Company closed a private offering (the “Offering”) of $250.0 million aggregate principal amount of its 5.625% senior secured notes due 2026 (the “Senior Secured Notes” or the “Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.The Company used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

20

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any credit facility (as defined in the indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

The Company may redeem the Senior Secured Notes, in whole or in part, at any time on or after February 15, 2023, at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

If the Company experiences a change of control (as defined in the Senior Secured Notes Indenture), the Company must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. The Company was in compliance with all covenants as of September 30, 2023.

The Company incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the effective interest method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, the Company also entered into a new $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). On May 10, 2023, the Company and certain of its subsidiaries, as guarantors, entered into an amendment (the “Amendment”) to the 2021 Revolving Credit Facility (as amended, the “Amended Revolving Credit Facility”).  The Amendment includes certain modifications to the 2021 Revolving Credit Facility relating to the replacement of the London Inter-Bank Offered Rate with a Secured Overnight Financing Rate (“SOFR”) as the interest rate benchmark under the 2021 Revolving Credit Facility and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

Letters of credit are limited to $10.0 million (and are a part of, and not in addition to, the revolving line of credit). The Company has not drawn any borrowings under the Amended Revolving Credit Facility but does have letters of credit of approximately $1.4 million outstanding under the facility as of September 30, 2023. The Amended Revolving Credit Facility will mature on August 11, 2025, if none of the Company’s Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is 91 days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.

Interest is payable on the Amended Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate or the Term SOFR rate, as applicable, plus an applicable margin of 3.50% (with step-downs upon de-leveraging). The Company also has the option to borrow at a rate determined by reference to the base rate.

The obligations under the Amended Revolving Credit Agreement are guaranteed on a joint and several basis by the Guarantors. The Company’s and Guarantors’ obligations under the Amended Revolving Credit Facility are secured on a pari passu basis with the Senior Secured Notes.

21

The Amended Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The Amended Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio (as defined in the Amended Revolving Credit Agreement) of 5.50 to 1.00 (with a step down to 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the Amended Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $5.0 million) in the aggregate outstanding exceeds 35% of the total commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Agreement provides for customary events of default. The Company was in compliance with all covenants as of September 30, 2023.

The Company incurred debt issuance costs attributable to the issuance of the Amended Revolving Credit Facility of $0.5 million which are amortized to interest expense using the effective interest method over the expected life of the Amended Revolving Credit Facility.

On November 7, 2023, in connection with the entry by a subsidiary of the Company in a new asset-backed revolving credit facility, the Company terminated the Amended Revolving Credit Agreement.

2023 ABL Facility

On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a new $75.0 million  asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and LILO Loans. The 2023 ABL Facility includes a $40.0 million accordion feature.  In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.

The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves.  The 2023 ABL Facility also includes a “last in last out” (“LILO”) borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of  (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters on or after the closing date if excess availability shall be less than the greater of (a) 12.5% of the line cap and (b) $9.4 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.4 million for thirty (30) consecutive calendar days; provided that such $9.4 million level shall automatically increase in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.

The 2023 ABL Facility shall mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

Convertible Senior Notes

In July 2019, the Company closed an offering of $172.5 million in aggregate principal amount of its 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes are senior unsecured obligations of the Company.

In the fourth quarter of 2022, a wholly owned subsidiary of the Company repurchased $10.0 million in aggregate principal amount of the Convertible Senior Notes on the open market resulting in a $0.9 million gain on extinguishment of debt. Subsequent principal repurchases occurred in the first, second and third quarters of 2023 for $13.9 million, $15.1 million and $15.0 million, respectively, in aggregate principal amounts resulting in gains on extinguishment of debt of $0.7 million, $0.6 million and $0.6 million, respectively. The repurchased notes continue to be held by our subsidiary and may be resold subject to compliance with applicable securities law. As of September 30, 2023, $118.5 million aggregate principal remains outstanding and held by third parties.

22

The Convertible Senior Notes held by third parties are convertible into approximately 2,216,029 shares of TPB Common Stock under certain circumstances prior to maturity at a conversion rate of 18.6942 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $53.49 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by the Company in excess of pre-determined thresholds of $0.04 per share. Upon conversion, the Company may pay cash, shares of common stock or a combination of cash and stock, as determined by the Company at its discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of September 30, 2023.

The Convertible Senior Notes of $118.5 million as of September 30, 2023, became current in the third quarter of 2023. As discussed above, on November 7, 2023, a wholly-owned subsidiary of the Company entered into the new 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior notes at maturity. As a result, the Company reclassified $70.0 million related to the Convertible Senior Notes from Current portion of long-term debt to Notes payable and long-term debt on the Company’s September 30, 2023 Balance Sheet. Based on current liquidity, free cash flow generation and availability under the 2023 ABL Facility, the Company believes it will have sufficient liquidity to address the maturity of the remaining Convertible Senior Notes.

The Company incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to interest expense using the effective interest method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, the Company entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $53.49 per and a cap price of $82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. The Company paid $20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

Note 11. Leases

The Company’s leases consist primarily of leased property for manufacturing, warehouse, corporate offices and retail space as well as vehicle leases. At lease inception, the Company recognizes a lease right of use asset and lease liability calculated as the present value of future minimum lease payments. In general, the Company does not recognize any renewal periods within the lease terms as there are no significant barriers to ending the lease at the initial term. Lease and non-lease components are accounted for as a single lease component.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for these leases is recognized on a straight-line basis over the lease term.

The components of lease expense consisted of the following:

	Three Months Ended September 30,
	2023		2022
Operating lease cost
Cost of sales	$	125	$	240
Selling, general and administrative		496		348
Variable lease cost (1)		301		235
Short-term lease cost		7		6
Total	$	929	$	829

(1) Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

	Three Months Ended September 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	397	$	332
Total	$	397	$	332

	Nine Months Ended September 30,
	2023		2022
Operating lease cost
Cost of sales	$	382	$	700
Selling, general and administrative		1,520		1,133
Variable lease cost (1)		933		558
Short-term lease cost		20		31
Total	$	2,855	$	2,422

	Nine Months Ended September 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	1,083	$	920
Total	$	1,083	$	920

23

	September 30,		December 31,
	2023		2022
Assets:
Right of use assets - Operating	$	10,332	$	10,967
Right of use assets - Financing		1,728		1,498
Total lease assets	$	12,060	$	12,465
Liabilities:
Current lease liabilities - Operating (2)	$	1,717	$	2,007
Current lease liabilities - Financing (2)		1,092		1,095
Long-term lease liabilities - Operating		9,854		10,243
Long-term lease liabilities - Financing		579		350
Total lease liabilities	$	13,242	$	13,695

(2) Reported within accrued liabilities on the balance sheets.

Note 12. Income Taxes

The Company’s effective income tax rate for the three and nine months ended September 30, 2023 was 25.7% and 25.5%, respectively. The Company’s effective income tax rate for the three and nine months ended September 30, 2022 was 25.2% and 24.2%, respectively, which includes a discrete tax deduction of $0.0 million and $0.7 million, respectively, relating to stock option exercises.

The Company follows the provisions of ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company has determined that the Company did not have any uncertain tax positions requiring recognition under the provisions of ASC 740-10-25. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of interest expense. The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. In general, the Company is no longer subject to U.S. federal and state tax examinations for years prior to 2019.

Note 13. Share Incentive Plans

On March 22, 2021, the Company’s Board of Directors adopted the Turning Point Brands, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2021 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2021 Plan, 1,290,000 shares, plus 100,052 shares remaining available for issuance under the 2015 Equity Incentive Plan (the “2015 Plan”), of TPB Common Stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2021 Plan is scheduled to terminate on March 21, 2031. The 2021 Plan is administered by the compensation committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in the award agreement. As of September 30, 2023, net of forfeitures, there were 276,484 Restricted Stock Units (“RSUs”), 118,519 options and 29,172 Performance-Based Restricted Stock Units (“PRSUs”) granted under the 2021 Plan. There are 965,877 shares available for grant under the 2021 Plan.

On April 28, 2016, the Board of Directors of the Company adopted the 2015 Plan, pursuant to which awards could have been granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provided for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2015 Plan, 1,400,000 shares of TPB Common Stock were reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2015 Plan was scheduled to terminate on April 27, 2026. Upon adoption of the 2021 Plan, the 2015 Plan was terminated, and the Company determined no additional grants would be made under the 2015 Plan. However, all awards issued under the 2015 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2015 Plan. The 2015 Plan was administrated by the Committee.

24

On February 8, 2006, the Board of Directors of the Company adopted the 2006 Equity Incentive Plan (the “2006 Plan”) of North Atlantic Holding Company, Inc., pursuant to which awards may be granted to employees. The 2006 Plan provides for the granting of nonqualified stock options and restricted stock awards to employees. Upon the adoption of the Company’s 2015 Equity Incentive Plan in connection with its IPO, the Company determined no additional grants would be made under the 2006 Plan. However, all awards issued under the 2006 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2006 Plan.

Stock option activity for the 2006, 2015 and 2021 Plans is summarized below:

				Weighted		Weighted
	Stock			Average		Average
	Option			Exercise		Grant Date
	Shares			Price		Fair Value
Outstanding, December 31, 2021		619,835		$	28.51	$	8.70
Granted		114,827			30.58		10.34
Exercised		(40,331	)		12.49		4.08
Forfeited		(11,117	)		32.60		9.35
Outstanding, December 31, 2022		683,214		$	29.74	$	9.24
Granted		77,519			20.71		6.45
Exercised		(30,214	)		13.87		4.37
Forfeited		(65,214	)		27.38		9.11
Outstanding, September 30, 2023		665,305		$	29.67	$	9.14

Under the 2006, 2015 and 2021 Plans, the total intrinsic value of options exercised during the nine months ended September 30, 2023 and 2022, was $0.2 million, and $0.7 million, respectively.

At September 30, 2023, under the 2006 Plan, the exercise price for the 46,824 outstanding options is $3.83 per share, all of which are exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $3.83 is approximately .85 years. The Company estimates the expected life of these stock options is ten years from the date of grant. For the $3.83 per share options, the weighted average fair value of options at the date of grant was determined using the Black-Scholes model with the following assumptions: a ten-year life from grant date, a current share price and exercise price of $3.83, a risk-free interest rate of 3.57%, volatility of 40%, and no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $2.17 per share option granted.

At September 30, 2023, under the 2015 and 2021 Plans, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.

The following table outlines the assumptions based on the number of options granted under the 2015 Plan.

	February 10,			May 17,			March 7,			March 20,			October 24,			March 18,			February 18,			May 3,
	2017			2017			2018			2019			2019			2020			2021			2021
Number of options granted		40,000			93,819			98,100			155,780			25,000			155,000			100,000			12,000
Options outstanding at September 30, 2023		20,000			39,983			51,567			125,834			25,000			80,975			90,253			12,000
Number exercisable at September 30, 2023		20,000			39,983			51,567			125,834			25,000			80,975			63,727			8,040
Exercise price	$	13.00		$	15.41		$	21.21		$	47.58		$	20.89		$	14.85		$	51.75		$	47.76
Remaining lives		3.37			3.63			4.44			5.47			6.07			6.47			7.39			7.59
Risk free interest rate		1.89	%		1.76	%		2.65	%		2.34	%		1.58	%		0.79	%		0.56	%		0.84	%
Expected volatility		27.44	%		26.92	%		28.76	%		30.95	%		31.93	%		35.72	%		28.69	%		29.03	%
Expected life		6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000
Dividend yield		–			–			0.83	%		0.42	%		0.95	%		1.49	%		0.55	%		0.59	%
Fair value at grant date	$	3.98		$	4.60		$	6.37		$	15.63		$	6.27		$	4.41		$	13.77		$	13.06

25

The following table outlines the assumptions based on the number of options granted under the 2021 Plan.

	May 17,			March 14,			April 29,			May 12,
	2021			2022			2022			2023
Number of options granted		7,500			100,000			14,827			77,519
Options outstanding at September 30, 2023		7,500			73,023			14,827			77,519
Number exercisable at September 30, 2023		5,100			24,995			5,042			58,139
Exercise price	$	45.05		$	30.46		$	31.39		$	20.71
Remaining lives		7.63			8.46			8.59			9.62
Risk free interest rate		0.84	%		2.10	%		2.92	%		3.41	%
Expected volatility		31.50	%		35.33	%		35.33	%		34.51	%
Expected life		6.000			6.000			6.000			5.186
Dividend yield		0.63	%		1.01	%		0.98	%		1.61	%
Fair value at grant date	$	13.23		$	10.23		$	11.07		$	6.45

The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $0.2 million and $0.3 million for the three months ended September 30, 2023 and 2022, respectively. The Company recorded compensation expense related to the options of approximately $0.6 million and $0.8 million for the nine months ended September 30, 2023 and 2022, respectively. Total unrecognized compensation expense related to options at September 30, 2023, is $0.3 million, which will be expensed over 0.94 years.

PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period provided the applicable service and performance conditions are satisfied. As of September 30, 2023, there are 456,922 PRSUs outstanding. The following table outlines the PRSUs granted and outstanding as of September 30, 2023.

	March 20,		March 18,		December 28,		February 18,		March 14,		May 4,
	2019		2020		2020		2021		2022		2023
Number of PRSUs granted		92,500		94,000		88,169		100,000		49,996		133,577
PRSUs outstanding at September 30, 2023		77,080		84,360		31,040		87,340		43,525		133,577
Fair value as of grant date	$	47.58	$	14.85	$	46.42	$	51.75	$	30.46	$	22.25
Remaining lives		0.25		1.25		0.25		2.25		3.25		2.50

The Company recorded compensation expense related to the PRSUs of approximately $0.8 million and $0.8 million in the consolidated statements of income for the three months ended September 30, 2023 and 2022, respectively, based on the probability of achieving the performance condition. The Company recorded compensation expense related to the PRSUs of approximately $1.9 million and $2.4 million in the consolidated statements of income for the nine months ended September 30, 2023 and 2022, respectively, based on the probability of achieving the performance condition. Total unrecognized compensation expense related to these awards at September 30, 2023, is $4.4 million which will be expensed over the service periods based on the probability of achieving the performance condition.

26

The Company has granted 228,640 RSUs which are outstanding and vest over one to five years. The following table outlines the RSUs granted and outstanding as of September 30, 2023.

	March 14,		March 14,		April 29,		May 5,		May 5,		May 8,
	2022		2022		2022		2023		2023		2023
Number of RSUs granted		50,004		28,726		4,522		130,873		22,472		20,101
RSUs outstanding at September 30, 2023		42,947		18,961		4,522		130,873		11,236		20,101
Fair value as of grant date	$	30.46	$	30.46	$	31.39	$	22.25	$	22.25	$	21.77
Remaining lives		3.25		1.25		3.25		2.50		0.25		0.60

The Company has recorded compensation expense related to the RSUs based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the RSUs on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the RSUs of approximately $0.8 million and $0.4 million for the three months ended September 30, 2023 and 2022. The Company recorded compensation expense related to the RSUs of approximately $2.2 million and $0.9 million for the nine months ended September 30, 2023 and 2022, respectively. Total unrecognized compensation expense related to RSUs at September 30, 2023, is $3.3 million, which will be expensed over 2.44 years.

Note 14. Contingencies

On October 9, 2020, a purported stockholder of Turning Point Brands, Inc. (“TPB” or the “Company”), Paul-Emile Berteau (the “Plaintiff”), filed a complaint in the Delaware Court of Chancery (the “Court”) relating to the merger of Standard Diversified, Inc. (“SDI”) with a TPB subsidiary (“Merger Sub”)pursuant to the Agreement and Plan of Merger and Reorganization, dated as of April 7, 2020, by and among TPB, SDI and Merger Sub (the “Action”). The complaint purports to assert two derivative counts for breach of fiduciary duty on TPB’s behalf and against the TPB Board of Directors and certain SDI affiliates (collectively, the “Defendants”). The third count also purports to assert a direct claim against TPB and its Board of Directors based on allegations that TPB’s Amended and Restated Bylaws are inconsistent with TPB’s certificate of incorporation. On October 26, 2020, the TPB Board of Directors adopted Amendment No. 1 to TPB’s Amended and Restated Bylaws, which amended the challenged section of the bylaws. On June 30, 2021, the Court granted in part and denied in part the Defendants’ motions to dismiss. Among other things, the Court dismissed TPB director H.C. Charles Diao as a defendant in the action and dismissed the third count of the Plaintiff’s complaint as moot.

The Defendants and the Company deny any wrongdoing but following a mediation in November 2022, the Defendants agreed to settle with the Plaintiff to eliminate the distraction, burden, expense, risks and potential delay of further litigation involving the asserted claims. The parties entered into a Stipulation and Agreement of Compromise, Settlement and Release, dated and filed with the Court on June 27, 2023 (together with the exhibits thereto, the “Settlement Stipulation”).  The material terms of the proposed settlement of the Action include, among other things, that the Defendants’ insurers will pay or cause to be paid an aggregate of $5,000,000 into an escrow account (the “Settlement Payment”) in exchange for a release of all claims.  Plaintiff also intends to seek an award of attorneys’ fees and expenses to Plaintiff’s counsel of up to $1,000,000 that will be paid out of the Settlement Payment with the remaining funds paid to the Company, and an additional mootness fee to Plaintiff’s counsel of up to $400,000 in connection with the third count of the complaint. The proposed settlement is subject to, and conditioned on approval by the Court, and no assurances can be given that such Court approval will be obtained. The impact to the Company is not expected to be material. 

Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages sought are significant and, if such a claim were brought against the Company, could have a material adverse effect on our business and results of operations. The Company is subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices or batteries and may be subject to claims in the future relating to other Creative Distribution Solutions products. The Company is still evaluating these claims and the potential defenses to them and may from time to time settle some such suits in order to eliminate distraction, burden, expense, risks and potential delay of further litigation involving the asserted claims. For example, the Company did not design or manufacture the products at issue; rather, the Company was merely the distributor. Nonetheless, there can be no assurance that the Company will prevail in these cases, and they could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.

27

We have several subsidiaries engaged in making, distributing, and selling vapor products. As a result of the overall publicity and controversy surrounding the vapor industry generally, many companies have received informational subpoenas from various regulatory bodies and in some jurisdictions regulatory lawsuits have been filed regarding marketing practices and possible underage sales. While we have received some such investigative requests with regard to the marketing of our vapor products, no regulatory bodies have taken action against us with regard to our marketing practices. To the extent that litigation becomes necessary, we believe that the subsidiaries have strong factual and legal defenses against claims that they unfairly marketed vapor products.

We have two franchisor subsidiaries. Like many franchise businesses, in the ordinary course of their business, these subsidiaries are from time-to-time responding parties to arbitration demands brought by franchisees. We recently won a dispositive motion in an arbitration brought by a former franchisee. We have one remaining former franchisee arbitration relating to claims of breach of contract and negligence allegations, among others. We believe we have good and valid substantive defenses against these claims and intend on vigorously defending our interests in this matter.

Note 15. Income Per Share

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:

	Three Months Ended September 30,
	2023						2022
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	10,831					$	11,536
Denominator
Weighted average				17,595,980	$	0.62				17,749,294	$	0.65
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	10,831					$	11,536
Interest expense related to Convertible Senior Notes, net of tax		743						1,054
Diluted net income attributable to Turning Point Brands. Inc.	$	11,574					$	12,590
Denominator
Basic weighted average				17,595,980						17,749,294
Convertible Senior Notes				2,311,086						3,213,589
Stock options and restricted stock units				191,384						139,123
				20,098,450	$	0.58				21,102,006	$	0.60

28

	Nine Months Ended September 30,
	2023						2022
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	28,353					$	27,958
Denominator
Weighted average				17,569,493	$	1.61				18,021,554	$	1.55
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	28,353					$	27,958
Interest expense related to Convertible Senior Notes		2,546						3,162
Diluted net income attributable to Turning Point Brands. Inc.	$	30,899					$	31,120
Denominator
Basic weighted average				17,569,493						18,021,554
Convertible Senior Notes				2,637,252						3,213,589
Stock options and restricted stock units				209,041						166,342
				20,415,786	$	1.51				21,401,485	$	1.45

Note 16. Segment Information

In accordance with ASC 280, Segment Reporting, the Company has three reportable segments: (1) Zig-Zag Products; (2) Stoker’s Products; and (3) Creative Distribution Solutions. The Zig-Zag Products segment markets and distributes (a) rolling papers, tubes, and related products; and (b) finished cigars and MYO cigar wraps and (c) CLIPPER reusable lighters and other accessories. The Stoker’s Products segment (a) manufactures and markets moist snuff and (b) contracts for and markets loose leaf chewing tobacco products. The Creative Distribution Solutions segment (a) markets and distributes liquid vapor products and certain other products without tobacco and/or nicotine; (b) distributes a wide assortment of products to non-traditional retail outlets via VaporBeast; and (c) markets and distributes a wide assortment of products to individual consumers via the VaporFi B2C online platform. Products in the Zig-Zag Products and Stoker’s Products segments are distributed primarily through wholesale distributors in the U.S. and Canada while products in the Creative Distribution Solutions segment are distributed primarily through e-commerce to non-traditional retail outlets and direct to consumers in the U.S. Corporate unallocated includes the costs and assets of the Company not assigned to one of the three reportable segments such as intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries.

The accounting policies of these segments are the same as those of the Company. Corporate costs are not directly charged to the three reportable segments in the ordinary course of operations. The Company evaluates the performance of its segments and allocates resources to them based on operating income.

29

The tables below present financial information about reported segments:

	Three Months Ended September 30,
	2023			2022
Net sales
Zig-Zag products	$	46,754		$	52,061
Stoker’s products		36,916			33,525
Total Zig-Zag and Stoker’s products	$	83,670		$	85,586
Creative Distribution Solutions		18,052			22,216
Total	$	101,722		$	107,802
Gross profit
Zig-Zag products	$	26,745		$	28,035
Stoker’s products		20,572			18,279
Total Zig-Zag and Stoker’s products	$	47,317		$	46,314
Creative Distribution Solutions		4,305			6,398
Total	$	51,622		$	52,712
Operating income (loss)
Zig-Zag products	$	16,672		$	18,740
Stoker’s products		15,703			13,653
Corporate unallocated (1)(2)		(11,678	)		(12,714	)
Total Zig-Zag and Stoker’s products	$	20,697		$	19,679
Creative Distribution Solutions		(460	)		142
Total	$	20,237		$	19,821
Interest expense, net		3,984			4,802
Investment loss		2,101			(75	)
Gain on extinguishment of debt		(481	)		–
Income before income taxes	$	14,633		$	15,094
Capital expenditures
Zig-Zag products	$	3		$	29
Stoker’s products		1,211			940
Total Zig-Zag and Stoker’s products	$	1,214		$	969
Creative Distribution Solutions		–			–
Total	$	1,214		$	969
Depreciation and amortization
Zig-Zag products	$	269		$	124
Stoker’s products		795			738
Total Zig-Zag and Stoker’s products	$	1,064		$	862
Creative Distribution Solutions		562			453
Total	$	1,626		$	1,315

(1) Includes corporate costs that are not allocated to any of the three reportable segments.

(2) Includes costs related to PMTA of $0.3 million in 2023 and $1.2 million in 2022.

30

	Nine Months Ended September 30,
	2023			2022
Net sales
Zig-Zag products	$	135,363		$	143,959
Stoker’s products		106,634			98,816
Total Zig-Zag and Stoker’s products	$	241,997		$	242,775
Creative Distribution Solutions		66,276			68,846
Total	$	308,273		$	311,621
Gross profit
Zig-Zag products	$	75,557		$	80,808
Stoker’s products		60,005			54,044
Total Zig-Zag and Stoker’s products	$	135,562		$	134,852
Creative Distribution Solutions		17,155			21,123
Total	$	152,717		$	155,975
Operating income (loss)
Zig-Zag products	$	47,313		$	55,980
Stoker’s products		45,375			40,536
Corporate unallocated (1)(2)		(34,325	)		(40,692	)
Total Zig-Zag and Stoker’s products	$	58,363		$	55,824
Creative Distribution Solutions		261			1,372
Total	$	58,624		$	57,196
Interest expense, net		12,013			15,142
Investment loss		10,980			6,074
Gain on extinguishment of debt		(1,858	)		–
Income before income taxes	$	37,489		$	35,980
Capital expenditures
Zig-Zag products	$	1,088		$	4,588
Stoker’s products		3,118			2,074
Total Zig-Zag and Stoker’s products	$	4,206		$	6,662
Creative Distribution Solutions		–			–
Total	$	4,206		$	6,662
Depreciation and amortization
Zig-Zag products	$	803		$	309
Stoker’s products		2,210			2,275
Total Zig-Zag and Stoker’s products	$	3,013		$	2,584
Creative Distribution Solutions		1,690			1,400
Total	$	4,703		$	3,984

(1) Includes corporate costs that are not allocated to any of the three reportable segments.

(2) Includes costs related to PMTA of $1.1 million in 2023 and $4.3 million in 2022.

31

	September 30,		December 31,
	2023		2022
Assets
Zig-Zag products	$	176,975	$	225,893
Stoker’s products		175,566		151,241
Corporate unallocated (1)		172,294		155,348
Total Zig-Zag and Stoker’s products	$	524,835	$	532,482
Creative Distribution Solutions		29,108		39,624
Total	$	553,943	$	572,106

(1) Includes assets not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments.

Revenue Disaggregation—Sales Channel

Revenues of the Zig-Zag Products and Stoker’s Products segments are primarily comprised of sales made to wholesalers while Creative Distribution Solutions sales are made business to business and business to consumer, both online and through our corporate retail stores. Creative Distribution Solutions net sales are broken out by sales channel below.

	Creative Distribution Solutions Segment
	Three Months Ended
	September 30,
	2023		2022
Business to Business	$	16,089	$	18,226
Business to Consumer - Online		1,912		3,884
Other		51		106
Total	$	18,052	$	22,216

	Creative Distribution Solutions Segment
	Nine Months Ended
	September 30,
	2023		2022
Business to Business	$	58,620	$	55,024
Business to Consumer - Online		7,247		13,453
Other		409		369
Total	$	66,276	$	68,846

32

Net Sales—Domestic vs. Foreign

The following table shows a breakdown of consolidated net sales between domestic and foreign customers.

	Three Months Ended
	September 30,
	2023		2022
Domestic	$	93,533	$	98,173
Foreign		8,189		9,629
Total	$	101,722	$	107,802

	Nine Months Ended
	September 30,
	2023		2022
Domestic	$	285,514	$	287,381
Foreign		22,759		24,240
Total	$	308,273	$	311,621

Note 17. Additional Information with Respect to Unrestricted Subsidiary

Under the terms of the Senior Secured Notes Indenture and Senior Secured Notes, the Company has designated its subsidiaries, South Beach Brands LLC, TPB Beast LLC and Intrepid Brands, LLC as “Unrestricted Subsidiaries”. South Beach Brands LLC is a holding company under which our vape business TPB Beast LLC operating as Creative Distribution Solutions sits. The Company is required under the terms of the Senior Secured Notes Indenture and the Senior Secured Notes to present additional information that reflects the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Company’s Unrestricted Subsidiaries as of and for the periods presented. This additional information is below.

Income Statement for the Three Months Ended September 30, 2023 and 2022 (unaudited):

	Three Months Ended September 30
	2023									2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries			Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	83,670		$	18,052		$	101,722		$	85,586		$	22,216	$	107,802
Cost of sales		36,353			13,747			50,100			39,272			15,818		55,090
Gross profit		47,317			4,305			51,622			46,314			6,398		52,712
Selling, general, and administrative expenses		26,620			4,765			31,385			26,635			6,256		32,891
Operating income		20,697			(460	)		20,237			19,679			142		19,821
Interest expense, net		3,984			–			3,984			4,802			–		4,802
Investment loss		2,101			–			2,101			(75	)		–		(75	)
Gain on extinguishment of debt		(481	)		–			(481	)		–			–		–
Income before income taxes		15,093			(460	)		14,633			14,952			142		15,094
Income tax expense		3,885			(118	)		3,767			3,761			36		3,797
Consolidated net income		11,208			(342	)		10,866			11,191			106		11,297
Net loss attributable to non-controlling interest		35			–			35			(239	)		–		(239	)
Net income attributable to Turning Point Brands, Inc.	$	11,173		$	(342	)	$	10,831		$	11,430		$	106	$	11,536

33

Income Statement for the Nine Months Ended September 30, 2023 and 2022 (unaudited):

	Nine Months Ended September 30
	2023								2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	241,997		$	66,276	$	308,273		$	242,775		$	68,846	$	311,621
Cost of sales		106,435			49,121		155,556			107,923			47,723		155,646
Gross profit		135,562			17,155		152,717			134,852			21,123		155,975
Selling, general, and administrative expenses		77,199			16,894		94,093			79,028			19,751		98,779
Operating income		58,363			261		58,624			55,824			1,372		57,196
Interest expense, net		12,013			–		12,013			15,142			–		15,142
Investment loss		10,980			–		10,980			6,074			–		6,074
Gain on extinguishment of debt		(1,858	)		–		(1,858	)		–			–		–
Income before income taxes		37,228			261		37,489			34,608			1,372		35,980
Income tax expense		9,506			67		9,573			8,374			332		8,706
Consolidated net income		27,722			194		27,916			26,234			1,040		27,274
Net loss attributable to non-controlling interest		(437	)		–		(437	)		(684	)		–		(684	)
Net income attributable to Turning Point Brands, Inc.	$	28,159		$	194	$	28,353		$	26,918		$	1,040	$	27,958

34

Balance Sheet as of September 30, 2023 (unaudited):

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	92,353	$	3,718	$	–		$	96,071
Accounts receivable, net		10,363		130		–			10,493
Inventories		109,867		7,059		–			116,926
Other current assets		20,417		2,905		–			23,322
Total current assets		233,000		13,812		–			246,812
Property, plant, and equipment, net		24,382		231		–			24,613
Deferred income taxes		8,190		–		–			8,190
Right of use assets		11,922		138		–			12,060
Deferred financing costs, net		203		–		–			203
Goodwill		136,280		–		–			136,280
Other intangible assets, net		66,798		14,927		–			81,725
Master Settlement Agreement (MSA) escrow deposits		27,534		–		–			27,534
Other assets		16,526		–		–			16,526
Investment in unrestricted subsidiaries		49,047		–		(49,047	)		–
Total assets	$	573,882	$	29,108	$	(49,047	)	$	553,943
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	10,305	$	932	$	–		$	11,237
Accrued liabilities		25,243		1,984		–			27,227
Current portion of long-term debt		48,248		–		–			48,248
Other current liabilities		6		–		–			6
Total current liabilities		83,802		2,916		–			86,718
Notes payable and long-term debt		316,573		–		–			316,573
Lease liabilities		10,363		70		–			10,433
Total liabilities		410,738		2,986		–			413,724
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		161,836		26,122		(49,047	)		138,911
Non-controlling interest		1,308		–		–			1,308
Total stockholders’ equity		163,144		26,122		(49,047	)		140,219
Total liabilities and stockholders’ equity	$	573,882	$	29,108	$	(49,047	)	$	553,943

35

Balance Sheet as of December 31, 2022:

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	103,990	$	2,413	$	–		$	106,403
Accounts receivable, net		7,374		1,003		–			8,377
Inventories		104,883		15,032		–			119,915
Other current assets		18,828		4,131		–			22,959
Total current assets		235,075		22,579		–			257,654
Property, plant, and equipment, net		22,261		527		–			22,788
Deferred income taxes		8,443		–		–			8,443
Right of use assets		12,328		137		–			12,465
Deferred financing costs, net		282		–		–			282
Goodwill		136,253		–		–			136,253
Other intangible assets, net		67,241		16,351		–			83,592
Master Settlement Agreement (MSA) escrow deposits		27,980		–		–			27,980
Other assets		22,619		30		–			22,649
Investment in unrestricted subsidiaries		60,120		–		(60,120	)		–
Total assets	$	592,602	$	39,624	$	(60,120	)	$	572,106
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,628	$	727	$	–		$	8,355
Accrued liabilities		31,118		1,883		–			33,001
Other current liabilities		20		–		–			20
Total current liabilities		38,766		2,610		–			41,376
Notes payable and long-term debt		406,757		–		–			406,757
Lease liabilities		10,593		–		–			10,593
Total liabilities		456,116		2,610		–			458,726
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		134,751		37,014		(60,120	)		111,645
Non-controlling interest		1,735		–		–			1,735
Total stockholders’ equity		136,486		37,014		(60,120	)		113,380
Total liabilities and stockholders’ equity	$	592,602	$	39,624	$	(60,120	)	$	572,106

Note 18. Dividends and Share Repurchases

A dividend of $0.065 per common share was paid on October 6, 2023, to shareholders of record at the close of business on September 15, 2023.

The Company currently pays a quarterly cash dividend. Dividends are considered restricted payments under the Senior Secured Notes Indenture and 2021 Revolving Credit Facility. The Company is generally permitted to make restricted payments provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional earnings and market capitalization restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year.

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022, in each case bringing the aggregate approval back to $50.0 million. $27.2 million remains available for share repurchases under the program at September 30, 2023.

36

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of the historical financial conditions and results of operations in conjunction with our consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements which are subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”

The following Management’s Discussion and Analysis (“MD&A”) relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. The MD&A is intended to enable the reader to understand the Company’s financial condition and results of operations, including any material changes in the Company’s financial condition and results of operations since December 31, 2022, and as compared with the three and nine months ended September 30, 2022.  The MD&A is provided as a supplement to and should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this Quarterly report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

In this MD&A, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.

Overview

Turning Point Brands, Inc. is a leading manufacturer, marketer and distributor of branded consumer products. We sell a wide range of products to adult consumers consisting of staple products with our iconic brands Zig-Zag^® and Stoker’s^® and our next generation products to fulfill evolving consumer preferences. Among other markets, we compete in the alternative smoking accessories and Other Tobacco Products (“OTP”) industries. The alternative smoking accessories market is a dynamic market experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and positively evolving consumer perception and acceptance in North America. The OTP industry, which consists of non-cigarette tobacco products, exhibited mid-single-digit consumer unit annualized growth over the three-year period ended 2022 as reported by Management Science Associates, Inc., a third-party analytics and information company. Our segments are led by our core, proprietary brands: Zig-Zag^® and CLIPPER^® in the Zig-Zag Products segment and Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment. Our businesses generate solid cash flows which we use to invest in our business, finance acquisitions, increase brand support, expand our distribution infrastructure, and strengthen our capital position. We currently ship to approximately 800 distributors with an additional 200 secondary, indirect wholesalers in the U.S. that carry and sell our products. Under the leadership of a senior management team with extensive experience in the consumer products, alternative smoking accessories and tobacco industries, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.

We believe there are meaningful opportunities to grow through acquisitions and joint ventures across all product categories. Our products are currently available in approximately 197,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 217,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores. We also have a growing e-commerce business.

In the fourth quarter of 2022, we contributed our NewGen Products business to South Beach Holdings LLC doing business as Creative Distribution Solutions (“CDS”), a newly-formed wholly-owned subsidiary. CDS is separately operated and reports to its own Board of Directors. During the first quarter of 2023, the business was designated an unrestricted subsidiary under the Senior Secured Notes (the “Notes”) and concurrently we renamed what we previously referred to as our NewGen Products segment as our Creative Distribution Solutions segment as we believe this name better aligns with the goals and strategies of the segment.

Products

We operate in three segments: Zig-Zag Products, Stoker’s Products and Creative Distribution Solutions. In our Zig-Zag Products segment, we principally market and distribute (i) rolling papers, tubes, and related products; and (ii) finished cigars and make-your-own (“MYO”) cigar wraps and (iii) lighters and other accessories.  In addition, we have a majority stake in Turning Point Brands Canada which markets and distributes cannabis accessories and tobacco products throughout Canada. In our Stoker’s Products segment, we (i) manufacture and market moist snuff tobacco (“MST”) and (ii) contract for and market loose leaf chewing tobacco products. In our Creative Distribution Solutions segment, we (i) market and distribute liquid vapor products and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of products to non-traditional retail via VaporBeast; and (iii) market and distribute a wide assortment of products to individual consumers via the VaporFi B2C online platform.

37

Operations

Our core Zig-Zag Products and Stoker’s Products segments primarily generate revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. More than 75% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists primarily of our moist snuff tobacco operations located in Dresden, Tennessee, and Louisville, Kentucky. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense and other expenses.

Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

● Our ability to further penetrate markets with our existing products;

● Our ability to introduce new products and product lines that complement our core business;

● Decreasing interest in some tobacco products among consumers;

● Price sensitivity in our end-markets;

● Marketing and promotional initiatives, which cause variability in our results;

● Cost and increasing regulation of promotional and advertising activities;

● General economic conditions, including consumer access to disposable income and other conditions affecting purchasing power such as inflation;

● Labor and production costs;

● Cost of complying with regulation, including the “deeming regulation”;

● Increasing and unpredictable regulation and/or marketing order decisions impacting Creative Distribution Solutions products;

● Counterfeit and other illegal products in our end-markets;

● Currency fluctuations;

● Our ability to identify attractive acquisition opportunities; and

● Our ability to successfully integrate acquisitions.

Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2022 Annual Report on Form 10-K.

Recent Accounting Pronouncements

There are no recent accounting pronouncements that impact the Company.

Recent Developments

On November 7, 2023, a wholly-owned subsidiary of the Company (the “ABL Borrower”) entered into a new $75.0 million asset-backed revolving credit facility (the “2023 ABL Facility”). The Company intends to use borrowings distributed to it by ABL Borrower  under the 2023 ABL Facility to refinance a portion of the Convertible Senior Notes at maturity.  In connection with entry into the 2023 ABL Facility, the Company terminated the Amended Revolving Credit Agreement originally entered into in 2021.  See Part II Other Information --Item 5. Other Information.

38

Results of Operations

Comparison of the Three Months Ended September 30, 2023, to the Three Months Ended September 30, 2022

The table and discussion set forth below displays our consolidated results of operations (in thousands):

	Three Months Ended September 30,
	2023			2022			% Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products	$	46,754		$	52,061			-10.2	%
Stoker’s products		36,916			33,525			10.1	%
Total Zig-Zag and Stoker’s products		83,670			85,586			-2.2	%
Creative Distribution Solutions		18,052			22,216			-18.7	%
Total net sales		101,722			107,802			-5.6	%
Cost of sales		50,100			55,090			-9.1	%
Gross profit
Zig-Zag products		26,745			28,035			-4.6	%
Stoker’s products		20,572			18,279			12.5	%
Total Zig-Zag and Stoker’s products		47,317			46,314			2.2	%
Creative Distribution Solutions		4,305			6,398			-32.7	%
Total gross profit		51,622			52,712			-2.1	%
Selling, general, and administrative expenses		31,385			32,891			-4.6	%
Operating income		20,237			19,821			2.1	%
Interest expense, net		3,984			4,802			-17.0	%
Investment loss (gain)		2,101			(75	)		-2,901.3	%
Gain on extinguishment of debt		(481	)		–		NM
Income before income taxes		14,633			15,094			-3.1	%
Income tax expense		3,767			3,797			-0.8	%
Consolidated net income		10,866			11,297			-3.8	%
Net gain (loss) attributable to non-controlling interest		35			(239	)		-114.6	%
Net income attributable to Turning Point Brands, Inc.	$	10,831		$	11,536			-6.1	%

Net Sales:  For the three months ended September 30, 2023, consolidated net sales decreased to $101.7 million from $107.8 million for the three months ended September 30, 2022, a decrease of $6.1 million or 5.6%.

For the three months ended September 30, 2023, net sales in the Zig-Zag Products segment decreased to $46.8 million from $52.1 million for the three months ended September 30, 2022, a decrease of $5.3 million or 10.2%. The decrease in net sales was driven by the benefits in the third quarter of 2022 from the initial load-in of CLIPPER lighters and approximately $5 million of sales that were pulled forward from the fourth quarter of last year due to the timing of promotional activities and Canadian deliveries. Additionally, a discontinuation of an unprofitable product line impacted Canadian sales by $1.8 million.

For the three months ended September 30, 2023, net sales in the Stoker’s Products segment increased to $36.9 million from $33.5 million for the three months ended September 30, 2022, an increase of $3.4 million or 10.1%. For the three months ended September 30, 2023, volume increased 2.2% and price/product mix increased 7.9%. The increase in net sales was driven by double-digit growth of Stoker’s^® MST and single-digit growth in loose-leaf chewing tobacco.

For the three months ended September 30, 2023, net sales in the Creative Distribution Solutions segment decreased to $18.1 million from $22.2 million for the three months ended September 30, 2022, a decrease of $4.1 million or 18.7%. The decrease in net sales was primarily the result of lower volumes in the vape distribution businesses.

Gross Profit:  For the three months ended September 30, 2023, consolidated gross profit decreased to $51.6 million from $52.7 million for the three months ended September 30, 2022, a decrease of $1.1 million or 2.1%. Gross profit as a percentage of net sales increased to 50.7% for the three months ended September 30, 2023, compared to 48.9% for the three months ended September 30, 2022 driven by decreased margin in Creative Distribution Solutions partially offset by increased margins in the Stoker’s Products and Zig-Zag Products segments.

39

For the three months ended September 30, 2023, gross profit in the Zig-Zag Products segment decreased to $26.7 million from $28.0 million for the three months ended September 30, 2022, a decrease of $1.3 million or 4.6% . Gross profit as a percentage of net sales increased to 57.2% of net sales for the three months ended September 30, 2023, from 53.9% of net sales for the three months ended September 30, 2022, driven primarily by product mix.

For the three months ended September 30, 2023, gross profit in the Stoker’s Products segment increased to $20.6 million from $18.3 million for the three months ended September 30, 2022, an increase of $2.3 million or 12.5%. Gross profit as a percentage of net sales increased to 55.7% of net sales for the three months ended September 30, 2023, from 54.5% of net sales for the three months ended September 30, 2022, primarily as a result of strong market share gains in MST and loose-leaf chewing tobacco and pricing gains in MST.

For the three months ended September 30, 2023, gross profit in the Creative Distribution Solutions segment decreased to $4.3 million from $6.4 million for the three months ended September 30, 2022, a decrease of $2.1 million or 32.7%. Gross profit as a percentage of net sales decreased to 23.8% of net sales for the three months ended September 30, 2023, from 28.8% of net sales for the three months ended September 30, 2022, primarily as a result of channel mix.

Selling, General, and Administrative Expenses:  For the three months ended September 30, 2023, selling, general, and administrative expenses decreased to $31.4 million from $32.9 million for the three months ended September 30, 2022, a decrease of $1.5 million or 4.6%. Selling, general and administrative expenses in the three months ended September 30, 2023, included $1.8 million of stock options, restricted stock and incentives expense, $0.3 million of expense related to PMTA, $0.2 million of expense related to corporate restructuring, $0.1 million of transaction costs and $0.1 million of expense related to the new ERP and CRM systems. Selling, general and administrative expenses in the three months ended September 30, 2022, included $1.4 million of stock option, restricted stock and incentives expense, $1.2 million of expense related to PMTA and $0.4 million of consulting expense related to the scoping and mobilization of the new ERP and CRM systems.

Interest Expense, net:  For the three months ended September 30, 2023, interest expense, net decreased to $4.0 million from $4.8 million for the three months ended September 30, 2022 as a result of the repurchase of $54.0 million total of Convertible Senior Notes as of September 30, 2023, and increased interest income on cash as a result of rising interest rates.

Investment Loss (Gain):  For the three months ended September 30, 2023, investment loss increased to $2.1 million compared to a $0.1 million gain for the three months ended September 30, 2022. The change is a result of an impairment charge recognized on our investment in Wild Hemp for $2.2 million in the third quarter of 2023.

Gain on Extinguishment of Debt: There was a gain on extinguishment of debt of $0.5 million for the three months ended September 30, 2023 as a result of repurchasing $15.0 million of Convertible Senior Notes compared to no gain on extinguishment of debt for the three months ended September 30, 2022.

Income Tax Expense:  Our income tax expense of $3.8 million was 25.7% of income before income taxes for the three months ended September 30, 2023. Our effective income tax rate was 25.2% for the three months ended September 30, 2022.

Net Gain (Loss) Attributable to Non-Controlling Interest:  Net gain attributable to non-controlling interest was $0.0 million for the three months ended September 30, 2023 compared to $0.2 million net loss for the three months ended September 30, 2022.

Net Income Attributable to Turning Point Brands, Inc.:  Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the three months ended September 30, 2023 and 2022, was $10.8 million and $11.5 million, respectively.

40

Comparison of the Nine Months Ended September 30, 2023, to the Six Months Ended September 30, 2022

The table and discussion set forth below displays our consolidated results of operations (in thousands):

	Nine Months Ended September 30,
	2023			2022			% Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products	$	135,363		$	143,959			-6.0	%
Stoker’s products		106,634			98,816			7.9	%
Total Zig-Zag and Stoker’s products		241,997			242,775			-0.3	%
Creative Distribution Solutions		66,276			68,846			-3.7	%
Total net sales		308,273			311,621			-1.1	%
Cost of sales		155,556			155,646			-0.1	%
Gross profit
Zig-Zag products		75,557			80,808			-6.5	%
Stoker’s products		60,005			54,044			11.0	%
Total Zig-Zag and Stoker’s products		135,562			134,852			0.5	%
Creative Distribution Solutions		17,155			21,123			-18.8	%
Total gross profit		152,717			155,975			-2.1	%
Selling, general, and administrative expenses		94,093			98,779			-4.7	%
Operating income		58,624			57,196			2.5	%
Interest expense, net		12,013			15,142			-20.7	%
Investment loss		10,980			6,074			80.8	%
Gain on extinguishment of debt		(1,858	)		–		NM
Income before income taxes		37,489			35,980			4.2	%
Income tax expense		9,573			8,706			10.0	%
Consolidated net income		27,916			27,274			2.4	%
Net loss attributable to non-controlling interest		(437	)		(684	)		-36.1	%
Net income attributable to Turning Point Brands, Inc.	$	28,353		$	27,958			1.4	%

Net Sales:  For the nine months ended September 30, 2023, consolidated net sales decreased to $308.3 million from $311.6 million for the nine months ended September 30, 2022, a decrease of $3.3 million or 1.1%.

For the nine months ended September 30, 2023, net sales in the Zig-Zag Products segment decreased to $135.4 million from $144.0 million for the nine months ended September 30, 2022, a decrease of $8.6 million or 6.0%. The decrease in net sales was driven by anticipated declines in the U.S. rolling papers and wraps businesses which were impacted by a reduction of trade inventory, offset by growth in our Clipper business. Additionally, a discontinuation of an unprofitable product line negatively impacted Canadian sales by $3.6 million against the previous year.

For the nine months ended September 30, 2023, net sales in the Stoker’s Products segment increased to $106.6 million from $98.8 million for the nine months ended September 30, 2022, an increase of $7.8 million or 7.9%. For the nine months ended September 30, 2023, volume increased 1.0% and price/product mix increased 6.9%. The increase in net sales was driven primarily by double-digit growth of Stoker’s^® MST.

For the nine months ended September 30, 2023, net sales in the Creative Distribution Solutions segment decreased to $66.3 million from $68.8 million for the nine months ended September 30, 2022, a decrease of $2.5 million or 3.7%. The decrease in net sales was primarily the result of reduced volumes in the vape distribution business.

41

Gross Profit:  For the nine months ended September 30, 2023, consolidated gross profit decreased to $152.7 million from $156.0 million for the nine months ended September 30, 2022, a decrease of $3.3 million or 2.1%. Gross profit as a percentage of net sales decreased to 49.5% for the nine months ended September 30, 2023, compared to 50.1% for the nine months ended September 30, 2022 driven by decreased margin in the Zig-Zag Products and Creative Distribution Solutions segments partially offset by increased margin in the Stoker’s Products segment.

For the nine months ended September 30, 2023, gross profit in the Zig-Zag Products segment decreased to $75.6 million from $80.8 million for the nine months ended September 30, 2022, a decrease of $5.2 million or 6.5%. Gross profit as a percentage of net sales decreased to 55.8% of net sales for the nine months ended September 30, 2023, from 56.1% of net sales for the nine months ended September 30, 2022, as a result of product mix including the decline in net sales of higher margin U.S. rolling paper and wraps products and contribution of CLIPPER lighters, as a result of the exclusive distribution deal entered into in February 2022, which operates at lower gross profit margins.

For the nine months ended September 30, 2023, gross profit in the Stoker’s Products segment increased to $60.0 million from $54.0 million for the nine months ended September 30, 2022, an increase of $6.0 million or 11.0%. Gross profit as a percentage of net sales increased to 56.3% of net sales for the nine months ended September 30, 2023, from 54.7% of net sales for the nine months ended September 30, 2022, primarily as a result of the strong incremental margin contribution of MST.

For the nine months ended September 30, 2023, gross profit in the Creative Distribution Solutions segment decreased to $17.2 million from $21.1 million for the nine months ended September 30, 2022, a decrease of $3.9 million or 18.8%. Gross profit as a percentage of net sales decreased to 25.9% of net sales for the nine months ended September 30, 2023, from 30.7% of net sales for the nine months ended September 30, 2022, primarily as a result of channel mix.

Selling, General, and Administrative Expenses:  For the nine months ended September 30, 2023, selling, general, and administrative expenses decreased to $94.1 million from $98.8 million for the nine months ended September 30, 2022, a decrease of $4.7 million or 4.7%. Selling, general and administrative expenses in the nine months ended September 30, 2023, included $4.7 million of stock options, restricted stock and incentives expense, $1.1 million of expense related to PMTA, $0.2 million of expense related to corporate restructuring, $0.4 million of expense related to the new ERP and CRM systems and $0.2 million related to transaction costs. Selling, general and administrative expenses in the nine months ended September 30, 2022, included $4.1 million of stock option, restricted stock and incentives expense, $0.8 million of transaction costs, $4.3 million of expense related to PMTA, $1.6 million of expense related to corporate restructuring and $1.6 million of consulting expense related to the scoping of the new ERP and CRM systems.

Interest Expense, net:  For the nine months ended September 30, 2023, interest expense, net decreased to $12.0 million, from $15.1 million for the nine months ended September 30, 2022 as a result of the repurchases of $44.0 million of Convertible Senior Notes through the third quarter of 2023, and increased interest income on cash as a result of rising interest rates.

Investment Loss:  For the nine months ended September 30, 2023, investment loss increased to $10.9 million compared to $6.1 million for the nine months ended September 30, 2022.  The change is a result of the year-to-date impairment charges recognized on our investments in Docklight and Wild Hemp for $6.5 million and $2.2 million, respectively, compared to an impairment charge of $6.3 million in the second quarter of 2022 related to our investment in Dosist.

Gain on Extinguishment of Debt: There was a gain on extinguishment of debt of $1.9 million for the nine months ended September 30, 2023 as a result of repurchasing $44.0 million of Convertible Senior Notes through the third quarter of 2023 compared to no gain on extinguishment of debt for the nine months ended September 30, 2022.

Income Tax Expense:  Our income tax expense of $9.6 million was 25.5% of income before income taxes for the nine months ended September 30, 2023. Our effective income tax rate was 24.2% for the nine months ended September 30, 2022 and included a discrete tax benefit $0.7 million relating to stock option exercises.

Net Loss Attributable to Non-Controlling Interest:  Net loss attributable to non-controlling interest was $0.4 million for the nine months ended September 30, 2023 compared to $0.7 million for the nine months ended September 30, 2022.

Net Income Attributable to Turning Point Brands, Inc.:  Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the nine months ended September 30, 2023 and 2022, was $28.4 million and $28.0 million, respectively.

42

EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our debt instruments contain covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider the ordinary course in our evaluation of ongoing operating performance noted in the reconciliation below.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

(in thousands)	Three Months Ended September 30,
	2023			2022
Net income attributable to Turning Point Brands, Inc.	$	10,831		$	11,536
Add:
Interest expense, net		3,984			4,802
Gain on extinguishment of debt		(481	)		–
Income tax expense		3,767			3,797
Depreciation expense		782			861
Amortization expense		844			454
EBITDA	$	19,727		$	21,450
Components of Adjusted EBITDA
Corporate restructuring (a)		190			17
ERP/CRM (b)		138			435
Stock options, restricted stock, and incentives expense (c)		1,824			1,442
Transactional expenses (d)		76			–
FDA PMTA (e)		275			1,169
Non-cash asset impairment (f)		2,173			–
Adjusted EBITDA	$	24,403		$	24,513

(a) Represents costs associated with corporate restructuring, including severance.

(b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.

(c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.

(d) Represents the fees incurred for transaction expenses.

(e) Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”).

(f) Represents impairment of investment assets.

43

(in thousands)	Nine Months Ended September 30,
	2023			2022
Net income attributable to Turning Point Brands, Inc.	$	28,353		$	27,958
Add:
Interest expense, net		12,013			15,142
Gain on extinguishment of debt		(1,858	)		–
Income tax expense		9,573			8,706
Depreciation expense		2,317			2,611
Amortization expense		2,386			1,373
EBITDA	$	52,784		$	55,790
Components of Adjusted EBITDA
Corporate restructuring (a)		190			1,619
ERP/CRM (b)		414			1,626
Stock options, restricted stock, and incentives expense (c)		4,660			4,103
Transactional expenses (d)		162			789
FDA PMTA (e)		1,095			4,265
Non-cash asset impairment (f)		11,162			6,300
Adjusted EBITDA	$	70,467		$	74,492

(a) Represents costs associated with corporate restructuring, including severance.

(b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.

(c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.

(d) Represents the fees incurred for transaction expenses.

(e) Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”).

(f) Represents impairment of investment assets.

Liquidity and Capital Resources

As of September 30, 2023, we had $96.1 million of cash on hand and have $23.6 million of availability under the 2021 Amended Revolving Credit Facility. Our principal uses for cash are working capital, debt service, and capital expenditures.

Our Convertible Senior Notes, with an outstanding balance of $118.5 million as of September 30, 2023, mature in July of 2024. On November 7, 2023, one of our wholly-owned subsidiaries entered into a new 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior Notes at maturity. As a result, we reclassified $70.0 million related to the Convertible Senior Notes from short-term to long-term liabilities on our September 30, 2023 Balance Sheet. With our strong cash balance, free cash flow generation and borrowing availability under the 2023 ABL Facility, we expect to have ample liquidity to address the remaining balance of the Convertible Senior Notes maturing next year, and to satisfy our operating cash requirements for the foreseeable future.

Our working capital, which we define as current assets less cash and current liabilities, decreased to $64.0 million at September 30, 2023, compared with $109.9 million at December 31, 2022 as a result of a portion of the Convertible Senior Notes becoming current during the quarter.

	As of
(in thousands)	September 30, 2023		December 31, 2022
Current assets	$	150,741	$	151,251
Current liabilities		86,718		41,376
Working capital	$	64,023	$	109,875

Cash Flows from Operating Activities

For the nine months ended September 30, 2023, net cash provided by operating activities was $40.0 million compared to net cash provided by operating activities of $16.4 million for the nine months ended September 30, 2022, an increase of $23.6 million, primarily due to the timing of changes of inventory and other working capital.

44

Cash Flows from Investing Activities

For the nine months ended September 30, 2023, net cash used in investing activities was $4.4 million compared to net cash used in investing activities of $17.8 million for the nine months ended September 30, 2022, a reduction in cash used in investing activities of $13.4 million, primarily due to a decrease in purchases of investments in our MSA escrow account.

Cash Flows from Financing Activities

For the nine months ended September 30, 2023, net cash used in financing activities was $46.0 million compared to net cash used in financing activities of $31.2 million for the nine months ended September 30, 2022, an increase of $14.8 million, primarily due to $41.8 million in repurchases of Convertible Senior Notes during the period, offset by a decrease in repurchases of common stock of $27.0 million during 2023.

Dividends and Share Repurchase

A dividend of $0.065 per common share was paid on October 6, 2023, to shareholders of record at the close of business on September 15, 2023.

On February 25, 2020, our Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022. $27.2 million remains available for share repurchases under the program as of September 30, 2023.

Long-Term Debt

As of September 30, 2023, we were in compliance with the financial and restrictive covenants of the Senior Secured Notes and 2021 Revolving Credit Facility. The following table provides outstanding balances of our debt instruments.

	September 30, 2023			December 31, 2022
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		118,541			162,500
Gross notes payable and long-term debt		368,541			412,500
Less deferred finance charges		(3,720	)		(5,743	)
Less current maturities		(48,248	)		-
Notes payable and long-term debt	$	316,573		$	406,757

Senior Secured Notes

On February 11, 2021, we closed a private offering (the “Offering”) of $250 million aggregate principal amount of our 5.625% senior secured notes due 2026 (the “Senior Secured Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.We used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any credit facility (as defined in the indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

45

The Company may redeem the Senior Secured Notes, in whole or in part, at any time on or after February 15, 2023, at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

If we experience a change of control (as defined in the Senior Secured Notes Indenture), we must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. We were in compliance with all covenants as of September 30, 2023.

We incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the effective interest method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, we also entered into a new $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). On May 10, 2023, the Company and certain of its subsidiaries, as guarantors, entered into an amendment (the “Amendment”) to the 2021 Revolving Credit Facility (as amended, the “Amended Revolving Credit Facility”). The Amendment includes certain modifications to the 2021 Revolving Credit Facility relating to the replacement of the London Inter-Bank Offered Rate with a Secured Overnight Financing Rate (“SOFR”) as the interest rate benchmark under the 2021 Revolving Credit Facility and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

Letters of credit are limited to $10.0 million (and are a part of, and not in addition to, the revolving line of credit). We have not drawn any borrowings under the Amended Revolving Credit Facility but do have letters of credit of approximately $1.4 million outstanding under the facility as of March 31, 2023. The Amended Revolving Credit Facility will mature on August 11, 2025 if none of our Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is 91 days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.

Interest is payable on the Amended 2021 Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate of Term SOFR rate, as applicable, plus an applicable margin of 3.50% (with step-downs upon de-leveraging). We also have the option to borrow at a rate determined by reference to the base rate.

The obligations under the Amended Revolving Credit Agreement are guaranteed on a joint and several basis by the Guarantors. The Company’s and Guarantors’ obligations under the Amended Revolving Credit Facility are secured on a pari passu basis with the Senior Secured Notes.

The Amended Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The Amended Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio of 5.50 to 1.00 (with a step down to 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the Amended Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $5.0 million) in the aggregate outstanding exceeds 35% of the total commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Agreement provides for customary events of default. We were in compliance with all covenants as of September 30, 2023.

46

We incurred debt issuance costs attributable to the issuance of the Amended Revolving Credit Facility of $0.5 million which are amortized to interest expense using the effective interest method over the expected life of the Amended Revolving Credit Facility.

On November 7, 2023, the Company terminated the Amended Revolving Credit Agreement in connection with entry into the new 2023 ABL Facility by one of its subsidiaries.

2023 ABL Facility

On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a $75.0 million asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and LILO Loans. The 2023 ABL Facility includes a $40.0  million accordion feature.  In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.

The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves.  The 2023 ABL Facility also includes a “last in last out” (“LILO”) borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of  (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters on or after the closing date if excess availability shall be less than the greater of (a) 12.5% of the line cap and (b) $9.4 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.4 million for thirty (30) consecutive calendar days; provided that such $9.4 million level shall automatically increase in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.

The 2023 ABL Facility shall mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

47

Convertible Senior Notes

In July 2019 we closed an offering of $172.5 million in aggregate principal amount of our 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes will mature on July 15, 2024, unless earlier repurchased, redeemed or converted. The Convertible Senior Notes are senior unsecured obligations.

In the fourth quarter of 2022, a wholly owned subsidiary of the Company repurchased $10.0 million in aggregate principal amount of the Convertible Senior Notes on the open market resulting in a $0.9 million gain on extinguishment of debt. Subsequent principal repurchases occurred in the first, second and third quarters of 2023 for $13.9 million, $15.1 million and $15.0 million, respectively, in aggregate principal amounts resulting in gains on extinguishment of debt of $0.7 million, $0.6 million and $0.6 million, respectively. The repurchased notes continue to be held by our subsidiary and may be resold subject to compliance with applicable securities law. As of September 30, 2023, $118.5 million aggregate principal remains outstanding and held by third parties.

The Convertible Senior Notes held by third parties are convertible into approximately 2,216,029 shares of TPB Common Stock under certain circumstances prior to maturity at a conversion rate of 18.6942 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $53.49 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by the Company in excess of pre-determined thresholds of $0.04 per share. Upon conversion, the Company may pay cash, shares of common stock or a combination of cash and stock, as determined by the Company at its discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of 2023.

We incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to the interest expense using the effective interest method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, we entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $53.49 per and a cap price of $82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. We paid $20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

Off-balance Sheet Arrangements

During the nine months ended September 30, 2023, we executed various foreign exchange contracts for the purchase of €20.1 million and sale of €15.2 million with maturity dates ranging from October 2023 to September 2024. At September 30, 2023, we had foreign currency contracts outstanding for the purchase of €17.1 million and sale of €15.2 million. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of $0.1 million included in Other current assets and a liability of $0.5 million included in Accrued liabilities at September 30, 2023. During 2022, we executed various foreign currency contracts for the purchase of €28.9 million and sale of €28.9 million. At December 31, 2022, we had foreign currency contracts for the purchase of €18.5 million and sale of €18.5 million. The fair value of the foreign currency contracts resulted in an asset of $1.2 million included in Other current assets and a liability of $0.0 million included in Accrued liabilities at December 31, 2022.

Inflation

Inflation in general, and the recent rapid increases in gas prices have had a substantial negative effect on the purchasing power of consumers. While historically, we have been able to increase prices at a rate equal to or greater than that of inflation, doing so would be difficult in the current inflationary environment. However, we have implemented price increases in areas where doing so has been feasible. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement regarding our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

48

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Sensitivity

There have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2022 Annual Report on Form 10-K, during the quarter ended September 30, 2023. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2022 Annual Report on Form 10-K filed with the SEC.

Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our 2022 Annual Report on Form 10-K, during the nine months ended September 30, 2023. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2022 Annual Report on Form 10-K filed with the SEC.

Interest Rate Sensitivity

In February 2021, we issued the Senior Secured Notes in an aggregate principal amount of $250 million. In July 2019, we issued Convertible Senior Notes in an aggregate principal amount of $172.5 million. We carry the Senior Secured Notes and Convertible Senior Notes at face value. Since the Senior Secured Notes and Convertible Senior Notes bear interest at a fixed rate, we have no financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Senior Notes changes when the market price of our stock fluctuates, or interest rates change. Our remaining debt instrument is a revolving credit facility, which has no borrowing outstanding.

Item 4. Controls and Procedures

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended as of September 30, 2023. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are not effective as of such date solely due to material weaknesses in internal controls over financial reporting that were disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, during our evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2022, we concluded that our internal control over financial reporting was not effective solely due to the existence of the following material weaknesses: we did not design and maintain effective internal controls related to our information technology general controls (“ITGCs”) in the areas of user access and program change-management over certain information technology systems that support the Company’s financial reporting processes. Our business process controls (automated and manual) that are dependent on the affected ITGCs were also deemed ineffective because they could have been adversely impacted.  We also did not appropriately design and operate controls associated with the risk assessment component of the internal control framework, specifically as it relates to identifying risks around segregation of duties within the financial reporting function, and the identification of all risks relating to the financial statements and controls that would address such risks. This impacts business process controls (automated and manual) throughout financial reporting and the business transaction cycles.

The material weaknesses did not result in any identified misstatements to our financial statements, and there were no changes to previously released financial results. The material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time, and management has concluded through testing that these controls are operating effectively.

During the nine months ended September 30, 2023, we have continued to make progress on our remediation plans to address the material weaknesses in the Company’s internal controls over financial reporting. These remediation efforts include hiring additional experienced accounting and internal control specialists and external consultants. In addition, the Company is in process of redesigning key controls for both business processes and information technology controls along with implementing a new enterprise resource planning system.

49

PART II—OTHER INFORMATION

Item 1.  Legal Proceedings

For a description of our material pending legal proceedings, please see Contingencies in Note 14 to the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report.

See ‘Risk Factors—We may become subject to significant product liability litigation’ within our 2022 Annual Report on Form 10-K for additional details.

Item 1A. Risk Factors

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2022 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2022 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million bringing the authority at the time back to $50.0 million (including approximately $19.3 million available for repurchases under the Board of Directors’ previous authorization). On February 24, 2022, the Board of Directors increased the approved share repurchase program by $24.6 million bringing total authority at that time to $50.0 million. This share repurchase program has no expiration date and is subject to the ongoing discretion of the Board of Directors. All repurchases to date under our stock repurchase programs have been made through open market transactions, but in the future, we may also purchase shares through privately negotiated transactions or 10b5-1 repurchase plans.

For the quarter ended September 30, 2023, the Company made no purchases of its common stock in connection with the repurchase program described above.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

50

Item 5. Other Information

Disclosure Pursuant to Item 1.01 of Current Report on Form 8-K - Entry into a Material Definitive Agreement.

On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a new $75.0 million asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and LILO Loans. The 2023 ABL Facility includes a $40.0 million accordion feature. In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.

The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves.  The 2023 ABL Facility also includes a “last in last out” (“LILO”) borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of  (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin  for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters on or after the closing date if excess availability shall be less than the greater of (a) 12.5% of the line cap and (b) $9.375 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.375 million for thirty (30) consecutive calendar days; provided that such $9.375 million level shall automatically increase in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.

The 2023 ABL Facility shall mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

Disclosure Pursuant to Item 1.02 of Current Report on Form 8-K – Termination of a Material Definitive Agreement.

On November 7, 2023, the Company terminated the 2021 Amended Revolving Credit Agreement in connection with the entry by one of its subsidiaries into the new 2023 ABL Facility.

51

Item 6. Exhibits

Exhibit No.	Description
10.1	Amendment No 1. Dated as of May 10, 2023, to the Credit Agreement, dated as of February 11, 2021, by and among Turning Point Brands, Inc., the obligors party thereto, Barclays Bank PLC, as administrative agent, and the lenders party thereto (incorporated herein by reference to Exhibit 10.1 of Turning Point Brand, Inc’s Current Report on Form 8-K filed with the Commission on May 16, 2023 (File No. 001-37763).
31.1	Rule 13a-14(a)/15d-14(a) Certification of Graham Purdy.*
31.2	Rule 13a-14(a)/15d-14(a) Certification of Luis Reformina.*
31.3	Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*
32.1	Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101	XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, filed on November 8, 2023, formatted in Inline XBRL (iXBRL): (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to consolidated financial statements.*
104	Cover Page Interactive Data File (formatted in iXBRL and included in Exhibit 101).*

* Filed or furnished herewith

52

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TURNING POINT BRANDS, INC.
		By: /s/ Graham Purdy
		Name: Graham Purdy
		Title:  President and Chief Executive Officer
		By: /s/ Luis Reformina
		Name:  Luis Reformina
		Title: Chief Financial Officer
		By:  /s/ Brian Wigginton
		Name:  Brian Wigginton
		Title:  Chief Accounting Officer
Date:  November 8, 2023

53

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Graham Purdy, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Turning Point Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2023	By:	/s/ Graham Purdy
		Graham Purdy
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Luis Reformina, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Turning Point Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2023	By:	/s/ Luis Reformina
		Luis Reformina
		Chief Financial Officer
		(Principal Financial Officer)

EX-31.3

Exhibit 31.3

CERTIFICATIONS

I, Brian Wigginton, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Turning Point Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2023	By:	/s/ Brian Wigginton
		Brian Wigginton
		Chief Accounting Officer

EX-32.1

Exhibit 32.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Turning Point Brands, Inc. (the "Company") for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Graham Purdy, President and Chief Executive Officer, Luis Reformina, Chief Financial Officer, and Brian Wigginton, Chief Accounting Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: November 8, 2023	By:	/s/ Graham Purdy
		Graham Purdy
		President and Chief Executive Officer
		(Principal Executive Officer)

Date: November 8, 2023	By:	/s/ Luis Reformina
		Luis Reformina
		Chief Financial Officer
		(Principal Financial Officer)

Date: November 8, 2023	By:	/s/ Brian Wigginton
		Brian Wigginton
		Chief Accounting Officer

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 01, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	001-37763
Entity Registrant Name	TURNING POINT BRANDS, INC.
Entity Central Index Key	0001290677
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-0709285
Entity Address, Address Line One	5201 Interchange Way
Entity Address, City or Town	Louisville
Entity Address, State or Province	KY
Entity Address, Postal Zip Code	40229
City Area Code	502
Local Phone Number	778-4421
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	TPB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,604,527

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 96,071	$ 106,403
Accounts receivable, net of allowances of $59 in 2023 and $114 in 2022	10,493	8,377
Inventories, net	116,926	119,915
Other current assets	23,322	22,959
Total current assets	246,812	257,654
Property, plant, and equipment, net	24,613	22,788
Deferred income taxes	8,190	8,443
Right of use assets	12,060	12,465
Deferred financing costs, net	203	282
Goodwill	136,280	136,253
Other intangible assets, net	81,725	83,592
Master Settlement Agreement (MSA) escrow deposits	27,534	27,980
Other assets	16,526	22,649
Total assets	553,943	572,106
Current liabilities:
Accounts payable	11,237	8,355
Accrued liabilities	27,227	33,001
Current portion of long-term debt	48,248	0
Other current liabilities	6	20
Total current liabilities	86,718	41,376
Notes payable and long-term debt	316,573	406,757
Lease liabilities	10,433	10,593
Total liabilities	413,724	458,726
Commitments and contingencies
Stockholders' equity:
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-	0	0
Additional paid-in capital	117,143	113,242
Cost of repurchased common stock (2,316,460 shares at September 30, 2023 and December 31, 2022)	(78,093)	(78,093)
Accumulated other comprehensive loss	(3,855)	(2,393)
Accumulated earnings	103,517	78,691
Non-controlling interest	1,308	1,735
Total stockholders' equity	140,219	113,380
Total liabilities and stockholders' equity	553,943	572,106
Common Stock, Voting [Member]
Stockholders' equity:
Common stock	199	198
Common Stock, Nonvoting [Member]
Stockholders' equity:
Common stock	$ 0	$ 0

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Accounts receivable, allowance	$ 59	$ 114
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	40,000,000	40,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Repurchased common stock (in shares)	2,316,460	2,316,460
Common Stock, Voting [Member]
Stockholders' equity:
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	190,000,000	190,000,000
Common stock, shares issued (in shares)	19,912,882	19,801,623
Common stock, shares outstanding (in shares)	17,596,422	17,485,163
Common Stock, Nonvoting [Member]
Stockholders' equity:
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

XML

Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Consolidated Statements of Income [Abstract]
Net sales	$ 101,722	$ 107,802	$ 308,273	$ 311,621
Cost of sales	50,100	55,090	155,556	155,646
Gross profit	51,622	52,712	152,717	155,975
Selling, general, and administrative expenses	31,385	32,891	94,093	98,779
Operating income	20,237	19,821	58,624	57,196
Interest expense, net	3,984	4,802	12,013	15,142
Investment loss (gain)	2,101	(75)	10,980	6,074
Gain on extinguishment of debt	(481)	0	(1,858)	0
Income before income taxes	14,633	15,094	37,489	35,980
Income tax expense	3,767	3,797	9,573	8,706
Consolidated net income	10,866	11,297	27,916	27,274
Net gain (loss) attributable to non-controlling interest	35	(239)	(437)	(684)
Net income attributable to Turning Point Brands, Inc.	$ 10,831	$ 11,536	$ 28,353	$ 27,958
Basic income per common share:
Net income attributable to Turning Point Brands, Inc. (in dollars per share)	$ 0.62	$ 0.65	$ 1.61	$ 1.55
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc. (in dollars per share)	$ 0.58	$ 0.6	$ 1.51	$ 1.45
Weighted average common shares outstanding:
Basic (in shares)	17,595,980	17,749,294	17,569,493	18,021,554
Diluted (in shares)	20,098,450	21,102,006	20,415,786	21,401,485

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Consolidated Statements of Comprehensive Income [Abstract]
Consolidated net income	$ 10,866	$ 11,297	$ 27,916	$ 27,274
Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax	(527)	(1,046)	(339)	(2,940)
Foreign currency translation, net of tax	270	(160)	23	(122)
Unrealized loss on derivative instruments, net of tax	(320)	(210)	(1,136)	(210)
Other comprehensive income, net of tax	(577)	(1,416)	(1,452)	(3,272)
Consolidated comprehensive income	10,289	9,881	26,464	24,002
Comprehensive gain (loss) attributable to non-controlling interest	35	(295)	(437)	(727)
Comprehensive income attributable to Turning Point Brands, Inc.	$ 10,254	$ 10,176	$ 26,901	$ 24,729

XML

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, tax	$ 168	$ 333	$ 108	$ 934
Foreign currency translation, tax	0	0	0	0
Unrealized loss on derivative instruments, tax	$ 102	$ 67	$ 361	$ 67

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Consolidated net income	$ 27,916	$ 27,274
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on extinguishment of debt	(1,858)	0
Loss (gain) on sale of property, plant, and equipment	34	(8)
Depreciation and other amortization expense	2,388	2,611
Amortization of other intangible assets	2,315	1,373
Amortization of deferred financing costs	1,795	1,936
Deferred income tax expense (benefit)	694	(431)
Stock compensation expense	4,660	4,103
Noncash lease income	(48)	0
Loss on investments	11,162	6,244
Changes in operating assets and liabilities:
Accounts receivable	(2,112)	(5,030)
Inventories	3,036	(26,467)
Other current assets	(1,384)	1,891
Other assets	(5,110)	1,211
Accounts payable	2,865	2,074
Accrued liabilities and other	(6,348)	(392)
Net cash provided by operating activities	40,005	16,389
Cash flows from investing activities:
Capital expenditures	(4,206)	(6,662)
Payments for investments	(200)	(1,000)
Restricted cash, MSA escrow deposits	0	(10,169)
Proceeds on the sale of property, plant and equipment	3	63
Net cash used in investing activities	(4,403)	(17,768)
Cash flows from financing activities:
Convertible Senior Notes repurchased	(41,794)	0
Proceeds from call options	114	0
Payment of dividends	(3,354)	(3,259)
Exercise of options	419	504
Redemption of options	(346)	(155)
Redemption of performance restricted stock units	(995)	(1,228)
Common stock repurchased	0	(27,032)
Net cash used in financing activities	(45,956)	(31,170)
Net decrease in cash	(10,354)	(32,549)
Effect of foreign currency translation on cash	22	(324)
Cash, beginning of period:
Unrestricted	106,403	128,320
Restricted	4,929	15,155
Total cash at beginning of period	111,332	143,475
Cash, end of period:
Unrestricted	96,071	105,672
Restricted	4,929	4,930
Total cash at end of period	101,000	110,602
Supplemental schedule of noncash investing activities:
Accrued capital expenditures	66	57
Accrued consideration for acquisition of investments	250	0
Supplemental schedule of noncash financing activities:
Dividends declared not paid	$ 1,187	$ 1,089

XML

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member] Voting [Member]	Additional Paid-In Capital [Member]	Cost of Repurchased Common Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Earnings [Member]	Non-Controlling Interest [Member]	Total
Beginning balance at Dec. 31, 2021	$ 197	$ 108,811	$ (48,869)	$ (195)	$ 71,460	$ 2,312	$ 133,716
Beginning balance (in shares) at Dec. 31, 2021							18,395,476
Unrealized gain (loss) on MSA investments, net of tax	0	0	0	(2,940)	0	0	$ (2,940)
Unrealized loss on derivative instruments, net of tax	0	0	0	(210)	0	0	(210)
Foreign currency translation, net of tax	0	0	0	(79)	0	(43)	(122)
Stock compensation expense	0	4,103	0	0	0	0	4,103
Exercise of options	$ 0	504	0	0	0	0	504
Exercise of options (in shares)	35,394
Redemption of options	$ 0	(155)	0	0	0	0	(155)
Redemption of options (in shares)	0
Performance restricted stock units issuance	$ 1	(1)	0	0	0	0	0
Performance restricted stock units issuance (in shares)	75,345
Performance restricted stock units redeemed	$ 0	(1,141)	0	0	0	0	(1,141)
Performance restricted stock units redeemed (in shares)	0
Redemption of restricted stock units	$ 0	(87)	0	0	0	0	(87)
Cost of repurchased common stock	0	0	$ (27,032)	0	0	0	(27,032)
Cost of repurchased common stock (in shares)			(919,093)
Dividends	0	0	$ 0	0	(3,330)	0	(3,330)
Net income	0	0	0	0	27,958	(684)	27,274
Ending balance at Sep. 30, 2022	198	112,034	(75,901)	(3,424)	96,088	1,585	$ 130,580
Ending balance (in shares) at Sep. 30, 2022							17,587,122
Beginning balance at Dec. 31, 2021	197	108,811	(48,869)	(195)	71,460	2,312	$ 133,716
Beginning balance (in shares) at Dec. 31, 2021							18,395,476
Ending balance at Dec. 31, 2022	198	113,242	(78,093)	(2,393)	78,691	1,735	$ 113,380
Ending balance (in shares) at Dec. 31, 2022							17,485,163
Beginning balance at Jun. 30, 2022	198	110,563	(68,287)	(2,064)	85,641	1,880	$ 127,931
Beginning balance (in shares) at Jun. 30, 2022							17,890,441
Unrealized gain (loss) on MSA investments, net of tax	0	0	0	(1,046)	0	0	$ (1,046)
Unrealized loss on derivative instruments, net of tax	0	0	0	(210)	0	0	(210)
Foreign currency translation, net of tax	0	0	0	(104)	0	(56)	(160)
Stock compensation expense	0	1,442	0	0	0	0	1,442
Exercise of options	$ 0	29	0	0	0	0	29
Exercise of options (in shares)	3,053
Performance restricted stock units issuance	$ 0	0	0	0	0	0	0
Performance restricted stock units issuance (in shares)	835
Cost of repurchased common stock	$ 0	0	$ (7,614)	0	0	0	(7,614)
Cost of repurchased common stock (in shares)			(307,207)
Dividends	0	0	$ 0	0	(1,089)	0	(1,089)
Net income	0	0	0	0	11,536	(239)	11,297
Ending balance at Sep. 30, 2022	198	112,034	(75,901)	(3,424)	96,088	1,585	$ 130,580
Ending balance (in shares) at Sep. 30, 2022							17,587,122
Beginning balance at Dec. 31, 2022	198	113,242	(78,093)	(2,393)	78,691	1,735	$ 113,380
Beginning balance (in shares) at Dec. 31, 2022							17,485,163
Unrealized gain (loss) on MSA investments, net of tax	0	0	0	(339)	0	0	$ (339)
Unrealized loss on derivative instruments, net of tax	0	0	0	(1,136)	0	0	(1,136)
Foreign currency translation, net of tax	0	0	0	13	0	10	23
Stock compensation expense	0	4,660	0	0	0	0	4,660
Exercise of options	$ 0	419	0	0	0	0	419
Exercise of options (in shares)	30,214
Redemption of options	$ 0	(346)	0	0	0	0	(346)
Redemption of options (in shares)	(15,985)
Performance restricted stock units issuance	$ 1	77	0	0	0	0	78
Performance restricted stock units issuance (in shares)	140,324
Performance restricted stock units redeemed	$ 0	(995)	0	0	0	0	(995)
Performance restricted stock units redeemed (in shares)	(43,294)
Settlement of call options, net of tax	$ 0	86	0	0	0	0	86
Dividends	0	0	0	0	(3,527)	0	(3,527)
Net income	0	0	0	0	28,353	(437)	27,916
Ending balance at Sep. 30, 2023	199	117,143	(78,093)	(3,855)	103,517	1,308	$ 140,219
Ending balance (in shares) at Sep. 30, 2023							17,596,422
Beginning balance at Jun. 30, 2023	199	115,272	(78,093)	(3,181)	93,873	1,176	$ 129,246
Beginning balance (in shares) at Jun. 30, 2023							17,595,579
Unrealized gain (loss) on MSA investments, net of tax	0	0	0	(527)	0	0	$ (527)
Unrealized loss on derivative instruments, net of tax	0	0	0	(320)	0	0	(320)
Foreign currency translation, net of tax	0	0	0	173	0	97	270
Stock compensation expense	0	1,824	0	0	0	0	1,824
Exercise of options	$ 0	13	0	0	0	0	13
Exercise of options (in shares)	843
Settlement of call options, net of tax	$ 0	34	0	0	0	0	34
Dividends	0	0	0	0	(1,187)	0	(1,187)
Net income	0	0	0	0	10,831	35	10,866
Ending balance at Sep. 30, 2023	$ 199	$ 117,143	$ (78,093)	$ (3,855)	$ 103,517	$ 1,308	$ 140,219
Ending balance (in shares) at Sep. 30, 2023							17,596,422

XML

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Consolidated Statements of Changes in Stockholders' Equity [Abstract]
Unrealized loss on MSA investments, tax	$ 168	$ 108
Unrealized loss on derivative instruments, tax	102	361
Foreign currency translation, tax	0	0
Settlement of call options, tax	$ 11	$ 28

XML

Description of Business and Basis of Presentation

9 Months Ended

Sep. 30, 2023

Description of Business and Basis of Presentation [Abstract]

Description of Business and Basis of Presentation

Note 1. Description of Business and Basis of Presentation

Description of Business

Turning Point Brands, Inc. and its subsidiaries (collectively referred to herein as the “Company,” “we,” “our,” or “us”) is a leading manufacturer, marketer and distributor of branded consumer products. The Company sells a wide range of products to adult consumers consisting of staple products with its iconic brands Zig-Zag^® and Stoker’s^® and its next generation products to fulfill evolving consumer preferences. Its segments are led by its core, proprietary brands: Zig-Zag^® and CLIPPER^® in the Zig-Zag Products segment and Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment. The Company’s products are available in more than 217,000 retail outlets in North America. The Company operates in three segments: (i) Zig-Zag Products, (ii) Stoker’s Products, and (iii) Creative Distribution Solutions (formerly known as NewGen).

Basis of Presentation

The accompanying unaudited, interim, consolidated financial statements have been prepared in accordance with the accounting practices described in the Company’s audited, consolidated financial statements as of and for the year ended December 31, 2022. In the opinion of management, the unaudited, interim, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods presented. Such adjustments, other than nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, 2022. The accompanying interim, consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the United States (“GAAP”) with respect to annual financial statements.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries, all of which are wholly-owned, and variable interest entities (“VIEs”) for which the Company is considered the primary beneficiary. All significant intercompany transactions have been eliminated.

Revenue Recognition

The Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606), which includes excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns and incentives, upon delivery of goods to the customer – at which time the Company’s performance obligation is satisfied - at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. The Company excludes from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on smokeless tobacco, cigars or vaping products billed to customers).

The Company records an allowance for sales returns, based principally on historical volume and return rates, which is included in accrued liabilities on the consolidated balance sheets. The Company records sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction in revenues (a portion of which is based on amounts estimated to be due to wholesalers, retailers and consumers at the end of the period) based principally on historical volume and utilization rates. Expected payments for sales incentives are included in accrued liabilities on the consolidated balance sheets.

A further requirement of ASC 606 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company’s management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16, “Segment Information”. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.

Shipping Costs

The Company records shipping costs incurred as a component of selling, general, and administrative expenses. Shipping costs incurred were approximately $5.1 million and $5.8 million for the three months ending September 30, 2023 and 2022, respectively. Shipping costs incurred were approximately $17.0 million and $17.9 million for the nine months ending September 30, 2023 and 2022, respectively.

Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out (“FIFO”) method. Leaf tobacco is presented in current assets in accordance with standard industry practice, notwithstanding the fact that such tobaccos are carried longer than one year for the purpose of curing.

Fair Value

GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

The three levels of the fair value hierarchy under GAAP are described below:

● Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.

● Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

Derivative Instruments

The Company enters into foreign currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging. Under the Company’s policy, the Company may hedge up to 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed twelve months. The Company may also, from time to time, hedge up to 100% of its non-inventory purchases (e.g. production equipment) in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are reclassified from other comprehensive income into inventory as the related inventories are received and are transferred to net income as inventory is sold. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

Risks and Uncertainties

Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others, labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In a number of states, targeted flavor bans have been proposed or enacted legislatively or by the administrative process. Depending on the number and location of such bans, that legislation or regulation could have a material adverse effect on the Company’s financial position, results of operations or cash flows. The U.S. Food and Drug Administration (“FDA”) continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing, and ultimate implementation of such measures remain unclear.

The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of Creative Distribution Solutions products due to malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

Master Settlement Agreement (MSA):  Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General) and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. Such companies are entitled to direct the investment of the escrowed funds and withdraw any appreciation but cannot withdraw the principal for twenty-five years from the year of each annual deposit, except to withdraw funds deposited pursuant to an individual state’s escrow statute to pay a final judgement to that state’s plaintiffs in the event of such a final judgement against the Company. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy to record amounts on deposit in the escrow account for prior years as a non-current asset. As of September 30, 2023, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $27.5 million. At December 31, 2022, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.0 million. The Company discontinued its generic category of MYO in 2019 and its Zig-Zag branded MYO cigarette smoking tobacco in 2017. Thus, pending a change in MSA legislation, the Company has no remaining product lines covered by the MSA and will not be required to make future escrow deposits. We expect to begin withdrawal of the funds deposited beginning in 2024 so long as these deposits do not become subject to litigation under the MSA-related statutes.

The Company has chosen to invest a portion of the MSA escrow, from time to time, in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity.

Fair values for the U.S. Governmental agency obligations are Level 2 in the fair value hierarchy. The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

	As of September 30, 2023							As of December 31, 2022
			Gross			Estimated				Gross			Estimated
			Unrealized			Fair				Unrealized			Fair
	Cost		Losses			Value		Cost		Losses			Value
Cash and cash equivalents	$	1,929	$	–		$	1,929	$	1,929	$	–		$	1,929
U.S. Governmental agency obligations (unrealized position < 12 months)		–		–			–		10,226		(1,251	)		8,975
U.S. Governmental agency obligations (unrealized position > 12 months)		30,144		(4,539	)		25,605		19,918		(2,842	)		17,076
	$	32,073	$	(4,539	)	$	27,534	$	32,073	$	(4,093	)	$	27,980

	As of
	September 30, 2023
Less than one year	$	2,200
One to five years		10,238
Five to ten years		15,751
Greater than ten years		1,955
Total	$	30,144

The following shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of
Sales Year	September 30, 2023		December 31, 2022
1999	$	211	$	211
2000		1,017		1,017
2001		1,673		1,673
2002		2,271		2,271
2003		4,249		4,249
2004		3,714		3,714
2005		4,553		4,553
2006		3,847		3,847
2007		4,167		4,167
2008		3,364		3,364
2009		1,619		1,619
2010		406		406
2011		193		193
2012		199		199
2013		173		173
2014		143		143
2015		101		101
2016		91		91
2017		82		82
Total	$	32,073	$	32,073

FDA: On June 22, 2009, the Family Smoking Prevention and Tobacco Control Act (the “FSPTCA”) authorized the FDA to immediately regulate the manufacturing, sale, and marketing of four categories of tobacco products – cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. On August 8, 2016, the FDA deeming regulation became effective. The deeming regulation gave the FDA the authority to also regulate cigars, pipe tobacco, e-cigarettes, vaporizers, and e-liquids as “deemed” tobacco products under the FSPTCA.

The FDA currently assesses tobacco product user fees on six classes of regulated tobacco products and computes user fees using a methodology similar to the methodology used by the U.S Department of Agriculture to compute the Tobacco Transition Payment Program (“TTPP,” also known as the “Tobacco Buyout”) assessment. First, the total, annual, congressionally established user fee assessment is allocated among the various classes of tobacco products using the federal excise tax weighted market share of tobacco products subject to regulation. Then, the assessment for each class of tobacco products is divided among individual manufacturers and importers.

In August 2016, the FDA’s regulatory authority under the Tobacco Control Act was extended to all tobacco products not previously covered, including: (i) certain Creative Distribution Solutions products (such as electronic cigarettes, vaporizers and e-liquids) and their components or parts (such as tanks, coils and batteries); (ii) cigars and their components or parts (such as cigar tobacco and wraps); (iii) pipe tobacco; (iv) hookah products; and (v) any other tobacco product “newly deemed” by the FDA. These “deeming regulations” apply to all products made or derived from tobacco intended for human consumption, but excluding accessories of tobacco products (such as lighters). Accordingly, the FDA has since regulated our cigar and cigar wrap products as well as our vapor products containing tobacco-derived nicotine and products intended or reasonably expected to be used to consume such e-liquids.

Subsequently, on April 14, 2022, the FDA Center for Tobacco Products also obtained jurisdiction over non-tobacco nicotine products (“NTN Products”), including synthetic nicotine. That law subjects NTN Products to the same requirements as tobacco-derived products, including not selling these products to persons under 21 years of age, not marketing these products as modified risk tobacco products without authorization, and not distributing free samples of these products. Additionally, NTN Products became subject to premarket filing requirements. Under the new law, manufacturers were required to file a Premarket Tobacco Application (“PMTA”) by May 14, 2022, in order to continue selling products currently on the market. NTN Products subject of a timely-filed PMTA, and not in receipt of a negative action, were allowed to remain on the market until July 13, 2022, at which time these products became subject to enforcement, similar to tobacco-derived products remaining under review.

A successful PMTA must demonstrate that the subject product is “appropriate for the protection of public health,” taking into account the effect of the marketing of the product on all sub-populations while a Substantial Equivalence Report must demonstrate that a new product either has the same characteristics as its predicate product or different characteristics but does not raise different questions of public health. We submitted premarket filings for certain of our regulated products in order to continue selling these products while they remain under review. We have continued to supplement these applications with additional information and have responded to information requests from the FDA; however, there can be no guarantee that the FDA will accept such amendments and responses or that the applications will meet the standard of “appropriate for the protection of public health” or “substantially equivalent,” as appropriate. The FDA has indicated its enforcement priority is those applicants who have received negative action on their application, such as a Marketing Denial Order or Refuse to File notification and who continue to illegally sell those unauthorized products, as well as products for which manufacturers failed to submit a marketing application. Despite these stated enforcement priorities, given the FDA’s limited resources we expect that for a period of time there may be a lack of enforcement, which may adversely impact our ability to compete in the marketplace against those who continue to sell unauthorized products. There can be no guarantee that the FDA will not shift its enforcement priorities or that it will increase in ability to enforce against unauthorized products over time.

On October 5, 2021, the FDA finalized two rules related to the Substantial Equivalence process and the Premarket Tobacco Product Application process, respectively, which both became effective November 4, 2021. Both final rules (collectively, the “Rules”) indicate that any new or additional requirements will not retroactively apply to currently pending PMTAs for tobacco and tobacco-derived products; however, the information outlined in the rule remains important to the FDA’s substantive review of an application. The FDA has yet to indicate how it might apply these Rules to NTN Product filings. We believe we have products that meet the Rules and have filed premarket filings supporting a showing of the respective required standards. However, there is no assurance that the FDA’s guidance or regulations will not change, or that the FDA will not prioritize its enforcement in a manner that negatively affects our pending applications, or that unforeseen circumstances will not arise that prevent us from sufficiently supplementing or completing our applications or otherwise increases the amount of time and money we are required to spend to receive all necessary marketing orders. Although we filed many premarket applications in a timely manner, no assurance can be given that the applications will ultimately be successful. This may result in the prioritization of supplementing or completing applications for high priority SKUs in our inventory position, which could adversely impact future revenues generated by lower priority SKUs.

In addition, we currently distribute many third-party manufactured vapor products for which we are completely dependent on the manufacturer complying with the premarket filing requirements. There can be no assurance that these third-party products will receive a marketing order or otherwise remain in compliance with relevant legal requirements. While we will take measures to pursue regulatory compliance for our own privately-branded or proprietary vape products that compete with these third-party products, there is no assurance that such proprietary products would be as successful in the marketplace or can fully displace third-party products that are currently being distributed by us, which could adversely affect our results of operations and liquidity. Additionally, FDA has limited resources, which may impact its ability to meaningfully enforce these provisions. This may adversely affect our ability to compete in the marketplace against those who continue to sell unauthorized products; however, regulatory uncertainty in the FDA’s enforcement policies may likewise affect operations or sales of our proprietary products if the FDA’s policies or priorities shift.

On May 4, 2022, the FDA proposed two tobacco product standards related to combusted tobacco products: (1) a ban on menthol as a characterizing flavor in cigarettes; and (2) a ban on all characterizing flavors (including menthol) in cigars. On June 21, 2022, the FDA also issued a proposed product standard related to restricting the level of nicotine in traditional cigarettes. These product standards are required to go through the formal rulemaking process where we have had the opportunity to provide comments with regard to the impact such standards would have on our products. These proposed rules remain pending. The FDA’s policy on these and other regulated products may change or expand over time in ways not yet known and may significantly impact our products or our premarket filings.

Prevent All Cigarette Trafficking Act (“PACT Act”): On December 27, 2020, President Trump signed the Further Consolidated Appropriations Act, 2021, into law. This law included an amendment to the Jenkins Act expanding the definition of “cigarette” to include “electronic nicotine delivery systems,” or ENDS, and required that the United States Postal Service (“USPS”) promulgate regulations clarifying the applicability of the prohibition on delivery sales of cigarettes to ENDS. USPS issued its final rule on October 21, 2021. We have received appropriate shipping exemptions from carrier services we use to carry the affected freight. Failure to comply with the PACT Act could result in significant financial or criminal penalties. To the extent we are unable to respond to, or comply with, these new requirements, we could lose our shipping exemptions, be subject to civil or criminal penalties, or there could be a material adverse effect on our business, results of operations and financial condition. 

XML

Derivative Instruments

9 Months Ended

Sep. 30, 2023

Derivative Instruments [Abstract]

Derivative Instruments

Note 3. Derivative Instruments

Foreign Currency

During the nine months ended September 30, 2023, the Company executed various foreign exchange contracts, which met hedge accounting requirements for the purchase of €20.1 million and the sale of €15.2 million.

At September 30, 2023, the Company had foreign currency contracts outstanding for the purchase of €17.1 million and sale of €15.2 million. The foreign currency contracts’ fair value at September 30, 2023, resulted in an asset of $0.1 million included in Other current assets and a liability of $0.5 million included in Accrued liabilities. At December 31, 2022, the Company had foreign currency contracts for the purchase of €18.5 million and sale of €18.5 million. The foreign currency contracts’ fair value at December 31, 2022, resulted in an asset of $1.2 million included in Other current assets and a liability of $0.0 million included in Accrued liabilities.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2023

Fair Value of Financial Instruments [Abstract]

Fair Value of Financial Instruments

Note 4. Fair Value of Financial Instruments

The estimated fair value amounts have been determined by the Company using the methods and assumptions described below. However, considerable judgment is required to interpret market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

Cash and Cash Equivalents

Cash and cash equivalents are, by definition, short-term. Thus, the carrying amount is a reasonable estimate of fair value.

Accounts Receivable

The fair value of accounts receivable approximates their carrying value due to their short-term nature.

Long-Term Debt

The Company’s Senior Secured Notes (as defined in Note 10) bear interest at a rate of 5.625% per year. As of September 30, 2023, the fair value approximated $226.7 million, with a carrying value of $250 million. As of December 31, 2022, the fair value of the Senior Secured Notes approximated $226.4 million, with a carrying value of $250 million.

The Convertible Senior Notes (as defined in Note 10) bear interest at a rate of 2.50% per year, and the fair value of the Convertible Senior Notes without the conversion feature approximated $112.4 million, with a carrying value of $118.5 million as of September 30, 2023. As of December 31, 2022, the fair value of the Convertible Senior Notes without the conversion feature approximated $139.2 million, with a carrying value of $162.5 million.

See Note 10, “Notes Payable and Long-Term Debt”, for further information regarding the Company’s long-term debt.

XML

Inventories

9 Months Ended

Sep. 30, 2023

Inventories [Abstract]

Inventories

Note 5. Inventories

The components of inventories are as follows:

	September 30,		December 31,
	2023		2022
Raw materials and work in process	$	5,512	$	7,283
Leaf tobacco		53,018		43,468
Finished goods - Zig-Zag Products		40,988		42,279
Finished goods - Stoker’s Products		8,729		9,667
Finished goods - Creative Distribution Solutions		7,059		15,431
Other		1,620		1,787
Inventories	$	116,926	$	119,915

The inventory valuation allowance was $4.1 million and $4.5 million as of  September 30, 2023, and December 31, 2022, respectively.

XML

Other Current Assets

9 Months Ended

Sep. 30, 2023

Other Current Assets [Abstract]

Other Current Assets

Note 6. Other Current Assets

Other current assets consist of:

	September 30,		December 31,
	2023		2022
Inventory deposits	$	5,357	$	6,395
Insurance deposit		3,000		3,000
Prepaid taxes		1,675		448
Other		13,290		13,116
Total	$	23,322	$	22,959

XML

Property, Plant, and Equipment

9 Months Ended

Sep. 30, 2023

Property, Plant, and Equipment [Abstract]

Property, Plant, and Equipment

Note 7. Property, Plant, and Equipment

Property, plant, and equipment consists of:

	September 30,			December 31,
	2023			2022
Land	$	22		$	22
Buildings and improvements		3,940			3,096
Leasehold improvements		5,252			5,404
Machinery and equipment		28,837			25,832
Furniture and fixtures		8,138			9,264
Gross property, plant and equipment		46,189			43,618
Accumulated depreciation		(21,576	)		(20,830	)
Net property, plant and equipment	$	24,613		$	22,788

XML

Other Assets

9 Months Ended

Sep. 30, 2023

Other Assets [Abstract]

Other Assets

Note 8. Other Assets

Other assets consist of:

	September 30,		December 31,
	2023		2022
Equity investments	$	2,421	$	13,376
Debt security investment		7,765		7,820
Other		6,340		1,453
Total	$	16,526	$	22,649

The Company records its equity investments without a readily determinable fair value, that are not accounted for under the equity method, at cost, with adjustments for impairment and observable price changes.

In July 2021, the Company invested $8.0 million in Old Pal Holding Company LLC (“Old Pal”). In July 2022, the Company invested an additional $1.0 million in Old Pal.  The Company invested in the form of a convertible note which includes additional follow-on investment rights. The accrued interest of $0.2 million from July 2021 to July 2022 was rolled into the convertible note in July 2022 resulting in a total investment of $9.2 million. Old Pal is a leading brand in the cannabis lifestyle space that operates a non-plant touching licensing model. The convertible note bears an interest rate of 3.0% per year and matures July 31, 2026.Interest and principal not paid to date are receivable at maturity. Old Pal has the option to extend the maturity date in one-year increments. The interest rate is subject to change based on Old Pal reaching certain sales thresholds. The weighted average interest rate on the convertible note was 3.0% for the three and nine months ended September 30, 2023. Old Pal has the option to convert the note into shares once sales reach a certain threshold. The conditions required to allow Old Pal to convert the note were not met as of September 30, 2023. Additionally, the Company has the right to convert the note into shares at any time after January 1, 2022. The Company has classified the debt security with Old Pal as available for sale. The Company reports interest income on available for sale debt securities in interest income in our Consolidated Statements of Income. Quarterly, we perform a qualitative assessment to determine if the fair value of the investment could be less than the amortized cost basis.  The fourth quarter 2022 qualitative assessment determined that the fair value of the investment could be less than the amortized cost basis and therefore the Company performed a quantitative assessment of the fair value of the investment.  The fair value as of December 31, 2022 was determined to be $7.9 million based on a Monte Carlo simulation (Level 3).  The Company determined that the impairment was a result of credit related factors and, as such, recorded an allowance for credit losses of $1.4 million which is included in investment loss for the year ended December 31, 2022. In the second quarter of 2023, based on a subsequent quantitative assessment of the fair value using a Monte Carlo simulation, the Company determined the fair value to be $7.7 million and recorded an additional allowance for credit losses of $0.3 million which is included in investment loss for the nine months ended September 30, 2023. The Company has recorded accrued interest receivable of $0.1 million and $0.1 million at September 30, 2023 and December 31, 2022, respectively, in other current assets on our Consolidated Balance Sheets.

In April 2021, the Company invested $8.7 million in Docklight Brands, Inc., a pioneering consumer products company with celebrated brands including Marley Natural® cannabis and Marley™ CBD. The Company has additional follow-on investment rights. As part of the investment, the Company has obtained exclusive U.S. distribution rights for Docklight’s Marley™ CBD topical products. In the first quarter of 2023, based on Docklight’s financial results and other operating difficulties, and the decline in the revenue multiples for public companies comparable to Docklight, the Company deemed the investment in Docklight was impaired resulting in the fair value of the Company’s investment decreasing to $3.8 million resulting in a loss of $4.9 million which was recorded for the three months ended March 31, 2023. In the second quarter of 2023, based on a significant change in Docklight’s business model, the Company deemed its investment in Docklight fully impaired resulting in an additional loss of $3.8 million bringing the fair value of the Company’s investment in Docklight to zero. Impairment losses for the Company’s investment in Docklight are recorded in Investment loss on our Consolidated Statements of Income.  Fair value for both periods was determined using a valuation derived from relevant revenue multiples (Level 3).

In October 2020, the Company invested $2.5 million to acquire a 20% stake in Wild Hempettes, LLC, a manufacturer of natural CBD cigarettes designed as the first cigarette-styled CBD pre-roll in the world. The Company has options to increase its stake to a 100% ownership position based on certain milestones. As part of the transaction, the Wild Hempettes joint venture was spun off from Crown Distributing LLC and formed as a vehicle for the Company to be the exclusive distributor of Hempettes™ cigarettes to U.S. bricks and mortar retailers under a profit-sharing arrangement. Effective January 2023, the Company terminated its distribution agreement. The Company accounts for its 20% share of Wild Hempettes profit or loss using the equity method of accounting. In the third quarter of 2023, based on Wild Hempettes financial results, the Company deemed its investment in Wild Hempettes to be other-than-temporarily impaired resulting in a $2.2 million impairment charge included in investment loss for the three and nine months ended September 30, 2023. Fair value for its share of investment in Wild Hempettes was determined using a valuation derived from relevant revenue multiples (Level 3).  As a result of the analysis, the Company’s 20% stake represents a fair value of $0.3 million.

In October 2020, the Company invested $15.0 million in dosist™ (“Dosist”), a global cannabinoid company, with an option to invest an additional $15.0 million on pre-determined terms over the twelve month period ending October 2021. The Company received a warrant exercisable for preferred shares of Dosist that would automatically be exercised upon the changing of certain federal cannabis laws in the United States, rescheduling cannabis and/or permitting the general cultivation, distribution and possession of cannabis. In the fourth quarter 2021, based on the financial results of Dosist and the overall cannabinoid market, the Company deemed its investment was impaired resulting in the fair value decreasing to $7.9 million. In the second quarter of 2022, based on a contemplated sale of the assets of Dosist, the Company deemed its investment was impaired resulting in a further decrease in fair value of the investment to $1.6 million. Fair value was determined using a valuation derived from the contemplated purchase price (Level 3). This resulted in a loss of $6.3 million which is recorded in investment loss for the nine months ended September 30, 2022. Subsequent to the second quarter of 2022 impairment, the contemplated sale of assets did not occur and Dosist entered into a new agreement with a new buyer receiving the assets of Dosist for the assumption of its liabilities. As such, the Company considered its $1.6 million remaining investment to be fully impaired as of December 31, 2022.

XML

Accrued Liabilities

9 Months Ended

Sep. 30, 2023

Accrued Liabilities [Abstract]

Accrued Liabilities

Note 9. Accrued Liabilities

Accrued liabilities consist of:

	September 30,		December 31,
	2023		2022
Accrued payroll and related items	$	6,299	$	7,685
Customer returns and allowances		6,384		7,291
Taxes payable		1,259		1,867
Lease liabilities		2,809		3,102
Accrued interest		2,507		7,277
Other		7,969		5,779
Total	$	27,227	$	33,001

XML

Notes Payable and Long-Term Debt

9 Months Ended

Sep. 30, 2023

Notes Payable and Long-Term Debt [Abstract]

Notes Payable and Long-Term Debt

Note 10. Notes Payable and Long-Term Debt

Notes payable and long-term debt consists of the following in order of preference:

	September 30,			December 31,
	2023			2022
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		118,541			162,500
Gross notes payable and long-term debt		368,541			412,500
Less deferred finance charges		(3,720	)		(5,743	)
Less current maturities		(48,248	)		–
Notes payable and long-term debt	$	316,573		$	406,757

Senior Secured Notes

On February 11, 2021, the Company closed a private offering (the “Offering”) of $250.0 million aggregate principal amount of its 5.625% senior secured notes due 2026 (the “Senior Secured Notes” or the “Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.The Company used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any credit facility (as defined in the indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

The Company may redeem the Senior Secured Notes, in whole or in part, at any time on or after February 15, 2023, at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

If the Company experiences a change of control (as defined in the Senior Secured Notes Indenture), the Company must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. The Company was in compliance with all covenants as of September 30, 2023.

The Company incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the effective interest method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, the Company also entered into a new $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). On May 10, 2023, the Company and certain of its subsidiaries, as guarantors, entered into an amendment (the “Amendment”) to the 2021 Revolving Credit Facility (as amended, the “Amended Revolving Credit Facility”).  The Amendment includes certain modifications to the 2021 Revolving Credit Facility relating to the replacement of the London Inter-Bank Offered Rate with a Secured Overnight Financing Rate (“SOFR”) as the interest rate benchmark under the 2021 Revolving Credit Facility and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

Letters of credit are limited to $10.0 million (and are a part of, and not in addition to, the revolving line of credit). The Company has not drawn any borrowings under the Amended Revolving Credit Facility but does have letters of credit of approximately $1.4 million outstanding under the facility as of September 30, 2023. The Amended Revolving Credit Facility will mature on August 11, 2025, if none of the Company’s Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is 91 days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.

Interest is payable on the Amended Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate or the Term SOFR rate, as applicable, plus an applicable margin of 3.50% (with step-downs upon de-leveraging). The Company also has the option to borrow at a rate determined by reference to the base rate.

The obligations under the Amended Revolving Credit Agreement are guaranteed on a joint and several basis by the Guarantors. The Company’s and Guarantors’ obligations under the Amended Revolving Credit Facility are secured on a pari passu basis with the Senior Secured Notes.

The Amended Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The Amended Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio (as defined in the Amended Revolving Credit Agreement) of 5.50 to 1.00 (with a step down to 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the Amended Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $5.0 million) in the aggregate outstanding exceeds 35% of the total commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Agreement provides for customary events of default. The Company was in compliance with all covenants as of September 30, 2023.

The Company incurred debt issuance costs attributable to the issuance of the Amended Revolving Credit Facility of $0.5 million which are amortized to interest expense using the effective interest method over the expected life of the Amended Revolving Credit Facility.

On November 7, 2023, in connection with the entry by a subsidiary of the Company in a new asset-backed revolving credit facility, the Company terminated the Amended Revolving Credit Agreement.

2023 ABL Facility

On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a new $75.0 million  asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and LILO Loans. The 2023 ABL Facility includes a $40.0 million accordion feature.  In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.

The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves.  The 2023 ABL Facility also includes a “last in last out” (“LILO”) borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of  (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters on or after the closing date if excess availability shall be less than the greater of (a) 12.5% of the line cap and (b) $9.4 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.4 million for thirty (30) consecutive calendar days; provided that such $9.4 million level shall automatically increase in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.

The 2023 ABL Facility shall mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

Convertible Senior Notes

In July 2019, the Company closed an offering of $172.5 million in aggregate principal amount of its 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes are senior unsecured obligations of the Company.

In the fourth quarter of 2022, a wholly owned subsidiary of the Company repurchased $10.0 million in aggregate principal amount of the Convertible Senior Notes on the open market resulting in a $0.9 million gain on extinguishment of debt. Subsequent principal repurchases occurred in the first, second and third quarters of 2023 for $13.9 million, $15.1 million and $15.0 million, respectively, in aggregate principal amounts resulting in gains on extinguishment of debt of $0.7 million, $0.6 million and $0.6 million, respectively. The repurchased notes continue to be held by our subsidiary and may be resold subject to compliance with applicable securities law. As of September 30, 2023, $118.5 million aggregate principal remains outstanding and held by third parties.

The Convertible Senior Notes held by third parties are convertible into approximately 2,216,029 shares of TPB Common Stock under certain circumstances prior to maturity at a conversion rate of 18.6942 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $53.49 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by the Company in excess of pre-determined thresholds of $0.04 per share. Upon conversion, the Company may pay cash, shares of common stock or a combination of cash and stock, as determined by the Company at its discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of September 30, 2023.

The Convertible Senior Notes of $118.5 million as of September 30, 2023, became current in the third quarter of 2023. As discussed above, on November 7, 2023, a wholly-owned subsidiary of the Company entered into the new 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior notes at maturity. As a result, the Company reclassified $70.0 million related to the Convertible Senior Notes from Current portion of long-term debt to Notes payable and long-term debt on the Company’s September 30, 2023 Balance Sheet. Based on current liquidity, free cash flow generation and availability under the 2023 ABL Facility, the Company believes it will have sufficient liquidity to address the maturity of the remaining Convertible Senior Notes.

The Company incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to interest expense using the effective interest method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, the Company entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $53.49 per and a cap price of $82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. The Company paid $20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

XML

Leases

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Leases

Note 11. Leases

The Company’s leases consist primarily of leased property for manufacturing, warehouse, corporate offices and retail space as well as vehicle leases. At lease inception, the Company recognizes a lease right of use asset and lease liability calculated as the present value of future minimum lease payments. In general, the Company does not recognize any renewal periods within the lease terms as there are no significant barriers to ending the lease at the initial term. Lease and non-lease components are accounted for as a single lease component.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for these leases is recognized on a straight-line basis over the lease term.

The components of lease expense consisted of the following:

	Three Months Ended September 30,
	2023		2022
Operating lease cost
Cost of sales	$	125	$	240
Selling, general and administrative		496		348
Variable lease cost (1)		301		235
Short-term lease cost		7		6
Total	$	929	$	829

(1) Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

	Three Months Ended September 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	397	$	332
Total	$	397	$	332

	Nine Months Ended September 30,
	2023		2022
Operating lease cost
Cost of sales	$	382	$	700
Selling, general and administrative		1,520		1,133
Variable lease cost (1)		933		558
Short-term lease cost		20		31
Total	$	2,855	$	2,422

	Nine Months Ended September 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	1,083	$	920
Total	$	1,083	$	920

	September 30,		December 31,
	2023		2022
Assets:
Right of use assets - Operating	$	10,332	$	10,967
Right of use assets - Financing		1,728		1,498
Total lease assets	$	12,060	$	12,465
Liabilities:
Current lease liabilities - Operating (2)	$	1,717	$	2,007
Current lease liabilities - Financing (2)		1,092		1,095
Long-term lease liabilities - Operating		9,854		10,243
Long-term lease liabilities - Financing		579		350
Total lease liabilities	$	13,242	$	13,695

(2) Reported within accrued liabilities on the balance sheets.

XML

Income Taxes

9 Months Ended

Sep. 30, 2023

Income Taxes [Abstract]

Income Taxes

Note 12. Income Taxes

The Company’s effective income tax rate for the three and nine months ended September 30, 2023 was 25.7% and 25.5%, respectively. The Company’s effective income tax rate for the three and nine months ended September 30, 2022 was 25.2% and 24.2%, respectively, which includes a discrete tax deduction of $0.0 million and $0.7 million, respectively, relating to stock option exercises.

The Company follows the provisions of ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company has determined that the Company did not have any uncertain tax positions requiring recognition under the provisions of ASC 740-10-25. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of interest expense. The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. In general, the Company is no longer subject to U.S. federal and state tax examinations for years prior to 2019.

XML

Share Incentive Plans

9 Months Ended

Sep. 30, 2023

Share Incentive Plans [Abstract]

Share Incentive Plans

Note 13. Share Incentive Plans

On March 22, 2021, the Company’s Board of Directors adopted the Turning Point Brands, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2021 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2021 Plan, 1,290,000 shares, plus 100,052 shares remaining available for issuance under the 2015 Equity Incentive Plan (the “2015 Plan”), of TPB Common Stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2021 Plan is scheduled to terminate on March 21, 2031. The 2021 Plan is administered by the compensation committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in the award agreement. As of September 30, 2023, net of forfeitures, there were 276,484 Restricted Stock Units (“RSUs”), 118,519 options and 29,172 Performance-Based Restricted Stock Units (“PRSUs”) granted under the 2021 Plan. There are 965,877 shares available for grant under the 2021 Plan.

On April 28, 2016, the Board of Directors of the Company adopted the 2015 Plan, pursuant to which awards could have been granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provided for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2015 Plan, 1,400,000 shares of TPB Common Stock were reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2015 Plan was scheduled to terminate on April 27, 2026. Upon adoption of the 2021 Plan, the 2015 Plan was terminated, and the Company determined no additional grants would be made under the 2015 Plan. However, all awards issued under the 2015 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2015 Plan. The 2015 Plan was administrated by the Committee.

On February 8, 2006, the Board of Directors of the Company adopted the 2006 Equity Incentive Plan (the “2006 Plan”) of North Atlantic Holding Company, Inc., pursuant to which awards may be granted to employees. The 2006 Plan provides for the granting of nonqualified stock options and restricted stock awards to employees. Upon the adoption of the Company’s 2015 Equity Incentive Plan in connection with its IPO, the Company determined no additional grants would be made under the 2006 Plan. However, all awards issued under the 2006 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2006 Plan.

Stock option activity for the 2006, 2015 and 2021 Plans is summarized below:

				Weighted		Weighted
	Stock			Average		Average
	Option			Exercise		Grant Date
	Shares			Price		Fair Value
Outstanding, December 31, 2021		619,835		$	28.51	$	8.70
Granted		114,827			30.58		10.34
Exercised		(40,331	)		12.49		4.08
Forfeited		(11,117	)		32.60		9.35
Outstanding, December 31, 2022		683,214		$	29.74	$	9.24
Granted		77,519			20.71		6.45
Exercised		(30,214	)		13.87		4.37
Forfeited		(65,214	)		27.38		9.11
Outstanding, September 30, 2023		665,305		$	29.67	$	9.14

Under the 2006, 2015 and 2021 Plans, the total intrinsic value of options exercised during the nine months ended September 30, 2023 and 2022, was $0.2 million, and $0.7 million, respectively.

At September 30, 2023, under the 2006 Plan, the exercise price for the 46,824 outstanding options is $3.83 per share, all of which are exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $3.83 is approximately .85 years. The Company estimates the expected life of these stock options is ten years from the date of grant. For the $3.83 per share options, the weighted average fair value of options at the date of grant was determined using the Black-Scholes model with the following assumptions: a ten-year life from grant date, a current share price and exercise price of $3.83, a risk-free interest rate of 3.57%, volatility of 40%, and no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $2.17 per share option granted.

At September 30, 2023, under the 2015 and 2021 Plans, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.

The following table outlines the assumptions based on the number of options granted under the 2015 Plan.

	February 10,			May 17,			March 7,			March 20,			October 24,			March 18,			February 18,			May 3,
	2017			2017			2018			2019			2019			2020			2021			2021
Number of options granted		40,000			93,819			98,100			155,780			25,000			155,000			100,000			12,000
Options outstanding at September 30, 2023		20,000			39,983			51,567			125,834			25,000			80,975			90,253			12,000
Number exercisable at September 30, 2023		20,000			39,983			51,567			125,834			25,000			80,975			63,727			8,040
Exercise price	$	13.00		$	15.41		$	21.21		$	47.58		$	20.89		$	14.85		$	51.75		$	47.76
Remaining lives		3.37			3.63			4.44			5.47			6.07			6.47			7.39			7.59
Risk free interest rate		1.89	%		1.76	%		2.65	%		2.34	%		1.58	%		0.79	%		0.56	%		0.84	%
Expected volatility		27.44	%		26.92	%		28.76	%		30.95	%		31.93	%		35.72	%		28.69	%		29.03	%
Expected life		6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000
Dividend yield		–			–			0.83	%		0.42	%		0.95	%		1.49	%		0.55	%		0.59	%
Fair value at grant date	$	3.98		$	4.60		$	6.37		$	15.63		$	6.27		$	4.41		$	13.77		$	13.06

The following table outlines the assumptions based on the number of options granted under the 2021 Plan.

	May 17,			March 14,			April 29,			May 12,
	2021			2022			2022			2023
Number of options granted		7,500			100,000			14,827			77,519
Options outstanding at September 30, 2023		7,500			73,023			14,827			77,519
Number exercisable at September 30, 2023		5,100			24,995			5,042			58,139
Exercise price	$	45.05		$	30.46		$	31.39		$	20.71
Remaining lives		7.63			8.46			8.59			9.62
Risk free interest rate		0.84	%		2.10	%		2.92	%		3.41	%
Expected volatility		31.50	%		35.33	%		35.33	%		34.51	%
Expected life		6.000			6.000			6.000			5.186
Dividend yield		0.63	%		1.01	%		0.98	%		1.61	%
Fair value at grant date	$	13.23		$	10.23		$	11.07		$	6.45

The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $0.2 million and $0.3 million for the three months ended September 30, 2023 and 2022, respectively. The Company recorded compensation expense related to the options of approximately $0.6 million and $0.8 million for the nine months ended September 30, 2023 and 2022, respectively. Total unrecognized compensation expense related to options at September 30, 2023, is $0.3 million, which will be expensed over 0.94 years.

PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period provided the applicable service and performance conditions are satisfied. As of September 30, 2023, there are 456,922 PRSUs outstanding. The following table outlines the PRSUs granted and outstanding as of September 30, 2023.

	March 20,		March 18,		December 28,		February 18,		March 14,		May 4,
	2019		2020		2020		2021		2022		2023
Number of PRSUs granted		92,500		94,000		88,169		100,000		49,996		133,577
PRSUs outstanding at September 30, 2023		77,080		84,360		31,040		87,340		43,525		133,577
Fair value as of grant date	$	47.58	$	14.85	$	46.42	$	51.75	$	30.46	$	22.25
Remaining lives		0.25		1.25		0.25		2.25		3.25		2.50

The Company recorded compensation expense related to the PRSUs of approximately $0.8 million and $0.8 million in the consolidated statements of income for the three months ended September 30, 2023 and 2022, respectively, based on the probability of achieving the performance condition. The Company recorded compensation expense related to the PRSUs of approximately $1.9 million and $2.4 million in the consolidated statements of income for the nine months ended September 30, 2023 and 2022, respectively, based on the probability of achieving the performance condition. Total unrecognized compensation expense related to these awards at September 30, 2023, is $4.4 million which will be expensed over the service periods based on the probability of achieving the performance condition.

The Company has granted 228,640 RSUs which are outstanding and vest over one to five years. The following table outlines the RSUs granted and outstanding as of September 30, 2023.

	March 14,		March 14,		April 29,		May 5,		May 5,		May 8,
	2022		2022		2022		2023		2023		2023
Number of RSUs granted		50,004		28,726		4,522		130,873		22,472		20,101
RSUs outstanding at September 30, 2023		42,947		18,961		4,522		130,873		11,236		20,101
Fair value as of grant date	$	30.46	$	30.46	$	31.39	$	22.25	$	22.25	$	21.77
Remaining lives		3.25		1.25		3.25		2.50		0.25		0.60

The Company has recorded compensation expense related to the RSUs based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the RSUs on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the RSUs of approximately $0.8 million and $0.4 million for the three months ended September 30, 2023 and 2022. The Company recorded compensation expense related to the RSUs of approximately $2.2 million and $0.9 million for the nine months ended September 30, 2023 and 2022, respectively. Total unrecognized compensation expense related to RSUs at September 30, 2023, is $3.3 million, which will be expensed over 2.44 years.

XML

Contingencies

9 Months Ended

Sep. 30, 2023

Contingencies [Abstract]

Contingencies

Note 14. Contingencies

On October 9, 2020, a purported stockholder of Turning Point Brands, Inc. (“TPB” or the “Company”), Paul-Emile Berteau (the “Plaintiff”), filed a complaint in the Delaware Court of Chancery (the “Court”) relating to the merger of Standard Diversified, Inc. (“SDI”) with a TPB subsidiary (“Merger Sub”)pursuant to the Agreement and Plan of Merger and Reorganization, dated as of April 7, 2020, by and among TPB, SDI and Merger Sub (the “Action”). The complaint purports to assert two derivative counts for breach of fiduciary duty on TPB’s behalf and against the TPB Board of Directors and certain SDI affiliates (collectively, the “Defendants”). The third count also purports to assert a direct claim against TPB and its Board of Directors based on allegations that TPB’s Amended and Restated Bylaws are inconsistent with TPB’s certificate of incorporation. On October 26, 2020, the TPB Board of Directors adopted Amendment No. 1 to TPB’s Amended and Restated Bylaws, which amended the challenged section of the bylaws. On June 30, 2021, the Court granted in part and denied in part the Defendants’ motions to dismiss. Among other things, the Court dismissed TPB director H.C. Charles Diao as a defendant in the action and dismissed the third count of the Plaintiff’s complaint as moot.

The Defendants and the Company deny any wrongdoing but following a mediation in November 2022, the Defendants agreed to settle with the Plaintiff to eliminate the distraction, burden, expense, risks and potential delay of further litigation involving the asserted claims. The parties entered into a Stipulation and Agreement of Compromise, Settlement and Release, dated and filed with the Court on June 27, 2023 (together with the exhibits thereto, the “Settlement Stipulation”).  The material terms of the proposed settlement of the Action include, among other things, that the Defendants’ insurers will pay or cause to be paid an aggregate of $5,000,000 into an escrow account (the “Settlement Payment”) in exchange for a release of all claims.  Plaintiff also intends to seek an award of attorneys’ fees and expenses to Plaintiff’s counsel of up to $1,000,000 that will be paid out of the Settlement Payment with the remaining funds paid to the Company, and an additional mootness fee to Plaintiff’s counsel of up to $400,000 in connection with the third count of the complaint. The proposed settlement is subject to, and conditioned on approval by the Court, and no assurances can be given that such Court approval will be obtained. The impact to the Company is not expected to be material. 

Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages sought are significant and, if such a claim were brought against the Company, could have a material adverse effect on our business and results of operations. The Company is subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices or batteries and may be subject to claims in the future relating to other Creative Distribution Solutions products. The Company is still evaluating these claims and the potential defenses to them and may from time to time settle some such suits in order to eliminate distraction, burden, expense, risks and potential delay of further litigation involving the asserted claims. For example, the Company did not design or manufacture the products at issue; rather, the Company was merely the distributor. Nonetheless, there can be no assurance that the Company will prevail in these cases, and they could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.

We have several subsidiaries engaged in making, distributing, and selling vapor products. As a result of the overall publicity and controversy surrounding the vapor industry generally, many companies have received informational subpoenas from various regulatory bodies and in some jurisdictions regulatory lawsuits have been filed regarding marketing practices and possible underage sales. While we have received some such investigative requests with regard to the marketing of our vapor products, no regulatory bodies have taken action against us with regard to our marketing practices. To the extent that litigation becomes necessary, we believe that the subsidiaries have strong factual and legal defenses against claims that they unfairly marketed vapor products.

We have two franchisor subsidiaries. Like many franchise businesses, in the ordinary course of their business, these subsidiaries are from time-to-time responding parties to arbitration demands brought by franchisees. We recently won a dispositive motion in an arbitration brought by a former franchisee. We have one remaining former franchisee arbitration relating to claims of breach of contract and negligence allegations, among others. We believe we have good and valid substantive defenses against these claims and intend on vigorously defending our interests in this matter.

XML

Income Per Share

9 Months Ended

Sep. 30, 2023

Income Per Share [Abstract]

Income Per Share

Note 15. Income Per Share

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:

	Three Months Ended September 30,
	2023						2022
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	10,831					$	11,536
Denominator
Weighted average				17,595,980	$	0.62				17,749,294	$	0.65
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	10,831					$	11,536
Interest expense related to Convertible Senior Notes, net of tax		743						1,054
Diluted net income attributable to Turning Point Brands. Inc.	$	11,574					$	12,590
Denominator
Basic weighted average				17,595,980						17,749,294
Convertible Senior Notes				2,311,086						3,213,589
Stock options and restricted stock units				191,384						139,123
				20,098,450	$	0.58				21,102,006	$	0.60

	Nine Months Ended September 30,
	2023						2022
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	28,353					$	27,958
Denominator
Weighted average				17,569,493	$	1.61				18,021,554	$	1.55
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	28,353					$	27,958
Interest expense related to Convertible Senior Notes		2,546						3,162
Diluted net income attributable to Turning Point Brands. Inc.	$	30,899					$	31,120
Denominator
Basic weighted average				17,569,493						18,021,554
Convertible Senior Notes				2,637,252						3,213,589
Stock options and restricted stock units				209,041						166,342
				20,415,786	$	1.51				21,401,485	$	1.45

XML

Segment Information

9 Months Ended

Sep. 30, 2023

Segment Information [Abstract]

Segment Information

Note 16. Segment Information

In accordance with ASC 280, Segment Reporting, the Company has three reportable segments: (1) Zig-Zag Products; (2) Stoker’s Products; and (3) Creative Distribution Solutions. The Zig-Zag Products segment markets and distributes (a) rolling papers, tubes, and related products; and (b) finished cigars and MYO cigar wraps and (c) CLIPPER reusable lighters and other accessories. The Stoker’s Products segment (a) manufactures and markets moist snuff and (b) contracts for and markets loose leaf chewing tobacco products. The Creative Distribution Solutions segment (a) markets and distributes liquid vapor products and certain other products without tobacco and/or nicotine; (b) distributes a wide assortment of products to non-traditional retail outlets via VaporBeast; and (c) markets and distributes a wide assortment of products to individual consumers via the VaporFi B2C online platform. Products in the Zig-Zag Products and Stoker’s Products segments are distributed primarily through wholesale distributors in the U.S. and Canada while products in the Creative Distribution Solutions segment are distributed primarily through e-commerce to non-traditional retail outlets and direct to consumers in the U.S. Corporate unallocated includes the costs and assets of the Company not assigned to one of the three reportable segments such as intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries.

The accounting policies of these segments are the same as those of the Company. Corporate costs are not directly charged to the three reportable segments in the ordinary course of operations. The Company evaluates the performance of its segments and allocates resources to them based on operating income.

The tables below present financial information about reported segments:

	Three Months Ended September 30,
	2023			2022
Net sales
Zig-Zag products	$	46,754		$	52,061
Stoker’s products		36,916			33,525
Total Zig-Zag and Stoker’s products	$	83,670		$	85,586
Creative Distribution Solutions		18,052			22,216
Total	$	101,722		$	107,802
Gross profit
Zig-Zag products	$	26,745		$	28,035
Stoker’s products		20,572			18,279
Total Zig-Zag and Stoker’s products	$	47,317		$	46,314
Creative Distribution Solutions		4,305			6,398
Total	$	51,622		$	52,712
Operating income (loss)
Zig-Zag products	$	16,672		$	18,740
Stoker’s products		15,703			13,653
Corporate unallocated (1)(2)		(11,678	)		(12,714	)
Total Zig-Zag and Stoker’s products	$	20,697		$	19,679
Creative Distribution Solutions		(460	)		142
Total	$	20,237		$	19,821
Interest expense, net		3,984			4,802
Investment loss		2,101			(75	)
Gain on extinguishment of debt		(481	)		–
Income before income taxes	$	14,633		$	15,094
Capital expenditures
Zig-Zag products	$	3		$	29
Stoker’s products		1,211			940
Total Zig-Zag and Stoker’s products	$	1,214		$	969
Creative Distribution Solutions		–			–
Total	$	1,214		$	969
Depreciation and amortization
Zig-Zag products	$	269		$	124
Stoker’s products		795			738
Total Zig-Zag and Stoker’s products	$	1,064		$	862
Creative Distribution Solutions		562			453
Total	$	1,626		$	1,315

(1) Includes corporate costs that are not allocated to any of the three reportable segments.

(2) Includes costs related to PMTA of $0.3 million in 2023 and $1.2 million in 2022.

	Nine Months Ended September 30,
	2023			2022
Net sales
Zig-Zag products	$	135,363		$	143,959
Stoker’s products		106,634			98,816
Total Zig-Zag and Stoker’s products	$	241,997		$	242,775
Creative Distribution Solutions		66,276			68,846
Total	$	308,273		$	311,621
Gross profit
Zig-Zag products	$	75,557		$	80,808
Stoker’s products		60,005			54,044
Total Zig-Zag and Stoker’s products	$	135,562		$	134,852
Creative Distribution Solutions		17,155			21,123
Total	$	152,717		$	155,975
Operating income (loss)
Zig-Zag products	$	47,313		$	55,980
Stoker’s products		45,375			40,536
Corporate unallocated (1)(2)		(34,325	)		(40,692	)
Total Zig-Zag and Stoker’s products	$	58,363		$	55,824
Creative Distribution Solutions		261			1,372
Total	$	58,624		$	57,196
Interest expense, net		12,013			15,142
Investment loss		10,980			6,074
Gain on extinguishment of debt		(1,858	)		–
Income before income taxes	$	37,489		$	35,980
Capital expenditures
Zig-Zag products	$	1,088		$	4,588
Stoker’s products		3,118			2,074
Total Zig-Zag and Stoker’s products	$	4,206		$	6,662
Creative Distribution Solutions		–			–
Total	$	4,206		$	6,662
Depreciation and amortization
Zig-Zag products	$	803		$	309
Stoker’s products		2,210			2,275
Total Zig-Zag and Stoker’s products	$	3,013		$	2,584
Creative Distribution Solutions		1,690			1,400
Total	$	4,703		$	3,984

(1) Includes corporate costs that are not allocated to any of the three reportable segments.

(2) Includes costs related to PMTA of $1.1 million in 2023 and $4.3 million in 2022.

	September 30,		December 31,
	2023		2022
Assets
Zig-Zag products	$	176,975	$	225,893
Stoker’s products		175,566		151,241
Corporate unallocated (1)		172,294		155,348
Total Zig-Zag and Stoker’s products	$	524,835	$	532,482
Creative Distribution Solutions		29,108		39,624
Total	$	553,943	$	572,106

(1) Includes assets not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments.

Revenue Disaggregation—Sales Channel

Revenues of the Zig-Zag Products and Stoker’s Products segments are primarily comprised of sales made to wholesalers while Creative Distribution Solutions sales are made business to business and business to consumer, both online and through our corporate retail stores. Creative Distribution Solutions net sales are broken out by sales channel below.

	Creative Distribution Solutions Segment
	Three Months Ended
	September 30,
	2023		2022
Business to Business	$	16,089	$	18,226
Business to Consumer - Online		1,912		3,884
Other		51		106
Total	$	18,052	$	22,216

	Creative Distribution Solutions Segment
	Nine Months Ended
	September 30,
	2023		2022
Business to Business	$	58,620	$	55,024
Business to Consumer - Online		7,247		13,453
Other		409		369
Total	$	66,276	$	68,846

Net Sales—Domestic vs. Foreign

The following table shows a breakdown of consolidated net sales between domestic and foreign customers.

	Three Months Ended
	September 30,
	2023		2022
Domestic	$	93,533	$	98,173
Foreign		8,189		9,629
Total	$	101,722	$	107,802

	Nine Months Ended
	September 30,
	2023		2022
Domestic	$	285,514	$	287,381
Foreign		22,759		24,240
Total	$	308,273	$	311,621

XML

Additional Information with Respect to Unrestricted Subsidiary

9 Months Ended

Sep. 30, 2023

Additional Information with Respect to Unrestricted Subsidiary [Abstract]

Additional Information with Respect to Unrestricted Subsidiary

Note 17. Additional Information with Respect to Unrestricted Subsidiary

Under the terms of the Senior Secured Notes Indenture and Senior Secured Notes, the Company has designated its subsidiaries, South Beach Brands LLC, TPB Beast LLC and Intrepid Brands, LLC as “Unrestricted Subsidiaries”. South Beach Brands LLC is a holding company under which our vape business TPB Beast LLC operating as Creative Distribution Solutions sits. The Company is required under the terms of the Senior Secured Notes Indenture and the Senior Secured Notes to present additional information that reflects the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Company’s Unrestricted Subsidiaries as of and for the periods presented. This additional information is below.

Income Statement for the Three Months Ended September 30, 2023 and 2022 (unaudited):

	Three Months Ended September 30
	2023									2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries			Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	83,670		$	18,052		$	101,722		$	85,586		$	22,216	$	107,802
Cost of sales		36,353			13,747			50,100			39,272			15,818		55,090
Gross profit		47,317			4,305			51,622			46,314			6,398		52,712
Selling, general, and administrative expenses		26,620			4,765			31,385			26,635			6,256		32,891
Operating income		20,697			(460	)		20,237			19,679			142		19,821
Interest expense, net		3,984			–			3,984			4,802			–		4,802
Investment loss		2,101			–			2,101			(75	)		–		(75	)
Gain on extinguishment of debt		(481	)		–			(481	)		–			–		–
Income before income taxes		15,093			(460	)		14,633			14,952			142		15,094
Income tax expense		3,885			(118	)		3,767			3,761			36		3,797
Consolidated net income		11,208			(342	)		10,866			11,191			106		11,297
Net loss attributable to non-controlling interest		35			–			35			(239	)		–		(239	)
Net income attributable to Turning Point Brands, Inc.	$	11,173		$	(342	)	$	10,831		$	11,430		$	106	$	11,536

Income Statement for the Nine Months Ended September 30, 2023 and 2022 (unaudited):

	Nine Months Ended September 30
	2023								2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	241,997		$	66,276	$	308,273		$	242,775		$	68,846	$	311,621
Cost of sales		106,435			49,121		155,556			107,923			47,723		155,646
Gross profit		135,562			17,155		152,717			134,852			21,123		155,975
Selling, general, and administrative expenses		77,199			16,894		94,093			79,028			19,751		98,779
Operating income		58,363			261		58,624			55,824			1,372		57,196
Interest expense, net		12,013			–		12,013			15,142			–		15,142
Investment loss		10,980			–		10,980			6,074			–		6,074
Gain on extinguishment of debt		(1,858	)		–		(1,858	)		–			–		–
Income before income taxes		37,228			261		37,489			34,608			1,372		35,980
Income tax expense		9,506			67		9,573			8,374			332		8,706
Consolidated net income		27,722			194		27,916			26,234			1,040		27,274
Net loss attributable to non-controlling interest		(437	)		–		(437	)		(684	)		–		(684	)
Net income attributable to Turning Point Brands, Inc.	$	28,159		$	194	$	28,353		$	26,918		$	1,040	$	27,958

Balance Sheet as of September 30, 2023 (unaudited):

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	92,353	$	3,718	$	–		$	96,071
Accounts receivable, net		10,363		130		–			10,493
Inventories		109,867		7,059		–			116,926
Other current assets		20,417		2,905		–			23,322
Total current assets		233,000		13,812		–			246,812
Property, plant, and equipment, net		24,382		231		–			24,613
Deferred income taxes		8,190		–		–			8,190
Right of use assets		11,922		138		–			12,060
Deferred financing costs, net		203		–		–			203
Goodwill		136,280		–		–			136,280
Other intangible assets, net		66,798		14,927		–			81,725
Master Settlement Agreement (MSA) escrow deposits		27,534		–		–			27,534
Other assets		16,526		–		–			16,526
Investment in unrestricted subsidiaries		49,047		–		(49,047	)		–
Total assets	$	573,882	$	29,108	$	(49,047	)	$	553,943
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	10,305	$	932	$	–		$	11,237
Accrued liabilities		25,243		1,984		–			27,227
Current portion of long-term debt		48,248		–		–			48,248
Other current liabilities		6		–		–			6
Total current liabilities		83,802		2,916		–			86,718
Notes payable and long-term debt		316,573		–		–			316,573
Lease liabilities		10,363		70		–			10,433
Total liabilities		410,738		2,986		–			413,724
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		161,836		26,122		(49,047	)		138,911
Non-controlling interest		1,308		–		–			1,308
Total stockholders’ equity		163,144		26,122		(49,047	)		140,219
Total liabilities and stockholders’ equity	$	573,882	$	29,108	$	(49,047	)	$	553,943

Balance Sheet as of December 31, 2022:

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	103,990	$	2,413	$	–		$	106,403
Accounts receivable, net		7,374		1,003		–			8,377
Inventories		104,883		15,032		–			119,915
Other current assets		18,828		4,131		–			22,959
Total current assets		235,075		22,579		–			257,654
Property, plant, and equipment, net		22,261		527		–			22,788
Deferred income taxes		8,443		–		–			8,443
Right of use assets		12,328		137		–			12,465
Deferred financing costs, net		282		–		–			282
Goodwill		136,253		–		–			136,253
Other intangible assets, net		67,241		16,351		–			83,592
Master Settlement Agreement (MSA) escrow deposits		27,980		–		–			27,980
Other assets		22,619		30		–			22,649
Investment in unrestricted subsidiaries		60,120		–		(60,120	)		–
Total assets	$	592,602	$	39,624	$	(60,120	)	$	572,106
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,628	$	727	$	–		$	8,355
Accrued liabilities		31,118		1,883		–			33,001
Other current liabilities		20		–		–			20
Total current liabilities		38,766		2,610		–			41,376
Notes payable and long-term debt		406,757		–		–			406,757
Lease liabilities		10,593		–		–			10,593
Total liabilities		456,116		2,610		–			458,726
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		134,751		37,014		(60,120	)		111,645
Non-controlling interest		1,735		–		–			1,735
Total stockholders’ equity		136,486		37,014		(60,120	)		113,380
Total liabilities and stockholders’ equity	$	592,602	$	39,624	$	(60,120	)	$	572,106

XML

Dividends and Share Repurchases

9 Months Ended

Sep. 30, 2023

Dividends and Share Repurchases [Abstract]

Dividends and Share Repurchases

Note 18. Dividends and Share Repurchases

A dividend of $0.065 per common share was paid on October 6, 2023, to shareholders of record at the close of business on September 15, 2023.

The Company currently pays a quarterly cash dividend. Dividends are considered restricted payments under the Senior Secured Notes Indenture and 2021 Revolving Credit Facility. The Company is generally permitted to make restricted payments provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional earnings and market capitalization restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year.

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022, in each case bringing the aggregate approval back to $50.0 million. $27.2 million remains available for share repurchases under the program at September 30, 2023.

XML

Insider Trading Arrangements	9 Months Ended
	Sep. 30, 2023
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Description of Business and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2023

Description of Business and Basis of Presentation [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited, interim, consolidated financial statements have been prepared in accordance with the accounting practices described in the Company’s audited, consolidated financial statements as of and for the year ended December 31, 2022. In the opinion of management, the unaudited, interim, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods presented. Such adjustments, other than nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, 2022. The accompanying interim, consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the United States (“GAAP”) with respect to annual financial statements.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Consolidation

Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries, all of which are wholly-owned, and variable interest entities (“VIEs”) for which the Company is considered the primary beneficiary. All significant intercompany transactions have been eliminated.

Revenue Recognition

Revenue Recognition

The Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606), which includes excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns and incentives, upon delivery of goods to the customer – at which time the Company’s performance obligation is satisfied - at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. The Company excludes from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on smokeless tobacco, cigars or vaping products billed to customers).

The Company records an allowance for sales returns, based principally on historical volume and return rates, which is included in accrued liabilities on the consolidated balance sheets. The Company records sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction in revenues (a portion of which is based on amounts estimated to be due to wholesalers, retailers and consumers at the end of the period) based principally on historical volume and utilization rates. Expected payments for sales incentives are included in accrued liabilities on the consolidated balance sheets.

A further requirement of ASC 606 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company’s management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16, “Segment Information”. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.

Shipping Costs

Shipping Costs

The Company records shipping costs incurred as a component of selling, general, and administrative expenses. Shipping costs incurred were approximately $5.1 million and $5.8 million for the three months ending September 30, 2023 and 2022, respectively. Shipping costs incurred were approximately $17.0 million and $17.9 million for the nine months ending September 30, 2023 and 2022, respectively.

Inventories

Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out (“FIFO”) method. Leaf tobacco is presented in current assets in accordance with standard industry practice, notwithstanding the fact that such tobaccos are carried longer than one year for the purpose of curing.

Fair Value

Fair Value

GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

The three levels of the fair value hierarchy under GAAP are described below:

● Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.

● Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

Derivative Instruments

Derivative Instruments

The Company enters into foreign currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging. Under the Company’s policy, the Company may hedge up to 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed twelve months. The Company may also, from time to time, hedge up to 100% of its non-inventory purchases (e.g. production equipment) in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are reclassified from other comprehensive income into inventory as the related inventories are received and are transferred to net income as inventory is sold. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

Risks and Uncertainties

Risks and Uncertainties

Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others, labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In a number of states, targeted flavor bans have been proposed or enacted legislatively or by the administrative process. Depending on the number and location of such bans, that legislation or regulation could have a material adverse effect on the Company’s financial position, results of operations or cash flows. The U.S. Food and Drug Administration (“FDA”) continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing, and ultimate implementation of such measures remain unclear.

The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of Creative Distribution Solutions products due to malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

Master Settlement Agreement (MSA):  Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General) and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. Such companies are entitled to direct the investment of the escrowed funds and withdraw any appreciation but cannot withdraw the principal for twenty-five years from the year of each annual deposit, except to withdraw funds deposited pursuant to an individual state’s escrow statute to pay a final judgement to that state’s plaintiffs in the event of such a final judgement against the Company. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy to record amounts on deposit in the escrow account for prior years as a non-current asset. As of September 30, 2023, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $27.5 million. At December 31, 2022, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.0 million. The Company discontinued its generic category of MYO in 2019 and its Zig-Zag branded MYO cigarette smoking tobacco in 2017. Thus, pending a change in MSA legislation, the Company has no remaining product lines covered by the MSA and will not be required to make future escrow deposits. We expect to begin withdrawal of the funds deposited beginning in 2024 so long as these deposits do not become subject to litigation under the MSA-related statutes.

The Company has chosen to invest a portion of the MSA escrow, from time to time, in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity.

Fair values for the U.S. Governmental agency obligations are Level 2 in the fair value hierarchy. The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

	As of September 30, 2023							As of December 31, 2022
			Gross			Estimated				Gross			Estimated
			Unrealized			Fair				Unrealized			Fair
	Cost		Losses			Value		Cost		Losses			Value
Cash and cash equivalents	$	1,929	$	–		$	1,929	$	1,929	$	–		$	1,929
U.S. Governmental agency obligations (unrealized position < 12 months)		–		–			–		10,226		(1,251	)		8,975
U.S. Governmental agency obligations (unrealized position > 12 months)		30,144		(4,539	)		25,605		19,918		(2,842	)		17,076
	$	32,073	$	(4,539	)	$	27,534	$	32,073	$	(4,093	)	$	27,980

	As of
	September 30, 2023
Less than one year	$	2,200
One to five years		10,238
Five to ten years		15,751
Greater than ten years		1,955
Total	$	30,144

The following shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of
Sales Year	September 30, 2023		December 31, 2022
1999	$	211	$	211
2000		1,017		1,017
2001		1,673		1,673
2002		2,271		2,271
2003		4,249		4,249
2004		3,714		3,714
2005		4,553		4,553
2006		3,847		3,847
2007		4,167		4,167
2008		3,364		3,364
2009		1,619		1,619
2010		406		406
2011		193		193
2012		199		199
2013		173		173
2014		143		143
2015		101		101
2016		91		91
2017		82		82
Total	$	32,073	$	32,073

FDA: On June 22, 2009, the Family Smoking Prevention and Tobacco Control Act (the “FSPTCA”) authorized the FDA to immediately regulate the manufacturing, sale, and marketing of four categories of tobacco products – cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. On August 8, 2016, the FDA deeming regulation became effective. The deeming regulation gave the FDA the authority to also regulate cigars, pipe tobacco, e-cigarettes, vaporizers, and e-liquids as “deemed” tobacco products under the FSPTCA.

The FDA currently assesses tobacco product user fees on six classes of regulated tobacco products and computes user fees using a methodology similar to the methodology used by the U.S Department of Agriculture to compute the Tobacco Transition Payment Program (“TTPP,” also known as the “Tobacco Buyout”) assessment. First, the total, annual, congressionally established user fee assessment is allocated among the various classes of tobacco products using the federal excise tax weighted market share of tobacco products subject to regulation. Then, the assessment for each class of tobacco products is divided among individual manufacturers and importers.

In August 2016, the FDA’s regulatory authority under the Tobacco Control Act was extended to all tobacco products not previously covered, including: (i) certain Creative Distribution Solutions products (such as electronic cigarettes, vaporizers and e-liquids) and their components or parts (such as tanks, coils and batteries); (ii) cigars and their components or parts (such as cigar tobacco and wraps); (iii) pipe tobacco; (iv) hookah products; and (v) any other tobacco product “newly deemed” by the FDA. These “deeming regulations” apply to all products made or derived from tobacco intended for human consumption, but excluding accessories of tobacco products (such as lighters). Accordingly, the FDA has since regulated our cigar and cigar wrap products as well as our vapor products containing tobacco-derived nicotine and products intended or reasonably expected to be used to consume such e-liquids.

Subsequently, on April 14, 2022, the FDA Center for Tobacco Products also obtained jurisdiction over non-tobacco nicotine products (“NTN Products”), including synthetic nicotine. That law subjects NTN Products to the same requirements as tobacco-derived products, including not selling these products to persons under 21 years of age, not marketing these products as modified risk tobacco products without authorization, and not distributing free samples of these products. Additionally, NTN Products became subject to premarket filing requirements. Under the new law, manufacturers were required to file a Premarket Tobacco Application (“PMTA”) by May 14, 2022, in order to continue selling products currently on the market. NTN Products subject of a timely-filed PMTA, and not in receipt of a negative action, were allowed to remain on the market until July 13, 2022, at which time these products became subject to enforcement, similar to tobacco-derived products remaining under review.

A successful PMTA must demonstrate that the subject product is “appropriate for the protection of public health,” taking into account the effect of the marketing of the product on all sub-populations while a Substantial Equivalence Report must demonstrate that a new product either has the same characteristics as its predicate product or different characteristics but does not raise different questions of public health. We submitted premarket filings for certain of our regulated products in order to continue selling these products while they remain under review. We have continued to supplement these applications with additional information and have responded to information requests from the FDA; however, there can be no guarantee that the FDA will accept such amendments and responses or that the applications will meet the standard of “appropriate for the protection of public health” or “substantially equivalent,” as appropriate. The FDA has indicated its enforcement priority is those applicants who have received negative action on their application, such as a Marketing Denial Order or Refuse to File notification and who continue to illegally sell those unauthorized products, as well as products for which manufacturers failed to submit a marketing application. Despite these stated enforcement priorities, given the FDA’s limited resources we expect that for a period of time there may be a lack of enforcement, which may adversely impact our ability to compete in the marketplace against those who continue to sell unauthorized products. There can be no guarantee that the FDA will not shift its enforcement priorities or that it will increase in ability to enforce against unauthorized products over time.

On October 5, 2021, the FDA finalized two rules related to the Substantial Equivalence process and the Premarket Tobacco Product Application process, respectively, which both became effective November 4, 2021. Both final rules (collectively, the “Rules”) indicate that any new or additional requirements will not retroactively apply to currently pending PMTAs for tobacco and tobacco-derived products; however, the information outlined in the rule remains important to the FDA’s substantive review of an application. The FDA has yet to indicate how it might apply these Rules to NTN Product filings. We believe we have products that meet the Rules and have filed premarket filings supporting a showing of the respective required standards. However, there is no assurance that the FDA’s guidance or regulations will not change, or that the FDA will not prioritize its enforcement in a manner that negatively affects our pending applications, or that unforeseen circumstances will not arise that prevent us from sufficiently supplementing or completing our applications or otherwise increases the amount of time and money we are required to spend to receive all necessary marketing orders. Although we filed many premarket applications in a timely manner, no assurance can be given that the applications will ultimately be successful. This may result in the prioritization of supplementing or completing applications for high priority SKUs in our inventory position, which could adversely impact future revenues generated by lower priority SKUs.

In addition, we currently distribute many third-party manufactured vapor products for which we are completely dependent on the manufacturer complying with the premarket filing requirements. There can be no assurance that these third-party products will receive a marketing order or otherwise remain in compliance with relevant legal requirements. While we will take measures to pursue regulatory compliance for our own privately-branded or proprietary vape products that compete with these third-party products, there is no assurance that such proprietary products would be as successful in the marketplace or can fully displace third-party products that are currently being distributed by us, which could adversely affect our results of operations and liquidity. Additionally, FDA has limited resources, which may impact its ability to meaningfully enforce these provisions. This may adversely affect our ability to compete in the marketplace against those who continue to sell unauthorized products; however, regulatory uncertainty in the FDA’s enforcement policies may likewise affect operations or sales of our proprietary products if the FDA’s policies or priorities shift.

On May 4, 2022, the FDA proposed two tobacco product standards related to combusted tobacco products: (1) a ban on menthol as a characterizing flavor in cigarettes; and (2) a ban on all characterizing flavors (including menthol) in cigars. On June 21, 2022, the FDA also issued a proposed product standard related to restricting the level of nicotine in traditional cigarettes. These product standards are required to go through the formal rulemaking process where we have had the opportunity to provide comments with regard to the impact such standards would have on our products. These proposed rules remain pending. The FDA’s policy on these and other regulated products may change or expand over time in ways not yet known and may significantly impact our products or our premarket filings.

Prevent All Cigarette Trafficking Act (“PACT Act”): On December 27, 2020, President Trump signed the Further Consolidated Appropriations Act, 2021, into law. This law included an amendment to the Jenkins Act expanding the definition of “cigarette” to include “electronic nicotine delivery systems,” or ENDS, and required that the United States Postal Service (“USPS”) promulgate regulations clarifying the applicability of the prohibition on delivery sales of cigarettes to ENDS. USPS issued its final rule on October 21, 2021. We have received appropriate shipping exemptions from carrier services we use to carry the affected freight. Failure to comply with the PACT Act could result in significant financial or criminal penalties. To the extent we are unable to respond to, or comply with, these new requirements, we could lose our shipping exemptions, be subject to civil or criminal penalties, or there could be a material adverse effect on our business, results of operations and financial condition. 

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Fair Value of MSA Escrow Account

The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

	As of September 30, 2023							As of December 31, 2022
			Gross			Estimated				Gross			Estimated
			Unrealized			Fair				Unrealized			Fair
	Cost		Losses			Value		Cost		Losses			Value
Cash and cash equivalents	$	1,929	$	–		$	1,929	$	1,929	$	–		$	1,929
U.S. Governmental agency obligations (unrealized position < 12 months)		–		–			–		10,226		(1,251	)		8,975
U.S. Governmental agency obligations (unrealized position > 12 months)		30,144		(4,539	)		25,605		19,918		(2,842	)		17,076
	$	32,073	$	(4,539	)	$	27,534	$	32,073	$	(4,093	)	$	27,980

Maturities of U.S. Governmental Agency Obligations

	As of
	September 30, 2023
Less than one year	$	2,200
One to five years		10,238
Five to ten years		15,751
Greater than ten years		1,955
Total	$	30,144

Deposits by Sales Year for MSA Escrow Account

The following shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of
Sales Year	September 30, 2023		December 31, 2022
1999	$	211	$	211
2000		1,017		1,017
2001		1,673		1,673
2002		2,271		2,271
2003		4,249		4,249
2004		3,714		3,714
2005		4,553		4,553
2006		3,847		3,847
2007		4,167		4,167
2008		3,364		3,364
2009		1,619		1,619
2010		406		406
2011		193		193
2012		199		199
2013		173		173
2014		143		143
2015		101		101
2016		91		91
2017		82		82
Total	$	32,073	$	32,073

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2023

Inventories [Abstract]

Inventories

The components of inventories are as follows:

	September 30,		December 31,
	2023		2022
Raw materials and work in process	$	5,512	$	7,283
Leaf tobacco		53,018		43,468
Finished goods - Zig-Zag Products		40,988		42,279
Finished goods - Stoker’s Products		8,729		9,667
Finished goods - Creative Distribution Solutions		7,059		15,431
Other		1,620		1,787
Inventories	$	116,926	$	119,915

XML

Other Current Assets (Tables)

9 Months Ended

Sep. 30, 2023

Other Current Assets [Abstract]

Other Current Assets

Other current assets consist of:

	September 30,		December 31,
	2023		2022
Inventory deposits	$	5,357	$	6,395
Insurance deposit		3,000		3,000
Prepaid taxes		1,675		448
Other		13,290		13,116
Total	$	23,322	$	22,959

XML

Property, Plant, and Equipment (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant, and Equipment [Abstract]

Property, Plant, and Equipment

Property, plant, and equipment consists of:

	September 30,			December 31,
	2023			2022
Land	$	22		$	22
Buildings and improvements		3,940			3,096
Leasehold improvements		5,252			5,404
Machinery and equipment		28,837			25,832
Furniture and fixtures		8,138			9,264
Gross property, plant and equipment		46,189			43,618
Accumulated depreciation		(21,576	)		(20,830	)
Net property, plant and equipment	$	24,613		$	22,788

XML

Other Assets (Tables)

9 Months Ended

Sep. 30, 2023

Other Assets [Abstract]

Other Assets

Other assets consist of:

	September 30,		December 31,
	2023		2022
Equity investments	$	2,421	$	13,376
Debt security investment		7,765		7,820
Other		6,340		1,453
Total	$	16,526	$	22,649

XML

Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2023

Accrued Liabilities [Abstract]

Accrued Liabilities

Accrued liabilities consist of:

	September 30,		December 31,
	2023		2022
Accrued payroll and related items	$	6,299	$	7,685
Customer returns and allowances		6,384		7,291
Taxes payable		1,259		1,867
Lease liabilities		2,809		3,102
Accrued interest		2,507		7,277
Other		7,969		5,779
Total	$	27,227	$	33,001

XML

Notes Payable and Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2023

Notes Payable and Long-Term Debt [Abstract]

Notes Payable and Long-Term Debt

Notes payable and long-term debt consists of the following in order of preference:

	September 30,			December 31,
	2023			2022
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		118,541			162,500
Gross notes payable and long-term debt		368,541			412,500
Less deferred finance charges		(3,720	)		(5,743	)
Less current maturities		(48,248	)		–
Notes payable and long-term debt	$	316,573		$	406,757

Redemption Prices of Senior Secured Notes

The Company may redeem the Senior Secured Notes, in whole or in part, at any time on or after February 15, 2023, at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

Interest Rate Margins

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Components of Lease Expense

The components of lease expense consisted of the following:

	Three Months Ended September 30,
	2023		2022
Operating lease cost
Cost of sales	$	125	$	240
Selling, general and administrative		496		348
Variable lease cost (1)		301		235
Short-term lease cost		7		6
Total	$	929	$	829

(1) Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

Amounts Related to Operating and Financing Leases

	Three Months Ended September 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	397	$	332
Total	$	397	$	332

	Nine Months Ended September 30,
	2023		2022
Operating lease cost
Cost of sales	$	382	$	700
Selling, general and administrative		1,520		1,133
Variable lease cost (1)		933		558
Short-term lease cost		20		31
Total	$	2,855	$	2,422

	Nine Months Ended September 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	1,083	$	920
Total	$	1,083	$	920

	September 30,		December 31,
	2023		2022
Assets:
Right of use assets - Operating	$	10,332	$	10,967
Right of use assets - Financing		1,728		1,498
Total lease assets	$	12,060	$	12,465
Liabilities:
Current lease liabilities - Operating (2)	$	1,717	$	2,007
Current lease liabilities - Financing (2)		1,092		1,095
Long-term lease liabilities - Operating		9,854		10,243
Long-term lease liabilities - Financing		579		350
Total lease liabilities	$	13,242	$	13,695

(2) Reported within accrued liabilities on the balance sheets.

XML

Share Incentive Plans (Tables)

9 Months Ended

Sep. 30, 2023

Share Incentive Plans [Abstract]

Stock Option Activity

Stock option activity for the 2006, 2015 and 2021 Plans is summarized below:

				Weighted		Weighted
	Stock			Average		Average
	Option			Exercise		Grant Date
	Shares			Price		Fair Value
Outstanding, December 31, 2021		619,835		$	28.51	$	8.70
Granted		114,827			30.58		10.34
Exercised		(40,331	)		12.49		4.08
Forfeited		(11,117	)		32.60		9.35
Outstanding, December 31, 2022		683,214		$	29.74	$	9.24
Granted		77,519			20.71		6.45
Exercised		(30,214	)		13.87		4.37
Forfeited		(65,214	)		27.38		9.11
Outstanding, September 30, 2023		665,305		$	29.67	$	9.14

Assumptions for Options Granted Under 2015 and 2021 Plan

The following table outlines the assumptions based on the number of options granted under the 2015 Plan.

	February 10,			May 17,			March 7,			March 20,			October 24,			March 18,			February 18,			May 3,
	2017			2017			2018			2019			2019			2020			2021			2021
Number of options granted		40,000			93,819			98,100			155,780			25,000			155,000			100,000			12,000
Options outstanding at September 30, 2023		20,000			39,983			51,567			125,834			25,000			80,975			90,253			12,000
Number exercisable at September 30, 2023		20,000			39,983			51,567			125,834			25,000			80,975			63,727			8,040
Exercise price	$	13.00		$	15.41		$	21.21		$	47.58		$	20.89		$	14.85		$	51.75		$	47.76
Remaining lives		3.37			3.63			4.44			5.47			6.07			6.47			7.39			7.59
Risk free interest rate		1.89	%		1.76	%		2.65	%		2.34	%		1.58	%		0.79	%		0.56	%		0.84	%
Expected volatility		27.44	%		26.92	%		28.76	%		30.95	%		31.93	%		35.72	%		28.69	%		29.03	%
Expected life		6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000
Dividend yield		–			–			0.83	%		0.42	%		0.95	%		1.49	%		0.55	%		0.59	%
Fair value at grant date	$	3.98		$	4.60		$	6.37		$	15.63		$	6.27		$	4.41		$	13.77		$	13.06

The following table outlines the assumptions based on the number of options granted under the 2021 Plan.

	May 17,			March 14,			April 29,			May 12,
	2021			2022			2022			2023
Number of options granted		7,500			100,000			14,827			77,519
Options outstanding at September 30, 2023		7,500			73,023			14,827			77,519
Number exercisable at September 30, 2023		5,100			24,995			5,042			58,139
Exercise price	$	45.05		$	30.46		$	31.39		$	20.71
Remaining lives		7.63			8.46			8.59			9.62
Risk free interest rate		0.84	%		2.10	%		2.92	%		3.41	%
Expected volatility		31.50	%		35.33	%		35.33	%		34.51	%
Expected life		6.000			6.000			6.000			5.186
Dividend yield		0.63	%		1.01	%		0.98	%		1.61	%
Fair value at grant date	$	13.23		$	10.23		$	11.07		$	6.45

PRSU Activity

PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period provided the applicable service and performance conditions are satisfied. As of September 30, 2023, there are 456,922 PRSUs outstanding. The following table outlines the PRSUs granted and outstanding as of September 30, 2023.

	March 20,		March 18,		December 28,		February 18,		March 14,		May 4,
	2019		2020		2020		2021		2022		2023
Number of PRSUs granted		92,500		94,000		88,169		100,000		49,996		133,577
PRSUs outstanding at September 30, 2023		77,080		84,360		31,040		87,340		43,525		133,577
Fair value as of grant date	$	47.58	$	14.85	$	46.42	$	51.75	$	30.46	$	22.25
Remaining lives		0.25		1.25		0.25		2.25		3.25		2.50

RSU Activity

The Company has granted 228,640 RSUs which are outstanding and vest over one to five years. The following table outlines the RSUs granted and outstanding as of September 30, 2023.

	March 14,		March 14,		April 29,		May 5,		May 5,		May 8,
	2022		2022		2022		2023		2023		2023
Number of RSUs granted		50,004		28,726		4,522		130,873		22,472		20,101
RSUs outstanding at September 30, 2023		42,947		18,961		4,522		130,873		11,236		20,101
Fair value as of grant date	$	30.46	$	30.46	$	31.39	$	22.25	$	22.25	$	21.77
Remaining lives		3.25		1.25		3.25		2.50		0.25		0.60

XML

Income Per Share (Tables)

9 Months Ended

Sep. 30, 2023

Income Per Share [Abstract]

Basic and Diluted Net Income per Share

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:

	Three Months Ended September 30,
	2023						2022
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	10,831					$	11,536
Denominator
Weighted average				17,595,980	$	0.62				17,749,294	$	0.65
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	10,831					$	11,536
Interest expense related to Convertible Senior Notes, net of tax		743						1,054
Diluted net income attributable to Turning Point Brands. Inc.	$	11,574					$	12,590
Denominator
Basic weighted average				17,595,980						17,749,294
Convertible Senior Notes				2,311,086						3,213,589
Stock options and restricted stock units				191,384						139,123
				20,098,450	$	0.58				21,102,006	$	0.60

	Nine Months Ended September 30,
	2023						2022
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	28,353					$	27,958
Denominator
Weighted average				17,569,493	$	1.61				18,021,554	$	1.55
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	28,353					$	27,958
Interest expense related to Convertible Senior Notes		2,546						3,162
Diluted net income attributable to Turning Point Brands. Inc.	$	30,899					$	31,120
Denominator
Basic weighted average				17,569,493						18,021,554
Convertible Senior Notes				2,637,252						3,213,589
Stock options and restricted stock units				209,041						166,342
				20,415,786	$	1.51				21,401,485	$	1.45

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2023

Segment Information [Abstract]

Financial Information of Reportable Segments

The tables below present financial information about reported segments:

	Three Months Ended September 30,
	2023			2022
Net sales
Zig-Zag products	$	46,754		$	52,061
Stoker’s products		36,916			33,525
Total Zig-Zag and Stoker’s products	$	83,670		$	85,586
Creative Distribution Solutions		18,052			22,216
Total	$	101,722		$	107,802
Gross profit
Zig-Zag products	$	26,745		$	28,035
Stoker’s products		20,572			18,279
Total Zig-Zag and Stoker’s products	$	47,317		$	46,314
Creative Distribution Solutions		4,305			6,398
Total	$	51,622		$	52,712
Operating income (loss)
Zig-Zag products	$	16,672		$	18,740
Stoker’s products		15,703			13,653
Corporate unallocated (1)(2)		(11,678	)		(12,714	)
Total Zig-Zag and Stoker’s products	$	20,697		$	19,679
Creative Distribution Solutions		(460	)		142
Total	$	20,237		$	19,821
Interest expense, net		3,984			4,802
Investment loss		2,101			(75	)
Gain on extinguishment of debt		(481	)		–
Income before income taxes	$	14,633		$	15,094
Capital expenditures
Zig-Zag products	$	3		$	29
Stoker’s products		1,211			940
Total Zig-Zag and Stoker’s products	$	1,214		$	969
Creative Distribution Solutions		–			–
Total	$	1,214		$	969
Depreciation and amortization
Zig-Zag products	$	269		$	124
Stoker’s products		795			738
Total Zig-Zag and Stoker’s products	$	1,064		$	862
Creative Distribution Solutions		562			453
Total	$	1,626		$	1,315

(1) Includes corporate costs that are not allocated to any of the three reportable segments.

(2) Includes costs related to PMTA of $0.3 million in 2023 and $1.2 million in 2022.

	Nine Months Ended September 30,
	2023			2022
Net sales
Zig-Zag products	$	135,363		$	143,959
Stoker’s products		106,634			98,816
Total Zig-Zag and Stoker’s products	$	241,997		$	242,775
Creative Distribution Solutions		66,276			68,846
Total	$	308,273		$	311,621
Gross profit
Zig-Zag products	$	75,557		$	80,808
Stoker’s products		60,005			54,044
Total Zig-Zag and Stoker’s products	$	135,562		$	134,852
Creative Distribution Solutions		17,155			21,123
Total	$	152,717		$	155,975
Operating income (loss)
Zig-Zag products	$	47,313		$	55,980
Stoker’s products		45,375			40,536
Corporate unallocated (1)(2)		(34,325	)		(40,692	)
Total Zig-Zag and Stoker’s products	$	58,363		$	55,824
Creative Distribution Solutions		261			1,372
Total	$	58,624		$	57,196
Interest expense, net		12,013			15,142
Investment loss		10,980			6,074
Gain on extinguishment of debt		(1,858	)		–
Income before income taxes	$	37,489		$	35,980
Capital expenditures
Zig-Zag products	$	1,088		$	4,588
Stoker’s products		3,118			2,074
Total Zig-Zag and Stoker’s products	$	4,206		$	6,662
Creative Distribution Solutions		–			–
Total	$	4,206		$	6,662
Depreciation and amortization
Zig-Zag products	$	803		$	309
Stoker’s products		2,210			2,275
Total Zig-Zag and Stoker’s products	$	3,013		$	2,584
Creative Distribution Solutions		1,690			1,400
Total	$	4,703		$	3,984

(1) Includes corporate costs that are not allocated to any of the three reportable segments.

(2) Includes costs related to PMTA of $1.1 million in 2023 and $4.3 million in 2022.

	September 30,		December 31,
	2023		2022
Assets
Zig-Zag products	$	176,975	$	225,893
Stoker’s products		175,566		151,241
Corporate unallocated (1)		172,294		155,348
Total Zig-Zag and Stoker’s products	$	524,835	$	532,482
Creative Distribution Solutions		29,108		39,624
Total	$	553,943	$	572,106

(1) Includes assets not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments.

Revenue Disaggregation - Sales Channel

Revenues of the Zig-Zag Products and Stoker’s Products segments are primarily comprised of sales made to wholesalers while Creative Distribution Solutions sales are made business to business and business to consumer, both online and through our corporate retail stores. Creative Distribution Solutions net sales are broken out by sales channel below.

	Creative Distribution Solutions Segment
	Three Months Ended
	September 30,
	2023		2022
Business to Business	$	16,089	$	18,226
Business to Consumer - Online		1,912		3,884
Other		51		106
Total	$	18,052	$	22,216

	Creative Distribution Solutions Segment
	Nine Months Ended
	September 30,
	2023		2022
Business to Business	$	58,620	$	55,024
Business to Consumer - Online		7,247		13,453
Other		409		369
Total	$	66,276	$	68,846

Net Sales - Domestic and Foreign

The following table shows a breakdown of consolidated net sales between domestic and foreign customers.

	Three Months Ended
	September 30,
	2023		2022
Domestic	$	93,533	$	98,173
Foreign		8,189		9,629
Total	$	101,722	$	107,802

	Nine Months Ended
	September 30,
	2023		2022
Domestic	$	285,514	$	287,381
Foreign		22,759		24,240
Total	$	308,273	$	311,621

XML

Additional Information with Respect to Unrestricted Subsidiary (Tables)

9 Months Ended

Sep. 30, 2023

Additional Information with Respect to Unrestricted Subsidiary [Abstract]

Income Statements

Income Statement for the Three Months Ended September 30, 2023 and 2022 (unaudited):

	Three Months Ended September 30
	2023									2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries			Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	83,670		$	18,052		$	101,722		$	85,586		$	22,216	$	107,802
Cost of sales		36,353			13,747			50,100			39,272			15,818		55,090
Gross profit		47,317			4,305			51,622			46,314			6,398		52,712
Selling, general, and administrative expenses		26,620			4,765			31,385			26,635			6,256		32,891
Operating income		20,697			(460	)		20,237			19,679			142		19,821
Interest expense, net		3,984			–			3,984			4,802			–		4,802
Investment loss		2,101			–			2,101			(75	)		–		(75	)
Gain on extinguishment of debt		(481	)		–			(481	)		–			–		–
Income before income taxes		15,093			(460	)		14,633			14,952			142		15,094
Income tax expense		3,885			(118	)		3,767			3,761			36		3,797
Consolidated net income		11,208			(342	)		10,866			11,191			106		11,297
Net loss attributable to non-controlling interest		35			–			35			(239	)		–		(239	)
Net income attributable to Turning Point Brands, Inc.	$	11,173		$	(342	)	$	10,831		$	11,430		$	106	$	11,536

Income Statement for the Nine Months Ended September 30, 2023 and 2022 (unaudited):

	Nine Months Ended September 30
	2023								2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	241,997		$	66,276	$	308,273		$	242,775		$	68,846	$	311,621
Cost of sales		106,435			49,121		155,556			107,923			47,723		155,646
Gross profit		135,562			17,155		152,717			134,852			21,123		155,975
Selling, general, and administrative expenses		77,199			16,894		94,093			79,028			19,751		98,779
Operating income		58,363			261		58,624			55,824			1,372		57,196
Interest expense, net		12,013			–		12,013			15,142			–		15,142
Investment loss		10,980			–		10,980			6,074			–		6,074
Gain on extinguishment of debt		(1,858	)		–		(1,858	)		–			–		–
Income before income taxes		37,228			261		37,489			34,608			1,372		35,980
Income tax expense		9,506			67		9,573			8,374			332		8,706
Consolidated net income		27,722			194		27,916			26,234			1,040		27,274
Net loss attributable to non-controlling interest		(437	)		–		(437	)		(684	)		–		(684	)
Net income attributable to Turning Point Brands, Inc.	$	28,159		$	194	$	28,353		$	26,918		$	1,040	$	27,958

Balance Sheets

Balance Sheet as of September 30, 2023 (unaudited):

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	92,353	$	3,718	$	–		$	96,071
Accounts receivable, net		10,363		130		–			10,493
Inventories		109,867		7,059		–			116,926
Other current assets		20,417		2,905		–			23,322
Total current assets		233,000		13,812		–			246,812
Property, plant, and equipment, net		24,382		231		–			24,613
Deferred income taxes		8,190		–		–			8,190
Right of use assets		11,922		138		–			12,060
Deferred financing costs, net		203		–		–			203
Goodwill		136,280		–		–			136,280
Other intangible assets, net		66,798		14,927		–			81,725
Master Settlement Agreement (MSA) escrow deposits		27,534		–		–			27,534
Other assets		16,526		–		–			16,526
Investment in unrestricted subsidiaries		49,047		–		(49,047	)		–
Total assets	$	573,882	$	29,108	$	(49,047	)	$	553,943
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	10,305	$	932	$	–		$	11,237
Accrued liabilities		25,243		1,984		–			27,227
Current portion of long-term debt		48,248		–		–			48,248
Other current liabilities		6		–		–			6
Total current liabilities		83,802		2,916		–			86,718
Notes payable and long-term debt		316,573		–		–			316,573
Lease liabilities		10,363		70		–			10,433
Total liabilities		410,738		2,986		–			413,724
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		161,836		26,122		(49,047	)		138,911
Non-controlling interest		1,308		–		–			1,308
Total stockholders’ equity		163,144		26,122		(49,047	)		140,219
Total liabilities and stockholders’ equity	$	573,882	$	29,108	$	(49,047	)	$	553,943

Balance Sheet as of December 31, 2022:

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	103,990	$	2,413	$	–		$	106,403
Accounts receivable, net		7,374		1,003		–			8,377
Inventories		104,883		15,032		–			119,915
Other current assets		18,828		4,131		–			22,959
Total current assets		235,075		22,579		–			257,654
Property, plant, and equipment, net		22,261		527		–			22,788
Deferred income taxes		8,443		–		–			8,443
Right of use assets		12,328		137		–			12,465
Deferred financing costs, net		282		–		–			282
Goodwill		136,253		–		–			136,253
Other intangible assets, net		67,241		16,351		–			83,592
Master Settlement Agreement (MSA) escrow deposits		27,980		–		–			27,980
Other assets		22,619		30		–			22,649
Investment in unrestricted subsidiaries		60,120		–		(60,120	)		–
Total assets	$	592,602	$	39,624	$	(60,120	)	$	572,106
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,628	$	727	$	–		$	8,355
Accrued liabilities		31,118		1,883		–			33,001
Other current liabilities		20		–		–			20
Total current liabilities		38,766		2,610		–			41,376
Notes payable and long-term debt		406,757		–		–			406,757
Lease liabilities		10,593		–		–			10,593
Total liabilities		456,116		2,610		–			458,726
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		134,751		37,014		(60,120	)		111,645
Non-controlling interest		1,735		–		–			1,735
Total stockholders’ equity		136,486		37,014		(60,120	)		113,380
Total liabilities and stockholders’ equity	$	592,602	$	39,624	$	(60,120	)	$	572,106

XML

Description of Business and Basis of Presentation (Details) Outlet in Thousands	9 Months Ended
	Sep. 30, 2023 Segment Outlet
Description of Business and Basis of Presentation [Abstract]
Number of reportable segments | Segment	3
Number of retail outlets in North America | Outlet	217

XML

Summary of Significant Accounting Policies, Shipping Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Shipping Costs [Abstract]
Shipping costs	$ 5.1	$ 5.8	$ 17.0	$ 17.9

XML

Summary of Significant Accounting Policies, Derivative Instruments (Details) - Maximum [Member]	9 Months Ended
	Sep. 30, 2023
Derivative Instruments [Abstract]
Percentage of anticipated purchases of inventory that may be hedged	100.00%
Term of hedge	12 months
Percentage of non-inventory purchases that may be hedged	100.00%

XML

Summary of Significant Accounting Policies, Master Settlement Agreement (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Master Settlement Agreement [Abstract]
Term for restricted withdrawal of principal from MSA escrow account	25 years
Fair Value of MSA Escrow Account, More than 12 Months [Abstract]
Estimated fair value, more than 12 months	$ 7,765	$ 7,820
Fair Value of MSA Escrow Account [Abstract]
Cost	32,073	32,073
Gross unrealized losses	(4,539)	(4,093)
Estimated fair value	27,534	27,980
Maturities of U.S. Governmental Agency Obligations [Abstract]
Less than one year	2,200
One to five years	10,238
Five to ten years	15,751
Greater than ten years	1,955
Total	30,144
Master Settlement Agreement Escrow Account by Sales Year [Abstract]
1999	211	211
2000	1,017	1,017
2001	1,673	1,673
2002	2,271	2,271
2003	4,249	4,249
2004	3,714	3,714
2005	4,553	4,553
2006	3,847	3,847
2007	4,167	4,167
2008	3,364	3,364
2009	1,619	1,619
2010	406	406
2011	193	193
2012	199	199
2013	173	173
2014	143	143
2015	101	101
2016	91	91
2017	82	82
Total	32,073	32,073
Cash and Cash Equivalents [Member]
Fair Value of MSA Escrow Account [Abstract]
Cost	1,929	1,929
Gross unrealized losses	0	0
Estimated fair value	1,929	1,929
U.S. Governmental Agency Obligations [Member]
Fair Value of MSA Escrow Account, Less than 12 Months [Abstract]
Cost, less than 12 months	0	10,226
Gross unrealized losses, less than 12 months	0	(1,251)
Estimated fair value, less than 12 months	0	8,975
Fair Value of MSA Escrow Account, More than 12 Months [Abstract]
Cost, more than 12 months	30,144	19,918
Gross unrealized losses, more than 12 months	(4,539)	(2,842)
Estimated fair value, more than 12 months	$ 25,605	$ 17,076

XML

Summary of Significant Accounting Policies, Food and Drug Administration (Details)	9 Months Ended
	Sep. 30, 2023 Standard Class Category	Oct. 05, 2021 Rule
Food and Drug Administration [Abstract]
Number of categories of tobacco products regulated by the FDA | Category	4
Number of classes of regulated tobacco products on which user fees are assessed | Class	6
Number of rules finalized by the FDA | Rule		2
Number of proposed tobacco product standards related to combusted tobacco products | Standard	2

XML

Derivative Instruments (Details) - Foreign Currency [Member] € in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 EUR (€)	Dec. 31, 2022 USD ($)
Other Current Assets [Member]
Derivative Instruments [Abstract]
Fair value, asset | $		$ 0.1		$ 1.2
Accrued Liabilities [Member]
Derivative Instruments [Abstract]
Fair value, liability | $		$ 0.5		$ 0.0
Purchase [Member]
Derivative Instruments [Abstract]
Notional amount of contracts executed	€ 20.1
Notional amount	17.1		€ 18.5
Sale [Member]
Derivative Instruments [Abstract]
Notional amount of contracts executed	15.2
Notional amount	€ 15.2		€ 18.5

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value of Financial Instruments [Abstract]
Carrying value of long-term debt	$ 368,541	$ 412,500
Senior Secured Notes [Member]
Fair Value of Financial Instruments [Abstract]
Interest rate	5.625%
Fair value of long-term debt	$ 226,700	226,400
Carrying value of long-term debt	$ 250,000	250,000
Convertible Senior Notes [Member]
Fair Value of Financial Instruments [Abstract]
Interest rate	2.50%
Carrying value of long-term debt	$ 118,541	162,500
Fair Value [Member] | Convertible Senior Notes [Member]
Fair Value of Financial Instruments [Abstract]
Fair value of long-term debt	$ 112,400	$ 139,200

XML

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Inventories [Abstract]
Raw materials and work in process	$ 5,512	$ 7,283
Leaf tobacco	53,018	43,468
Other	1,620	1,787
Inventories	116,926	119,915
Inventory valuation allowance	4,100	4,500
Zig-Zag Products [Member]
Inventories [Abstract]
Finished goods	40,988	42,279
Stoker's Products [Member]
Inventories [Abstract]
Finished goods	8,729	9,667
Creative Distribution Solutions [Member]
Inventories [Abstract]
Finished goods	$ 7,059	$ 15,431

XML

Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Other Current Assets [Abstract]
Inventory deposits	$ 5,357	$ 6,395
Insurance deposit	3,000	3,000
Prepaid taxes	1,675	448
Other	13,290	13,116
Total	$ 23,322	$ 22,959

XML

Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant, and Equipment [Abstract]
Property, plant and equipment	$ 46,189	$ 43,618
Accumulated depreciation	(21,576)	(20,830)
Net property, plant and equipment	24,613	22,788
Land [Member]
Property, Plant, and Equipment [Abstract]
Property, plant and equipment	22	22
Buildings and Improvements [Member]
Property, Plant, and Equipment [Abstract]
Property, plant and equipment	3,940	3,096
Leasehold Improvements [Member]
Property, Plant, and Equipment [Abstract]
Property, plant and equipment	5,252	5,404
Machinery and Equipment [Member]
Property, Plant, and Equipment [Abstract]
Property, plant and equipment	28,837	25,832
Furniture and Fixtures [Member]
Property, Plant, and Equipment [Abstract]
Property, plant and equipment	$ 8,138	$ 9,264

XML

Other Assets (Details) - USD ($) $ in Thousands		1 Months Ended			3 Months Ended			9 Months Ended		12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2020	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Other Assets [Abstract]
Equity investments					$ 2,421			$ 2,421		$ 13,376
Debt security investment					7,765			7,765		7,820
Other					6,340			6,340		1,453
Total					16,526			16,526		22,649
Payment for investment								200	$ 1,000
Wild Hempettes [Member]
Other Assets [Abstract]
Payment for investment				$ 2,500
Ownership interest				20.00%
Percentage interest that can be acquired				100.00%
Impairment charge					2,200			2,200
Fair value of investment					$ 300			$ 300
dosist [Member]
Other Assets [Abstract]
Payment for investment				$ 15,000
Gain (loss) on investment									$ (6,300)
Additional investment that can be made				$ 15,000
Period to make additional investment								12 months
Fair value of investment										1,600	$ 1,600	$ 7,900
Old Pal Holding Company LLC [Member]
Other Assets [Abstract]
Debt security investment	$ 9,200
Payment for investment	1,000	$ 8,000
Interest rate					3.00%			3.00%
Extension period for maturity date								1 year
Weighted average interest rate					3.00%			3.00%
Allowance for credit losses								$ 300		1,400
Accrued interest receivable	$ 200
Old Pal Holding Company LLC [Member] | Other Current Assets [Member]
Other Assets [Abstract]
Accrued interest receivable					$ 100			100		100
Old Pal Holding Company LLC [Member] | Level 3 [Member]
Other Assets [Abstract]
Debt security investment					$ 7,700			$ 7,700		$ 7,900
Docklight Brands, Inc. [Member]
Other Assets [Abstract]
Equity investments						$ 0	$ 3,800
Payment for investment			$ 8,700
Gain (loss) on investment						$ (3,800)	$ (4,900)

XML

Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Accrued Liabilities [Abstract]
Accrued payroll and related items	$ 6,299	$ 7,685
Customer returns and allowances	6,384	7,291
Taxes payable	1,259	1,867
Lease liabilities	2,809	3,102
Accrued interest	2,507	7,277
Other	7,969	5,779
Total	$ 27,227	$ 33,001

XML

Notes Payable and Long-Term Debt, Summary of Notes Payable and Long-Term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Notes Payable and Long-Term Debt [Abstract]
Gross notes payable and long-term debt	$ 368,541	$ 412,500
Less deferred finance charges	(3,720)	(5,743)
Less current maturities	(48,248)	0
Net notes payable and long-term debt	316,573	406,757
Senior Secured Notes [Member]
Notes Payable and Long-Term Debt [Abstract]
Gross notes payable and long-term debt	250,000	250,000
Convertible Senior Notes [Member]
Notes Payable and Long-Term Debt [Abstract]
Gross notes payable and long-term debt	$ 118,541	$ 162,500

XML

Notes Payable and Long-Term Debt, Senior Secured Notes (Details) - Senior Secured Notes [Member] - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Feb. 11, 2021
Notes Payable and Long-Term Debt [Abstract]
Face amount		$ 250.0
Interest rate	5.625%
Maturity date	Feb. 15, 2026
Guarantee threshold amount for obligations	$ 15.0
Redemption price (expressed as a percentage of the principal amount to be redeemed) if the Company experiences a change in control	101.00%
Debt issuance costs		$ 6.4
On or after February 15, 2023 [Member]
Notes Payable and Long-Term Debt [Abstract]
Redemption price (expressed as a percentage of the principal amount to be redeemed)	102.813%
On or after February 15, 2024 [Member]
Notes Payable and Long-Term Debt [Abstract]
Redemption price (expressed as a percentage of the principal amount to be redeemed)	101.406%
On or after February 15, 2025 and thereafter [Member]
Notes Payable and Long-Term Debt [Abstract]
Redemption price (expressed as a percentage of the principal amount to be redeemed)	100.00%

XML

Notes Payable and Long-Term Debt, 2021 Revolving Credit Facility (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)	Mar. 31, 2023	Dec. 31, 2022	Feb. 11, 2021 USD ($)
Amended Revolving Credit Facility [Member]
Notes Payable and Long-Term Debt [Abstract]
Maximum borrowing capacity				$ 25.0
Amount drawn under credit facility	$ 0.0
Letters of credit outstanding	$ 1.4
Maturity date	Aug. 11, 2025
Period prior to maturity date of Convertible Senior Notes	91 days
Consolidated Leverage Ratio		5.25	5.5
Exclusion threshold for letters of credit	$ 5.0
Threshold percentage of total commitments outstanding	35.00%
Debt issuance costs	$ 0.5
Amended Revolving Credit Facility [Member] | Eurodollar [Member]
Notes Payable and Long-Term Debt [Abstract]
Margin on variable rate	3.50%
Amended Revolving Credit Facility [Member] | SOFR [Member]
Notes Payable and Long-Term Debt [Abstract]
Margin on variable rate	3.50%
Letters of Credit [Member]
Notes Payable and Long-Term Debt [Abstract]
Maximum borrowing capacity				$ 10.0

XML

Notes Payable and Long-Term Debt, 2023 ABL Facility (Details) - Subsequent Event [Member] $ in Millions	Nov. 07, 2023 USD ($) qtr
2023 ABL Facility [Member]
Notes Payable and Long-Term Debt [Abstract]
Maximum borrowing capacity	$ 75.0
Accordion feature	$ 40.0
Percentage used in calculation of borrowing base	85.00%
Percentage used in calculation of LILO borrowing base	10.00%
Fixed charge coverage ratio	1
Number of consecutive quarters to maintain minimum fixed charge coverage ratio | qtr	4
Percentage of line cap	12.50%
Threshold excess availability	$ 9.4
Period to maintain excess availability	30 days
Period prior to maturity date of any material debt outstanding	91 days
Excess availability threshhold	$ 15.0
2023 ABL Facility [Member] | Minimum [Member]
Notes Payable and Long-Term Debt [Abstract]
Historical excess availability threshold	33.33%
2023 ABL Facility [Member] | Maximum [Member]
Notes Payable and Long-Term Debt [Abstract]
Historical excess availability threshold	66.66%
SOFR Loans [Member]
Notes Payable and Long-Term Debt [Abstract]
Interest rate margin	2.25%
Applicable margin on variable rate, Level I	1.75%
Applicable margin on variable rate, Level II	2.00%
Applicable margin on variable rate, Level III	2.25%
Base Rate Loans [Member]
Notes Payable and Long-Term Debt [Abstract]
Interest rate margin	1.25%
Applicable margin on variable rate, Level I	0.75%
Applicable margin on variable rate, Level II	1.00%
Applicable margin on variable rate, Level III	1.25%
LILO Loans that are Base Rate Loans [Member]
Notes Payable and Long-Term Debt [Abstract]
Interest rate margin	2.25%
LILO Loans that are SOFR Loans [Member]
Notes Payable and Long-Term Debt [Abstract]
Interest rate margin	3.25%

XML

Notes Payable and Long-Term Debt, Convertible Senior Notes (Details)	1 Months Ended	3 Months Ended					9 Months Ended
	Jul. 31, 2019 USD ($)	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) shares $ / shares	Sep. 30, 2022 USD ($)	Nov. 07, 2023 USD ($)
Notes Payable and Long-Term Debt [Abstract]
Gain on extinguishment of debt		$ 481,000				$ 0	$ 1,858,000	$ 0
Outstanding principal amount		368,541,000			$ 412,500,000		368,541,000
Current portion of long-term debt		48,248,000			0		48,248,000
Notes payable and long-term debt		$ 316,573,000			406,757,000		$ 316,573,000
Strike price (in dollars per share) | $ / shares		53.49					53.49
Cap price (in dollars per share) | $ / shares		82.86					82.86
Payment for cost of capped call transactions	$ 20,530,000
Convertible Senior Notes [Member]
Notes Payable and Long-Term Debt [Abstract]
Face amount	172,500,000
Interest rate		2.50%					2.50%
Maturity date							Jul. 15, 2024
Principal amount of convertible debt repurchased		$ 15,000,000	$ 15,100,000	$ 13,900,000	10,000,000		$ 15,000,000
Gain on extinguishment of debt		600,000	$ 600,000	$ 700,000	900,000
Outstanding principal amount		$ 118,541,000			$ 162,500,000		$ 118,541,000
Shares issued upon conversion (in shares) | shares							2,216,029
Conversion rate							18.6942
Principal amount of notes to be converted							$ 1,000
Conversion price (in dollars per share) | $ / shares		$ 53.49					$ 53.49
Pre-determined threshold value for adjusting conversion price as a result of dividends paid (in dollars per share) | $ / shares							$ 0.04
Notes payable, current		$ 118,500,000					$ 118,500,000
Debt issuance costs	$ 5,900,000
Convertible Senior Notes [Member] | Reclassification [Member]
Notes Payable and Long-Term Debt [Abstract]
Current portion of long-term debt		(70,000,000)					(70,000,000)
Notes payable and long-term debt		$ 70,000,000					$ 70,000,000
Convertible Senior Notes [Member] | Subsequent Event [Member]
Notes Payable and Long-Term Debt [Abstract]
Notes to be refinanced									$ 75,000,000

XML

Leases (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Operating Lease Cost [Abstract]
Variable lease cost	[1]	$ 301	$ 235	$ 933	$ 558
Short-term lease cost		7	6	20	31
Total operating lease cost		929	829	2,855	2,422
Financing Lease Cost [Abstract]
Financing lease cost		397	332	1,083	920
Assets [Abstract]
Right of use assets - Operating		$ 10,332		$ 10,332		$ 10,967
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]		Total lease assets		Total lease assets		Total lease assets
Right of use assets - Financing		$ 1,728		$ 1,728		$ 1,498
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]		Total lease assets		Total lease assets		Total lease assets
Total lease assets		$ 12,060		$ 12,060		$ 12,465
Liabilities [Abstract]
Current lease liabilities - Operating	[2]	$ 1,717		$ 1,717		$ 2,007
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]		Accrued Liabilities, Current		Accrued Liabilities, Current		Accrued Liabilities, Current
Current lease liabilities - Financing	[2]	$ 1,092		$ 1,092		$ 1,095
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Accrued Liabilities, Current		Accrued Liabilities, Current		Accrued Liabilities, Current
Long-term lease liabilities - Operating		$ 9,854		$ 9,854		$ 10,243
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Operating and Finance Lease, Liability, Noncurrent		Operating and Finance Lease, Liability, Noncurrent		Operating and Finance Lease, Liability, Noncurrent
Long-term lease liabilities - Financing		$ 579		$ 579		$ 350
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Operating and Finance Lease, Liability, Noncurrent		Operating and Finance Lease, Liability, Noncurrent		Operating and Finance Lease, Liability, Noncurrent
Total lease liabilities		$ 13,242		$ 13,242		$ 13,695
Cost of Sales [Member]
Operating Lease Cost [Abstract]
Operating lease cost		125	240	382	700
Selling, General and Administrative [Member]
Operating Lease Cost [Abstract]
Operating lease cost		496	348	1,520	1,133
Financing Lease Cost [Abstract]
Financing lease cost		$ 397	$ 332	$ 1,083	$ 920

[1] Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

[2] Reported within accrued liabilities on the balance sheets.

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Taxes [Abstract]
Effective income tax rate	25.70%	25.20%	25.50%	24.20%
Income tax deduction related to exercise of stock options		$ 0.0		$ 0.7

XML

Share Incentive Plans, Equity Incentive Plans (Details) - shares	Sep. 30, 2023	Mar. 22, 2021	Apr. 28, 2016
RSUs [Member]
Share Incentive Plans [Abstract]
Number of awards granted, net of forfeitures (in shares)	228,640
2021 Plan [Member]
Share Incentive Plans [Abstract]
Number of shares authorized for issuance (in shares)		1,290,000
Number of shares available for grant (in shares)	965,877
2021 Plan [Member] | RSUs [Member]
Share Incentive Plans [Abstract]
Number of awards granted, net of forfeitures (in shares)	276,484
2021 Plan [Member] | Stock Options [Member]
Share Incentive Plans [Abstract]
Number of awards granted, net of forfeitures (in shares)	118,519
2021 Plan [Member] | Performance-Based Restricted Stock Units [Member]
Share Incentive Plans [Abstract]
Number of awards granted, net of forfeitures (in shares)	29,172
2015 Plan [Member]
Share Incentive Plans [Abstract]
Number of shares authorized for issuance (in shares)		100,052	1,400,000
Number of shares available for grant (in shares)	0
2006 Plan [Member]
Share Incentive Plans [Abstract]
Number of shares available for grant (in shares)	0

XML

Share Incentive Plans, Stock Option Activity (Details) - 2006, 2015 and 2021 Plans [Member] - Stock Options [Member] - USD ($) $ / shares in Units, $ in Millions	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Stock Option Shares [Roll Forward]
Outstanding, beginning balance (in shares)	683,214	619,835	619,835
Granted (in shares)	77,519		114,827
Exercised (in shares)	(30,214)		(40,331)
Forfeited (in shares)	(65,214)		(11,117)
Outstanding, ending balance (in shares)	665,305		683,214
Weighted Average Exercise Price [Abstract]
Outstanding, beginning balance (in dollars per share)	$ 29.74	$ 28.51	$ 28.51
Granted (in dollars per share)	20.71		30.58
Exercised (in dollars per share)	13.87		12.49
Forfeited (in dollars per share)	27.38		32.6
Outstanding, ending balance (in dollars per share)	29.67		29.74
Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning balance (in dollars per share)	9.24	$ 8.7	8.7
Granted (in dollars per share)	6.45		10.34
Exercised (in dollars per share)	4.37		4.08
Forfeited (in dollars per share)	9.11		9.35
Outstanding, ending balance (in dollars per share)	$ 9.14		$ 9.24
Intrinsic value of options exercised	$ 0.2	$ 0.7

XML

Share Incentive Plans, Assumptions for Options Granted Under 2006 Plan (Details) - 2006 Plan [Member] - Stock Options [Member] - Exercise Price $3.83 [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share Incentive Plans [Abstract]
Number of options (in shares) | shares	46,824
Exercise price (in dollars per share)	$ 3.83
Number of options exercisable (in shares) | shares	46,824
Remaining lives	10 months 6 days
Expected life	10 years
Exercise price (in dollars per share)	$ 3.83
Risk free interest rate	3.57%
Expected volatility	40.00%
Dividend yield	0.00%
Fair value at grant date (in dollars per share)	$ 2.17

XML

Share Incentive Plans, Assumptions for Options Granted Under 2015 Plan (Details) - 2015 Plan [Member] - Stock Options [Member] - $ / shares									9 Months Ended
	May 03, 2021	Feb. 18, 2021	Mar. 18, 2020	Oct. 24, 2019	Mar. 20, 2019	Mar. 07, 2018	May 17, 2017	Feb. 10, 2017	Sep. 30, 2023
February 10, 2017 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)								40,000
Options outstanding (in shares)									20,000
Number exercisable (in shares)									20,000
Exercise price (in dollars per share)									$ 13
Remaining lives									3 years 4 months 13 days
Risk free interest rate									1.89%
Expected volatility									27.44%
Expected life									6 years
Dividend yield									0.00%
Fair value at grant date (in dollars per share)									$ 3.98
May 17, 2017 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)							93,819
Options outstanding (in shares)									39,983
Number exercisable (in shares)									39,983
Exercise price (in dollars per share)									$ 15.41
Remaining lives									3 years 7 months 17 days
Risk free interest rate									1.76%
Expected volatility									26.92%
Expected life									6 years
Dividend yield									0.00%
Fair value at grant date (in dollars per share)									$ 4.6
March 7, 2018 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)						98,100
Options outstanding (in shares)									51,567
Number exercisable (in shares)									51,567
Exercise price (in dollars per share)									$ 21.21
Remaining lives									4 years 5 months 8 days
Risk free interest rate									2.65%
Expected volatility									28.76%
Expected life									6 years
Dividend yield									0.83%
Fair value at grant date (in dollars per share)									$ 6.37
March 20, 2019 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)					155,780
Options outstanding (in shares)									125,834
Number exercisable (in shares)									125,834
Exercise price (in dollars per share)									$ 47.58
Remaining lives									5 years 5 months 19 days
Risk free interest rate									2.34%
Expected volatility									30.95%
Expected life									6 years
Dividend yield									0.42%
Fair value at grant date (in dollars per share)									$ 15.63
October 24, 2019 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)				25,000
Options outstanding (in shares)									25,000
Number exercisable (in shares)									25,000
Exercise price (in dollars per share)									$ 20.89
Remaining lives									6 years 25 days
Risk free interest rate									1.58%
Expected volatility									31.93%
Expected life									6 years
Dividend yield									0.95%
Fair value at grant date (in dollars per share)									$ 6.27
March 18, 2020 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)			155,000
Options outstanding (in shares)									80,975
Number exercisable (in shares)									80,975
Exercise price (in dollars per share)									$ 14.85
Remaining lives									6 years 5 months 19 days
Risk free interest rate									0.79%
Expected volatility									35.72%
Expected life									6 years
Dividend yield									1.49%
Fair value at grant date (in dollars per share)									$ 4.41
February 18, 2021 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)		100,000
Options outstanding (in shares)									90,253
Number exercisable (in shares)									63,727
Exercise price (in dollars per share)									$ 51.75
Remaining lives									7 years 4 months 20 days
Risk free interest rate									0.56%
Expected volatility									28.69%
Expected life									6 years
Dividend yield									0.55%
Fair value at grant date (in dollars per share)									$ 13.77
May 3, 2021 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)	12,000
Options outstanding (in shares)									12,000
Number exercisable (in shares)									8,040
Exercise price (in dollars per share)									$ 47.76
Remaining lives									7 years 7 months 2 days
Risk free interest rate									0.84%
Expected volatility									29.03%
Expected life									6 years
Dividend yield									0.59%
Fair value at grant date (in dollars per share)									$ 13.06

XML

Share Incentive Plans, Assumptions for Options Granted Under 2021 Plan (Details) - 2021 Plan [Member] - Stock Options [Member] - $ / shares					9 Months Ended
	May 12, 2023	Apr. 29, 2022	Mar. 14, 2022	May 17, 2021	Sep. 30, 2023
May 17, 2021 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)				7,500
Options outstanding (in shares)					7,500
Number exercisable (in shares)					5,100
Exercise price (in dollars per share)					$ 45.05
Remaining lives					7 years 7 months 17 days
Risk free interest rate					0.84%
Expected volatility					31.50%
Expected life					6 years
Dividend yield					0.63%
Fair value at grant date (in dollars per share)					$ 13.23
March 14, 2022 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)			100,000
Options outstanding (in shares)					73,023
Number exercisable (in shares)					24,995
Exercise price (in dollars per share)					$ 30.46
Remaining lives					8 years 5 months 15 days
Risk free interest rate					2.10%
Expected volatility					35.33%
Expected life					6 years
Dividend yield					1.01%
Fair value at grant date (in dollars per share)					$ 10.23
April 29, 2022 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)		14,827
Options outstanding (in shares)					14,827
Number exercisable (in shares)					5,042
Exercise price (in dollars per share)					$ 31.39
Remaining lives					8 years 7 months 2 days
Risk free interest rate					2.92%
Expected volatility					35.33%
Expected life					6 years
Dividend yield					0.98%
Fair value at grant date (in dollars per share)					$ 11.07
May 12, 2023 [Member]
Share Incentive Plans [Abstract]
Number of options granted (in shares)	77,519
Options outstanding (in shares)					77,519
Number exercisable (in shares)					58,139
Exercise price (in dollars per share)					$ 20.71
Remaining lives					9 years 7 months 13 days
Risk free interest rate					3.41%
Expected volatility					34.51%
Expected life					5 years 2 months 7 days
Dividend yield					1.61%
Fair value at grant date (in dollars per share)					$ 6.45

XML

Share Incentive Plans, Compensation Expense Related to Options (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Compensation Expense [Abstract]
Compensation expense (income) related to options	$ 0.2	$ 0.3	$ 0.6	$ 0.8
Unrecognized compensation expense related to options	$ 0.3		$ 0.3
Period over which unrecognized compensation expense will be expensed			11 months 8 days

XML

Share Incentive Plans, Performance-Based Restricted Stock Units (Details) - Performance-Based Restricted Stock Units [Member] - USD ($) $ / shares in Units, $ in Millions							3 Months Ended		9 Months Ended
	May 04, 2023	Mar. 14, 2022	Feb. 18, 2021	Dec. 28, 2020	Mar. 18, 2020	Mar. 20, 2019	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share Incentive Plans [Abstract]
Period between performance period and measurement date									65 days
PRSUs outstanding (in shares)							456,922		456,922
Compensation expense							$ 0.8	$ 0.8	$ 1.9	$ 2.4
Unrecognized compensation expense							$ 4.4		$ 4.4
Employees [Member]
Share Incentive Plans [Abstract]
Performance period									5 years
March 20, 2019 [Member] | Employees [Member]
Share Incentive Plans [Abstract]
Number of PRSUs granted (in shares)						92,500
PRSUs outstanding (in shares)							77,080		77,080
Fair value as of grant date (in dollars per share)						$ 47.58
Remaining lives									3 months
March 18, 2020 [Member] | Employees [Member]
Share Incentive Plans [Abstract]
Number of PRSUs granted (in shares)					94,000
PRSUs outstanding (in shares)							84,360		84,360
Fair value as of grant date (in dollars per share)					$ 14.85
Remaining lives									1 year 3 months
December 28, 2020 [Member] | Employees [Member]
Share Incentive Plans [Abstract]
Number of PRSUs granted (in shares)				88,169
PRSUs outstanding (in shares)							31,040		31,040
Fair value as of grant date (in dollars per share)				$ 46.42
Remaining lives									3 months
February 18, 2021 [Member] | Employees [Member]
Share Incentive Plans [Abstract]
Number of PRSUs granted (in shares)			100,000
PRSUs outstanding (in shares)							87,340		87,340
Fair value as of grant date (in dollars per share)			$ 51.75
Remaining lives									2 years 3 months
March 14, 2022 [Member] | Employees [Member]
Share Incentive Plans [Abstract]
Number of PRSUs granted (in shares)		49,996
PRSUs outstanding (in shares)							43,525		43,525
Fair value as of grant date (in dollars per share)		$ 30.46
Remaining lives									3 years 3 months
May 4, 2023 [Member] | Employees [Member]
Share Incentive Plans [Abstract]
Number of PRSUs granted (in shares)	133,577
PRSUs outstanding (in shares)							133,577		133,577
Fair value as of grant date (in dollars per share)	$ 22.25
Remaining lives									2 years 6 months

XML

Share Incentive Plans, Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Millions					3 Months Ended		9 Months Ended
	May 08, 2023	May 05, 2023	Apr. 29, 2022	Mar. 14, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Period over which unrecognized compensation expense will be expensed							11 months 8 days
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of awards granted (in shares)					228,640		228,640
Compensation expense					$ 0.8	$ 0.4	$ 2.2	$ 0.9
Unrecognized compensation expense					$ 3.3		$ 3.3
Period over which unrecognized compensation expense will be expensed							2 years 5 months 8 days
RSUs [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Vesting period							1 year
RSUs [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Vesting period							5 years
RSUs [Member] | March 14, 2022 [Member] | Vest in Five Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of RSUs granted (in shares)				50,004
RSUs outstanding (in shares)					42,947		42,947
Fair value as of grant date (in dollars per share)				$ 30.46
Remaining lives							3 years 3 months
RSUs [Member] | March 14, 2022 [Member] | Vest in Three Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of RSUs granted (in shares)				28,726
RSUs outstanding (in shares)					18,961		18,961
Fair value as of grant date (in dollars per share)				$ 30.46
Remaining lives							1 year 3 months
RSUs [Member] | April 29, 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of RSUs granted (in shares)			4,522
RSUs outstanding (in shares)					4,522		4,522
Fair value as of grant date (in dollars per share)			$ 31.39
Remaining lives							3 years 3 months
RSUs [Member] | May 5, 2023 [Member] | Vest in Five Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of RSUs granted (in shares)		130,873
RSUs outstanding (in shares)					130,873		130,873
Fair value as of grant date (in dollars per share)		$ 22.25
Remaining lives							2 years 6 months
RSUs [Member] | May 5, 2023 [Member] | Vest in Three Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of RSUs granted (in shares)		22,472
RSUs outstanding (in shares)					11,236		11,236
Fair value as of grant date (in dollars per share)		$ 22.25
Remaining lives							3 months
RSUs [Member] | May 8, 2023 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of RSUs granted (in shares)	20,101
RSUs outstanding (in shares)					20,101		20,101
Fair value as of grant date (in dollars per share)	$ 21.77
Remaining lives							7 months 6 days

XML

Contingencies (Details)			9 Months Ended
	Jun. 27, 2023 USD ($)	Oct. 09, 2020 Count	Sep. 30, 2023 Subsidiary
Contingencies [Abstract]
Number of franchisor subsidiaries | Subsidiary			2
Complaint Related to Merger of Standard Diversified, Inc. [Member]
Contingencies [Abstract]
Number of derivative counts filed in complaint | Count		2
Settlement payment into escrow account	$ 5,000,000
Complaint Related to Merger of Standard Diversified, Inc. [Member] | Maximum [Member]
Contingencies [Abstract]
Attorneys' fees and expenses sought by Plaintiff	1,000,000
Mootness fee sought by Plaintiff	$ 400,000

XML

Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator [Abstract]
Net income attributable to Turning Point Brands, Inc.	$ 10,831	$ 11,536	$ 28,353	$ 27,958
Denominator [Abstract]
Basic weighted average shares (in shares)	17,595,980	17,749,294	17,569,493	18,021,554
Basic EPS (in dollars per share)	$ 0.62	$ 0.65	$ 1.61	$ 1.55
Numerator [Abstract]
Net income attributable to Turning Point Brands, Inc.	$ 10,831	$ 11,536	$ 28,353	$ 27,958
Interest expense related to Convertible Senior Notes, net of tax	743	1,054	2,546	3,162
Diluted net income attributable to Turning Point Brands. Inc.	$ 11,574	$ 12,590	$ 30,899	$ 31,120
Denominator [Abstract]
Basic weighted average shares (in shares)	17,595,980	17,749,294	17,569,493	18,021,554
Convertible Senior Notes (in shares)	2,311,086	3,213,589	2,637,252	3,213,589
Stock options and restricted stock units (in shares)	191,384	139,123	209,041	166,342
Diluted weighted average shares (in shares)	20,098,450	21,102,006	20,415,786	21,401,485
Diluted EPS (in dollars per share)	$ 0.58	$ 0.6	$ 1.51	$ 1.45

XML

Segment Information, Financial Information of Reportable Segments (Details) $ in Thousands		3 Months Ended				9 Months Ended
		Sep. 30, 2023 USD ($)		Sep. 30, 2022 USD ($)		Sep. 30, 2023 USD ($) Segment		Sep. 30, 2022 USD ($)		Dec. 31, 2022 USD ($)
Segment Information [Abstract]
Number of reportable segments | Segment						3
Segment Information [Abstract]
Net sales		$ 101,722		$ 107,802		$ 308,273		$ 311,621
Gross profit		51,622		52,712		152,717		155,975
Operating income (loss)		20,237		19,821		58,624		57,196
Interest expense, net		3,984		4,802		12,013		15,142
Investment loss		2,101		(75)		10,980		6,074
Gain on extinguishment of debt		(481)		0		(1,858)		0
Income before income taxes		14,633		15,094		37,489		35,980
Capital expenditures		1,214		969		4,206		6,662
Depreciation and amortization		1,626		1,315		4,703		3,984
Assets		553,943				553,943				$ 572,106
Zig- Zag and Stoker's Products [Member]
Segment Information [Abstract]
Net sales		83,670		85,586		241,997		242,775
Gross profit		47,317		46,314		135,562		134,852
Operating income (loss)		20,697		19,679		58,363		55,824
Capital expenditures		1,214		969		4,206		6,662
Depreciation and amortization		1,064		862		3,013		2,584
Assets		524,835				524,835				532,482
Creative Distribution Solutions [Member]
Segment Information [Abstract]
Net sales		18,052		22,216		66,276		68,846
Reportable Segments [Member] | Zig-Zag Products [Member]
Segment Information [Abstract]
Net sales		46,754		52,061		135,363		143,959
Gross profit		26,745		28,035		75,557		80,808
Operating income (loss)		16,672		18,740		47,313		55,980
Capital expenditures		3		29		1,088		4,588
Depreciation and amortization		269		124		803		309
Assets		176,975				176,975				225,893
Reportable Segments [Member] | Stoker's Products [Member]
Segment Information [Abstract]
Net sales		36,916		33,525		106,634		98,816
Gross profit		20,572		18,279		60,005		54,044
Operating income (loss)		15,703		13,653		45,375		40,536
Capital expenditures		1,211		940		3,118		2,074
Depreciation and amortization		795		738		2,210		2,275
Assets		175,566				175,566				151,241
Reportable Segments [Member] | Creative Distribution Solutions [Member]
Segment Information [Abstract]
Net sales		18,052		22,216		66,276		68,846
Gross profit		4,305		6,398		17,155		21,123
Operating income (loss)		(460)		142		261		1,372
Capital expenditures		0		0		0		0
Depreciation and amortization		562		453		1,690		1,400
Assets		29,108				29,108				39,624
Corporate Unallocated [Member]
Segment Information [Abstract]
Operating income (loss)	[2]	(11,678)	[1]	(12,714)	[1]	(34,325)	[3]	(40,692)	[3]
Operating costs related to PMTA		300		$ 1,200		1,100		$ 4,300
Assets	[4]	$ 172,294				$ 172,294				$ 155,348

[1] Includes costs related to PMTA of $0.3 million in 2023 and $1.2 million in 2022.

[2] Includes corporate costs that are not allocated to any of the three reportable segments.

[3] Includes costs related to PMTA of $1.1 million in 2023 and $4.3 million in 2022.

[4] Includes assets not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments.

XML

Segment Information, Revenue Disaggregation - Sales Channel (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Net Sales by Sales Channel [Abstract]
Net sales	$ 101,722	$ 107,802	$ 308,273	$ 311,621
Creative Distribution Solutions [Member]
Net Sales by Sales Channel [Abstract]
Net sales	18,052	22,216	66,276	68,846
Creative Distribution Solutions [Member] | Business to Business [Member]
Net Sales by Sales Channel [Abstract]
Net sales	16,089	18,226	58,620	55,024
Creative Distribution Solutions [Member] | Business to Consumer - Online [Member]
Net Sales by Sales Channel [Abstract]
Net sales	1,912	3,884	7,247	13,453
Creative Distribution Solutions [Member] | Other [Member]
Net Sales by Sales Channel [Abstract]
Net sales	$ 51	$ 106	$ 409	$ 369

XML

Segment Information, Net Sales - Domestic and Foreign (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Information [Abstract]
Net sales	$ 101,722	$ 107,802	$ 308,273	$ 311,621
Reportable Geographical Component [Member] | Domestic [Member]
Segment Information [Abstract]
Net sales	93,533	98,173	285,514	287,381
Reportable Geographical Component [Member] | Foreign [Member]
Segment Information [Abstract]
Net sales	$ 8,189	$ 9,629	$ 22,759	$ 24,240

XML

Additional Information with Respect to Unrestricted Subsidiary, Income Statements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales	$ 101,722	$ 107,802	$ 308,273	$ 311,621
Cost of sales	50,100	55,090	155,556	155,646
Gross profit	51,622	52,712	152,717	155,975
Selling, general, and administrative expenses	31,385	32,891	94,093	98,779
Operating income	20,237	19,821	58,624	57,196
Interest expense, net	3,984	4,802	12,013	15,142
Investment loss	2,101	(75)	10,980	6,074
Gain on extinguishment of debt	(481)	0	(1,858)	0
Income before income taxes	14,633	15,094	37,489	35,980
Income tax expense	3,767	3,797	9,573	8,706
Consolidated net income	10,866	11,297	27,916	27,274
Net loss attributable to non-controlling interest	35	(239)	(437)	(684)
Net income attributable to Turning Point Brands, Inc.	10,831	11,536	28,353	27,958
Company and Restricted Subsidiaries [Member]
Income Statement [Abstract]
Net sales	83,670	85,586	241,997	242,775
Cost of sales	36,353	39,272	106,435	107,923
Gross profit	47,317	46,314	135,562	134,852
Selling, general, and administrative expenses	26,620	26,635	77,199	79,028
Operating income	20,697	19,679	58,363	55,824
Interest expense, net	3,984	4,802	12,013	15,142
Investment loss	2,101	(75)	10,980	6,074
Gain on extinguishment of debt	(481)	0	(1,858)	0
Income before income taxes	15,093	14,952	37,228	34,608
Income tax expense	3,885	3,761	9,506	8,374
Consolidated net income	11,208	11,191	27,722	26,234
Net loss attributable to non-controlling interest	35	(239)	(437)	(684)
Net income attributable to Turning Point Brands, Inc.	11,173	11,430	28,159	26,918
Unrestricted Subsidiary [Member]
Income Statement [Abstract]
Net sales	18,052	22,216	66,276	68,846
Cost of sales	13,747	15,818	49,121	47,723
Gross profit	4,305	6,398	17,155	21,123
Selling, general, and administrative expenses	4,765	6,256	16,894	19,751
Operating income	(460)	142	261	1,372
Interest expense, net	0	0	0	0
Investment loss	0	0	0	0
Gain on extinguishment of debt	0	0	0	0
Income before income taxes	(460)	142	261	1,372
Income tax expense	(118)	36	67	332
Consolidated net income	(342)	106	194	1,040
Net loss attributable to non-controlling interest	0	0	0	0
Net income attributable to Turning Point Brands, Inc.	$ (342)	$ 106	$ 194	$ 1,040

XML

Additional Information with Respect to Unrestricted Subsidiary, Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 96,071		$ 106,403	$ 105,672		$ 128,320
Accounts receivable, net	10,493		8,377
Inventories, net	116,926		119,915
Other current assets	23,322		22,959
Total current assets	246,812		257,654
Property, plant, and equipment, net	24,613		22,788
Deferred income taxes	8,190		8,443
Right of use assets	12,060		12,465
Deferred financing costs, net	203		282
Goodwill	136,280		136,253
Other intangible assets, net	81,725		83,592
Master Settlement Agreement (MSA) escrow deposits	27,534		27,980
Other assets	16,526		22,649
Investment in unrestricted subsidiaries	0		0
Total assets	553,943		572,106
Current liabilities:
Accounts payable	11,237		8,355
Accrued liabilities	27,227		33,001
Current portion of long-term debt	48,248		0
Other current liabilities	6		20
Total current liabilities	86,718		41,376
Notes payable and long-term debt	316,573		406,757
Lease liabilities	10,433		10,593
Total liabilities	413,724		458,726
Commitments and contingencies
Stockholders' equity:
Total Turning Point Brands Inc. Stockholders' Equity/Net parent investment in unrestricted subsidiaries	138,911		111,645
Non-controlling interest	1,308		1,735
Total stockholders' equity	140,219	$ 129,246	113,380	$ 130,580	$ 127,931	$ 133,716
Total liabilities and stockholders' equity	553,943		572,106
Eliminations [Member]
Current assets:
Cash	0		0
Accounts receivable, net	0		0
Inventories, net	0		0
Other current assets	0		0
Total current assets	0		0
Property, plant, and equipment, net	0		0
Deferred income taxes	0		0
Right of use assets	0		0
Deferred financing costs, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Master Settlement Agreement (MSA) escrow deposits	0		0
Other assets	0		0
Investment in unrestricted subsidiaries	(49,047)		(60,120)
Total assets	(49,047)		(60,120)
Current liabilities:
Accounts payable	0		0
Accrued liabilities	0		0
Current portion of long-term debt	0
Other current liabilities	0		0
Total current liabilities	0		0
Notes payable and long-term debt	0		0
Lease liabilities	0		0
Total liabilities	0		0
Commitments and contingencies
Stockholders' equity:
Total Turning Point Brands Inc. Stockholders' Equity/Net parent investment in unrestricted subsidiaries	(49,047)		(60,120)
Non-controlling interest	0		0
Total stockholders' equity	(49,047)		(60,120)
Total liabilities and stockholders' equity	(49,047)		(60,120)
Company and Restricted Subsidiaries [Member]
Current assets:
Cash	92,353		103,990
Accounts receivable, net	10,363		7,374
Inventories, net	109,867		104,883
Other current assets	20,417		18,828
Total current assets	233,000		235,075
Property, plant, and equipment, net	24,382		22,261
Deferred income taxes	8,190		8,443
Right of use assets	11,922		12,328
Deferred financing costs, net	203		282
Goodwill	136,280		136,253
Other intangible assets, net	66,798		67,241
Master Settlement Agreement (MSA) escrow deposits	27,534		27,980
Other assets	16,526		22,619
Investment in unrestricted subsidiaries	49,047		60,120
Total assets	573,882		592,602
Current liabilities:
Accounts payable	10,305		7,628
Accrued liabilities	25,243		31,118
Current portion of long-term debt	48,248
Other current liabilities	6		20
Total current liabilities	83,802		38,766
Notes payable and long-term debt	316,573		406,757
Lease liabilities	10,363		10,593
Total liabilities	410,738		456,116
Commitments and contingencies
Stockholders' equity:
Total Turning Point Brands Inc. Stockholders' Equity/Net parent investment in unrestricted subsidiaries	161,836		134,751
Non-controlling interest	1,308		1,735
Total stockholders' equity	163,144		136,486
Total liabilities and stockholders' equity	573,882		592,602
Unrestricted Subsidiary [Member]
Current assets:
Cash	3,718		2,413
Accounts receivable, net	130		1,003
Inventories, net	7,059		15,032
Other current assets	2,905		4,131
Total current assets	13,812		22,579
Property, plant, and equipment, net	231		527
Deferred income taxes	0		0
Right of use assets	138		137
Deferred financing costs, net	0		0
Goodwill	0		0
Other intangible assets, net	14,927		16,351
Master Settlement Agreement (MSA) escrow deposits	0		0
Other assets	0		30
Investment in unrestricted subsidiaries	0		0
Total assets	29,108		39,624
Current liabilities:
Accounts payable	932		727
Accrued liabilities	1,984		1,883
Current portion of long-term debt	0
Other current liabilities	0		0
Total current liabilities	2,916		2,610
Notes payable and long-term debt	0		0
Lease liabilities	70		0
Total liabilities	2,986		2,610
Commitments and contingencies
Stockholders' equity:
Total Turning Point Brands Inc. Stockholders' Equity/Net parent investment in unrestricted subsidiaries	26,122		37,014
Non-controlling interest	0		0
Total stockholders' equity	26,122		37,014
Total liabilities and stockholders' equity	$ 29,108		$ 39,624

XML

Dividends and Share Repurchases (Details) - USD ($) $ / shares in Units, $ in Millions				9 Months Ended
	Oct. 06, 2023	Feb. 24, 2022	Oct. 25, 2021	Sep. 30, 2023	Feb. 25, 2020
Share Repurchases [Abstract]
Share repurchase program authorized amount		$ 50.0	$ 50.0		$ 50.0
Increase in share repurchase program authorized amount		$ 24.6	$ 30.7
Remaining share repurchase program authorized amount				$ 27.2
Dividend Declared Q3-2023 [Member]
Dividends [Abstract]
Dividend payable, date to be paid				Oct. 06, 2023
Dividend payable, date of record				Sep. 15, 2023
Dividend Declared Q3-2023 [Member] | Subsequent Event [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)	$ 0.065